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ABSTRACT 
 
THE IN SILICO PREDICTION OF FOOT-AND-MOUTH DISEASE VIRUS 
(FMDV) EPITOPES ON THE SOUTH AFRICAN TERRITORIES (SAT)1, 
SAT2 AND SAT3 SEROTYPES 
 
 
Department of Life Sciences 
College of Agriculture and Environmental Sciences 
University of South Africa 
 
 
Michelle Mukonyora 
 
 
Foot-and-mouth disease (FMD) is a highly contagious and economically 
important disease that affects even-toed hoofed mammals. The FMD virus 
(FMDV) is the causative agent of FMD, of which there are seven clinically 
indistinguishable serotypes. Three serotypes, namely, South African 
Territories (SAT)1, SAT2 and SAT3 are endemic to southern Africa and are 
the most antigenically diverse among the FMDV serotypes. A negative 
consequence of this antigenic variation is that infection or vaccination with 
one virus may not provide immune protection from other strains or it may only 
confer partial protection. The identification of B-cell epitopes is therefore key 
to rationally designing cross-reactive vaccines that recognize the 
immunologically distinct serotypes present within the population. 
Computational epitope prediction methods that exploit the inherent 
physicochemical properties of epitopes in their algorithms have been 
proposed as a cost and time-effective alternative to the classical experimental 
methods. The aim of this project is to employ in silico epitope prediction 
programmes to predict B-cell epitopes on the capsids of the SAT serotypes. 
Sequence data for 18 immunologically distinct SAT1, SAT2 and SAT3 strains 
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from across southern Africa were collated. Since, only one SAT1 virus has 
had its structure elucidated by X-ray crystallography (PDB ID: 2WZR), 
homology models of the 18 virus capsids were built computationally using 
Modeller v9.12. They were then subjected to energy minimizations using the 
AMBER force field. The quality of the models was evaluated and validated 
stereochemically and energetically using the PROMOTIF and ANOLEA 
servers respectively. The homology models were subsequently used as input 
to two different epitope prediction servers, namely Discotope1.0 and Ellipro. 
Only those epitopes predicted by both programmes were defined as epitopes. 
Both previously characterised and novel epitopes were predicted on the SAT 
strains. Some of the novel epitopes are located on the same loops as 
experimentally derived epitopes, while others are located on a putative novel 
antigenic site, which is located close to the five-fold axis of symmetry. A 
consensus set of 11 epitopes that are common on at least 15 out of 18 SAT 
strains was collated. In future work, the epitopes predicted in this study will be 
experimentally validated using mutagenesis studies. Those found to be true 
epitopes may be used in the rational design of broadly reactive SAT vaccines. 
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INTRODUCTION 
 
1.1 FOOT-AND-MOUTH DISEASE VIRUS AND EPITOPE PREDICTION 
REVIEW 
 
1.1.1 Foot-and-Mouth Disease and Its Impact on Health and Agriculture 
 
Foot-and-mouth disease (FMD) is an economically important disease that 
affects animals of the order Artiodactyla (even-toed hoofed mammals). Both 
livestock and wild animals, such as cattle and buffalo respectively, reside 
within this order (Aggarwal & Barnett, 2002; Jamal & Belsham, 2013). FMD is 
endemic to southern Africa, South America and Asia and it is absent in North 
America, parts of western Europe and Australia (Borley et al., 2013; 
Thomson, 1995). It is one of the most contagious animal diseases and causes 
high morbidity in adult animals, mainly fever and vesicles on the feet, mouth 
and mammary glands. These symptoms of FMD consequently affect herd 
productivity (Ferris & Donaldson, 1992; Longjam et al., 2011).  
 
Despite a low mortality rate in adult animals, the economic effects of FMD 
outbreaks are particularly catastrophic (Aggarwal & Barnett, 2002; Longjam et 
al., 2011). In FMD-free countries all infected and close-contact animals have 
to be slaughtered and destroyed (Ferris & Donaldson, 1992; Jamal & 
Belsham, 2013) and in countries where the disease is endemic, their trade 
with FMD-free countries is restricted (Borley et al., 2013; Thomson, 1995). For 
example, southern Africa has been incapable of penetrating the largest beef 
market, which is the United States of America (Thomson, 1995) and beef 
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exports to the European Union are strictly regulated (Ferris & Donaldson, 
1992; Paton & Taylor, 2011). The effective control of FMD in southern Africa 
is therefore of paramount importance to the economic development of the 
region. As an FMD endemic region, the disease is controlled through animal 
movement control and vaccination, the latter of which has proven successful 
in the elimination of FMD in parts of Europe (Ferris & Donaldson, 1992; Paton 
& Taylor, 2011).  
 
1.1.2 Foot-And-Mouth Disease Virus 
 
The FMD virus (FMDV) is the causative agent of FMD and it is a member of 
the family Picornaviridae and genus Aphthovirus. Although FMD is a clinically 
indistinguishable disease, seven serotypes of the FMDV are recognized, 
namely, A, C, O, Asia-1, South African Territories (SAT)1, SAT2 and SAT3 
(Ferris & Donaldson, 1992; Maree et al., 2011; OIE, 2012). FMDV serotypes 
are distinguished serologically and therefore show no-cross protection (Brehm 
et al., 2008; Jamal & Belsham, 2013). 
 
Six of the serotypes, with the exception of type Asia-1 have been implicated in 
cases of FMD in Sub-Saharan Africa since the early 20th century (OIE, 2012; 
Thomson, 1995; Vosloo, Knowles, & Thomson, 1992). From data collected in 
cattle between 2000 and 2010, it was revealed that, SAT2 is the predominant 
cause of FMD outbreaks accounting for 41% of the outbreaks. Type O is the 
second leading cause of outbreaks of FMD at 23% followed by SAT1 at 19% 
and type A at 15%. FMDV types C and SAT3 are the least prevalent as only 
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four outbreaks between them were reported (OIE, 2012). An outbreak of type 
C was last reported in 2004 (Sangula et al., 2011). Types SAT1, SAT2 and 
SAT3 are unique to Sub-Saharan Africa though SAT1 and SAT2 have 
infiltrated the Middle East on a few occasions (Bastos et al., 2001; Ferris & 
Donaldson, 1992; Grubman & Baxt, 2004; Valdazo-González et al., 2012).  
 
1.1.3 The Structure of FMDV  
 
The FMDV particle consists of a non-enveloped, non-glycosylated capsid with 
icosahedral symmetry, enclosing a single-stranded positive sense RNA 
genome (Acharya et al., 1989; Cooper et al., 1978).  
 
1.1.3.1 FMDV Genome Structure 
 
The FMDV has a linear non-segmented 8,500 nucleotide (nt) long genome 
(Acharya et al., 1990), which is larger than most Picornaviruses (Sobrino et 
al., 2001). The genome has a 5’ untranslated region (UTR) that is 
approximately 1,300nt long (Forss et al., 1984). The 5’ UTR is divided into 
three distinct regions. The first region is the S fragment, which is 400nt in 
length and folds into a large clover-leaf structure (Carrillo, 2012; Newton et al., 
1985). The second region of the 5’ UTR is the polcytidyl (polyC) tract, which is 
between 100 and 200nt long (Acharya et al., 1990; Carrillo, 2012). The third 
region of the 5’ UTR is thought to form pseudo-knots, and it is approximately 
720nt long (Clarke et al., 1987; Longjam et al., 2011). A viral encoded protein 
referred to as either the viral protein genome (VPg) or 3B is attached to the 5’ 
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UTR. 3B exists in three different forms, 3B1, 3B2 and 3B3 (Grubman & Baxt, 
2004; Sangar et al., 1977). At the 3’ end of the genome is an 89nt long UTR 
whose function is unknown. There is also a polyadenyl (polyA) tail, 50-100nt 
long that is thought to be associated with the virulence of the virus, but this 
has not been conclusively proven (Bachrach et al., 1975; Grubman & Baxt, 
2004; Harris & Brown, 1977; Longjam et al., 2011). 
 
The FMDV RNA genome has a single open reading frame that is 6,996nt long 
in serotype O. This open reading frame encodes a polyprotein that is 2,332 
amino acid residues long (Forss et al., 1984) (Figure 1). The polyprotein is 
divided into four elements, L, P1-2A, P2 and P3 (Carrillo, 2012; Ryan et al., 
1989). The elements L, P2 and P3 are precursors to eight different mature 
non-structural proteins (Sobrino et al., 2001). L is a short N-terminal protease 
(Lpro) that exists in two forms Lab and Lb (Grubman & Baxt, 2004; Strebel & 
Beck, 1986), which are the result of the ribosomal use of two alternative 
initiation sites (Sangar et al., 1987). The active form of either Lab or Lb is 
dependent on the host cells and initiation site used (Belsham, 2013).  
 
During processing of the polypeptide (Figure 1), L cleaves itself off first thus 
initiating the maturation of the structural proteins encoded by the adjacent P1-
2A region (Belsham, 2013; Palmenberg, 1990; Strebel & Beck, 1986). The 2A 
proteins are proteinases (2Apro) (Ryan et al., 1991) and P1 is a precursor 
protein that encodes the structural proteins of the virus; 1A, 1B, 1C, 1D 
(Belsham, 1993). The second cleavage event is catalysed by 2Apro and takes 
place at a site between 2A and 2B, giving rise to the P1-2A polypeptide 
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(Belsham, 1993; Jamal & Belsham, 2013; Ryan et al., 1991). The 2B protein 
is involved inducing autophagy by disrupting the integrity of the host 
membrane (Ao et al., 2015). The third cleavage event is when 2Apro auto 
catalyses its cleavage from P1 (Ryan et al., 1991). The 3C serine proteinase 
(3Cpro) catalyses the fourth cleavage event that takes place between the 
elements 2C and 3A. Following their release, the 3Cpro are responsible for all 
the downstream protein processing reactions. The 3Cpro cleave the P1 
element thereby releasing the proteins 1AB, 1C and 1D (Bablanian & 
Grubman, 1993; Jamal & Belsham, 2013; Ryan et al., 1989). Proteins 1A/1B 
are believed to self-cleave at the later stage of viral genome encapsidation 
(Belsham, 1993; Harber et al., 1991).  
 
The 3A and 3AB proteins are hypothesized to be intracellular membrane 
anchors for the replication complex and therefore play a critical role in the 
pathogenesis of the FMDV (Carrillo, 2012; Xiang et al., 1997). They are also 
thought to be involved in vesicle formation (Carrillo, 2012; Weber et al., 1996). 
The three different copies of the 3B protein are located in tandem and they 
have been implicated in the virulence of the FMDV (Forss et al., 1984; King et 
al., 1980). The 3D protein is the RNA dependant RNA polymerase (Grubman 
& Baxt, 2004; Newman et al., 1979).  
 
1.1.3.2 FMDV Structural Proteins 
 
The FMDV capsid is roughly spherical and has a relatively smooth surface 
(Acharya et al., 1989; Jamal & Belsham, 2013). It is 30nm in diameter (Fry et 
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al., 1990) and is made up of 60 copies each of four different structural 
proteins, viral protein (VP)1, VP2, VP3 and VP4, which are also known as 1D, 
1B, 1C and 1A respectively (Cooper et al., 1978; Goodwin et al., 2009). VP1, 
VP2 and VP3 are found on the surface of the virion and VP4 is internally 
located (Acharya et al., 1989) (Figure 2). VP4 is smaller than the other capsid 
proteins and it interacts with the genome. Additionally, its N-terminal end has 
a myristic acid (Acharya et al., 1989; Chow et al., 1987; Goodwin et al., 2009).  
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Figure 1: The organization of the foot-and-mouth disease virus genome, 
the encoded polyprotein and mature proteins  
The leader protein L is highlighted yellow.   
Viral proteins (VP1-4) are highlighted red.   
Nonstructural proteins 2A-C are highlighted green.   
Nonstructural proteins 3A-D are highlighted blue.   
Adapted from: (Sobrino et al., 2001). 
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The FMDV capsid has icosahedral symmetry. VP1 to VP4 assemble into 
asymmetrical units also known as protomers (Acharya et al., 1990) (Figures 2 
and 3). A protomer is the smallest repetitive unit of an oligomeric protein 
(Monod et al., 1965). Five protomers arrange to form a pentamer and 12 
pentamers form the enclosing capsid (Acharya et al., 1989). Non-covalent 
interactions among the N- and C-termini of VP1, VP3 and VP4 stabilize the 
pentamers, and the pentamers are in turn held together by hydrogen bonds 
formed between VP2 and VP3 (Stanway, 1990). Five copies of VP1 are 
arranged around the five-fold axis of symmetry while VP2 and VP3 are 
arranged around the two- and three-fold axes of symmetry (Acharya et al., 
1989, 1990) (Figure 3).  
 
The core regions of VP1, VP2 and VP3 each consist of an eight-stranded anti-
parallel E-barrel, i.e. two four stranded E-sheets, a feature also known as the 
jelly-roll fold (Acharya et al., 1989, 1990). The jelly-roll fold (Figure 4) is a 
conserved feature that is common among many icosahedral viruses including 
the Picornaviruses (Acharya et al., 1990; Larsson, 2012). The β-strands are 
interspersed by non-conserved loop regions (Barnett et al., 1998; Grubman & 
Baxt, 2004), which when surface exposed form protrusions that correlate with 
antibody binding sites and therefore contain antigenically important residues 
(Acharya et al., 1990). Studies have shown that the surface-exposed 
structural proteins of the FMDV capsid are capable of inducing both 
neutralizing and non-neutralizing antibodies (Abs) (Ouldridge et al., 1984). 
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Figure 2: The organization of the foot-and-mouth disease virus capsid 
viral proteins (VP) in a SAT1 (PDB ID: 2WZR) protomer  
VP1 is illustrated as a blue ribbon. 
VP2 is illustrated as a green ribbon. 
VP3 is illustrated as a red ribbon. 
VP4 is illustrated as a yellow ribbon. 
Image was generated using UCSF Chimera (Petterson et al., 2004). 
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economic losses. Thedisease iscaused by a singlestran-
ded positive sense RNA virus, foot-and-mouth disease
virus(FMDV), belongingto thegenusAphthoviruswithin
the family Picornaviridae. This review includes a des-
cription of thepropertiesof thevirusand thesystemsfor
detecting and characterizing FMD outbreaks. This infor-
mation isthen used todescribethecurrent distribution of
thedisease/virusand howtheFAO/EuFMD/OIEProgres-
siveControl Pathway can assist in diseasecontrol within
endemic countries and hence reduce the risk of incur-
sions into disease free regions. The major focus here
ison Eurasiabut other regionsarealso considered when
appropriate.
2. Structure of FMDV
The FMDV particle is roughly spherical in shape and
about 25–30 nm in diameter. It consists of the RNA
genome surrounded by a protein shell or capsid. The
capsid iscomposed of 60 copiesof the capsomers. Each
capsomer consists of four structural polypeptides, VP1,
VP2, VP3 and VP4. TheVP1, VP2 and VP3 areexposed
on the surface of the virus while VP4 is located in-
ternally. The protein coat surrounds a single stranded,
positive senseRNA genomeabout 8400 nucleotides (nt)
in length. TheRNA includesthreeseparateparts i.e. the
5′ untranslated region (5′ UTR), a long coding region
and the 3′ untranslated region (3′ UTR) (Figure 1). A
small protein (24 or 25 residues long), termed VPg,
which isencoded by the3Bportion of theviral genome
region, iscovalently linked to the5′ end of thegenome.
The5′ UTRisabout 1300nt in length [1] and consists
of an Sfragment at its5′ end, apoly C tract, aseriesof
RNA pseudoknot structures, a cis-acting replication
element (cre) (also known as the 3B-uridylylation site
(bus)), and the internal ribosome entry site (IRES). The
Sfragment is360 nt in length and ispredicted to fold to
form a large hairpin structure. The poly C tract is of
variable length (150–250 nt) but is comprised of over
90%C residues. The function of thepseudoknots isun-
known. The cre/bus is a stable stem-loop element of
about 55 nucleotides and contains a conserved motif
(AAACA) which acts as a template for uridylylation of
VPg (3B1-3) by the viral RNA polymerase. Thus thecre/
busis involved in the initiation of RNA replication. The
IRES is about 450 nt in length and is responsible for
cap-independent initiation of viral protein synthesis[1].
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Figure 1 Genomeorganization of FMDVand thestructure of virus. TheFMDVgenomeincludesasingle largeORF, indicated by theshaded
rectangle.Theregionswithin therectangle indicatetheindividual proteins.The5’ UTRincludesseveral distinct structural elementsincluding:a
poly(C) tract (Cn),3or 4pseudoknots(PK) and theinternal ribosomeentrysite(IRES).TheVPg peptideismadein 3different forms(encoded by
the3B1-3) and each actsastheprimer for RNAsynthesisso each RNAgenome,when synthesized, iscovalently linked to aVPg.Theassemblyof
virusparticlesfromprotomericand pentamericsubunitsisindicated.Assembled virusparticlescontain asinglecopyof theviral RNAand 60
copiesof the4different capsid proteins(VP1-VP4).Self-assemblyof emptycapsid particles, lacking theRNAgenome,can also occur.TheVP4
protein isinternal.
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Figure 3: Diagram illustrating the arrangements of the subunits that 
constitute the outer viral capsid   
The arrangement of the viral proteins (VP)1 (blue), VP2 (green) and VP3 (red) 
in a protomer, pentamer and capsid are shown. A grey ellipse, triangle and 
circle on the pentamer representation indicate the two-fold, three-fold and 
five-fold axes of symmetry respectively.  
Adapted from (Jamal & Belsham, 2013; Sobrino et al., 2001).  
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Figure 4: An eight-stranded anti-parallel E-barrel, a feature also known 
as the jelly roll fold from the satellite tobacco necrosis virus 
Each strand is labelled EB to EH. The N- and C-terminal ends of the protein 
are labelled Nt and Ct respectively. 
From (Larsson, 2012). 
 
 
1.1.4 Epitopes and Antigenic Sites 
 
An epitope or antigenic determinant is a collection of distinct amino acid 
residues on an antigen that antibodies recognize and specifically bind to 
thereby activating an immune response (Larsen et al., 2006; Peters et al., 
2005; Zhao et al., 2012). It may also be defined as the smallest immune unit 
that is capable of activating an immune response (Sun et al., 2013). Linear 
epitopes comprise of contiguous residues in the primary structure (Larsen et 
al., 2006). On the other hand, discontinuous epitopes comprise of residues 
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remotely located in the primary structure that are brought into close proximity 
due to the folding of the protein (Larsen et al., 2006). Discontinuous epitopes 
are also known as conformational epitopes (Pellequer et al., 1991). Only 10% 
of B-cell epitopes are linear and 90% are discontinuous (Zhao et al., 2012). 
Since linear epitopes do in fact adopt a conformation, the distinction between 
linear and discontinuous epitopes is a grey area (Peters et al., 2005; 
Sweredoski & Baldi, 2008). In the context of this review, an antigenic site 
refers to a patch on the surface of the virus capsid that may contain multiple 
epitopes (McCahon et al., 1989).  
 
Virus molecules are structurally and antigenically complex, and consequently 
contain multiple antigenic sites (Ferris & Donaldson, 1992). The high mutation 
rate in the surface-exposed capsid proteins is responsible for the variations in 
immunogenicity and virulence of FMDV. Structural studies in combination with 
virus neutralization tests have revealed that variations in immunogenicity are 
attributed to the hypervariable regions on surface-exposed loop regions, 
which link E-sheets in the capsid proteins (Acharya et al., 1989, 1990; Aktas & 
Samuel, 2000; Hogle et al., 1985). Though the P1 coding region is generally 
well conserved among the Picornaviruses, the hypervariable regions explain 
why there is a low cross-reactivity among the different FMDV serotypes 
(Aktas & Samuel, 2000; Maree et al., 2011; Thomas et al., 1988; Usherwood 
& Nash, 1995).  
 
1.1.5 Antigenic Sites on the FMDV Capsid 
 
 31 
Though there are several structural and functional similarities among the 
antigenic sites of the various serotypes, their locations and constitutive 
epitopic residues tend to differ (Grazioli et al., 2012; Maree et al., 2011; 
Usherwood & Nash, 1995). Antigenic sites close to the two-, three- and five-
fold axes of symmetry are structurally related, as they lie in close proximity to 
each other in the pentamer subunit of the viral capsid (Grazioli et al., 2012). 
The nomenclature used to describe the antigenic sites on type O viruses will 
be used in this review for easier interpretation across the serotypes. The 
locations of the known epitopes across six of the serotypes are illustrated in 
Figure 5. There are five known antigenic sites in total, found on the surface-
exposed structural proteins of type O viruses (Crowther et al., 1993; Kitson et 
al., 1990; Mateu, 1995; Usherwood & Nash, 1995).  
 
Antigenic site one contains the immunodominant region of the FMDV (Logan 
et al., 1993). This major antigenic site is a highly variable region among the 
different FMDV serotypes with a number of overlapping B-cell epitopes 
(Bolwell et al., 1989). Antigenic site one may be either discontinuous or linear. 
The discontinuous form comprises the amino acids 144-154 of the EG-EH 
loop of VP1 (GH loop) in combination with amino acids 200-213 on the C-
terminus of VP1 (Kitson et al., 1990; Pfaff et al., 1982; Xie et al., 1987) (Table 
1). In this instance, the C-terminus of one VP1 lies across an adjacent 
protomer (Acharya et al., 1989), thus bringing critical residue 208 in type O 
(Aktas & Samuel, 2000; Kitson et al., 1990), 209 in type A (Baxt et al., 1989) 
or 210 in SAT2 (Opperman et al., 2014) in close proximity to the base of the 
GH loop.  
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The linear form of antigenic site one is characterised by the GH loop only 
(Kitson et al., 1990; Pfaff et al., 1982; Xie et al., 1987). In this case, the C-
terminal end of VP1 forms an independent antigenic site (Aktas & Samuel, 
2000). The critical residues of antigenic site one are as described in Table 1. 
Residue 79 of VP2 has also been proposed as constituting a part of antigenic 
site one in SAT2, but its role is unknown (Grazioli et al., 2006). The GH loop 
of VP1 is highly disordered and flexible (Acharya et al., 1989), which plays a 
role in its antigenic diversity. A flexible loop structure allows for greater 
sequence diversity without compromising the integrity of the capsid structure 
(Grazioli et al., 2012). The C-terminus, though flexible, has a more ordered 
structure (Acharya et al., 1989). Antigenic site one is situated at the centre of 
the protomer (Kitson et al., 1990) (Figure 3) and it is trypsin sensitive 
(Aggarwal & Barnett, 2002).  
 
 Antigenic site two comprises amino acids located on VP2 (Table 1) and it is 
found at the three-fold axis of the viral capsid (Figure 3) (Crowther et al. (a), 
1993). In type O, the epitopes are residues 31 (Aggarwal & Barnett, 2002) 
and on the EB-EC loop they are residues 70-73, 75 and 77 (Kitson et al., 
1990). On the adjacent EE-DB loop the critical residues are 131 and 134 
(Acharya et al., 1989; Kitson et al., 1990). Residues 40-50 of VP2 were 
defined as antigenic site two on type Asia1 (Zhang et al., 2010) (Table 1). For 
the type A viruses, antigenic site two is made up of amino acids 72 and 79 on 
the EB-EC loop (Saiz et al., 1991), and amino acids 80 and 196 on the EC-DA 
loop and EH-EI loops respectively (Thomas et al., 1988) (Table 1).  
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In type O, antigenic site three consists of a single patch of epitopes on VP1 
(Table 1), namely residues 43, 44, 45 and 48 on the EB-EC loop (Kitson et al., 
1990). On type Asia1, the corresponding antigenic site comprises residue 49, 
which is also found on the EB-EC loop (Grazioli et al., 2012). The epitope in 
type C that is located at this antigenic site is residue 83, and it is found on the 
ED-EE1 loop. Antigenic site 3 in all serotypes is situated at the five-fold axis of 
the virion (Crowther et al. (a), 1993; Kitson et al., 1990) (Figure 3).  
 
Antigenic site four comprises residues on VP3 (Table 1), which are situated 
on an insert that is known as the EB-EB knob. In type SAT1, the epitopes are 
residues 58 and 59 (Borley et al., 2013). Amino acids 58-61 and 69-70 on 
VP3 form a part of antigenic four on type A viruses (Thomas et al., 1988). 
Residues 58 and 59 are the epitopes on antigenic site four of type Asia1 
(Grazioli et al., 2012). Antigenic site four is located close to the three-fold axis 
of the virion (Kitson et al., 1990). 
 
The interaction between the GH loop of VP1 and other surface amino acids is 
believed to form antigenic site five. An epitope at residue 149 on the GH loop 
of VP1 forms part of site five for type O (Crowther et al. (a), 1993).  
 
Grazioli et al. (2012) described a novel independent antigenic site on VP3 of 
type Asia1. The epitope at this site is amino acid 218, and it is close to the 
five-fold axis of symmetry. 
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Table 1: Known epitopes on various foot-and-mouth disease virus 
serotypes 
 
Chain ID Type A Type Asia1 Type C Type O Type SAT1 Type SAT2 
VP1  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1981 
2092 
C-terminus 
483  
bB-bC  
 
 
 
 
 
 
 
 
 
140, 141, 1423  
bG-bH  
 
 
 
 
 
 
 
 
 
2073  
C-terminus 
 
 
 
 
 
 
834  
bD-bE  
 
 
 
138, 139, 146, 
148, 149, 1505  
bG-bH 
 
 
 
 
 
 
 
1981  
2045  
C-terminus 
43, 44, 45, 486  
bB-bC  
 
 
 
 
 
 
 
 
 
144, 148, 1546–8  
bG-bH 
1499  
bG-bH  
 
 
 
 
 
 
 
2086,10  
C-terminus 
46, 4711  
bB-bC  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
20011 
C-terminus 
 
 
 
 
 
 
 
 
 
 
 
147, 148, 149, 
156, 15812  
bG-bH  
15413  
bG-bH  
15914  
bG-bH 
 
 
 
 
21014  
C-terminus 
VP2  
 
 
 
721  
bB-bC 
791, 8015  
bC-aA  
 
 
 
 
 
 
 
 
 
 
 
 
 
19615  
bH-b I  
40-5016 
 
 
 
67, 72, 74, 77, 
793  
bB-bC  
 
 
 
 
705  
bB-bC  
7111 
72, 7417  
bB-bC  
 
 
 
 
 
13417  
bE-aB 
 
 
 
18811 
bH 
19611  
bH-bI 
3118  
 
 
 
70, 71, 72, 73, 
75, 776  
bB-bC  
 
 
 
 
 
131,  
bE-aB  
1346,19  
aB 
 
 
 
 
7211  
bB-bC 
 
 
 
 
 
 
 
 
13411 
aB 
 
VP3  
 
 
 
 
 
58, 59, 60, 6115  
bB-bB  
 
 
 
69,7015  
bB-bC  
 
 
 
136, 13915  
bE-aB  
 
 
 
 
 
 
 
 
 
 
19515  
bH-b I  
 
 
 
 
 
 
58, 593  
bB-bB  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
2183  
C-terminus 
9, 134  
N-terminus 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1484  
bF 
 
 
 
19511  
bH-bI 
 
 
 
 
 
 
 
 
 
 
 
 
6911 
bB-bC 
 
 
 
 
 
 
58, 5911 
bB-bB 
 
 
 
 
69, 7011 
bB-bC 
 
 
 
13511 
bE-aB 
 
   
Experimentally determined epitopes and the loops on which they are located 
are shown. 
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Type A    Type Asia1 
  
Type C    Type O 
  
Type SAT1    Type SAT2 
Figure 5: Known foot-and-mouth disease virus epitopes mapped on 
representative protomers 
Epitopes located on VP1 are highlighted in blue. 
Epitopes located on VP2 are highlighted in green. 
Epitopes located on VP3 are highlighted in red.  
Image was generated using UCSF Chimera (Petterson et al., 2004). 
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Currently, there is a paucity of information on SAT epitopes. Most of the 
studies that have been carried out in the literature of the FMDV epitopes are 
on the Euro-Asiatic types A, Asia1 and O. It is thereby imperative to focus on 
identifying SAT specific epitopes to aid in the development of distinctly African 
vaccines (Maree et al., 2011). Identification of the specific amino acids on a 
virus that are capable of eliciting a protective immune response against FMDV 
is key to the design of more broadly reactive and effective vaccines (Aggarwal 
& Barnett, 2002; Mateu et al., 1990). 
 
1.1.6 Antigenic Diversity of FMDV and the Implications 
 
Antigenic variation is observed among the strains of the different FMDV 
serotypes (Bolwell et al., 1989) and the SAT viruses show the most diversity 
(Vosloo et al., 1992). Phylogenetic analyses illustrate that various strains of 
SAT viruses, like other serotypes, differ antigenically and evolve separately 
with respect to the geographical locations where they are persistent. These 
are known as topotypes (Bastos et al., 2001; Maree et al., 2011; Samuel & 
Knowles, 2001; Vosloo et al., 1992). Figure 6 is a minimum evolution tree that 
illustrates the topotype concept. It was built using nucleotide sequences of the 
P1 gene that encodes the structural proteins of SAT viruses from African FMD 
outbreaks over a period of 28 years. The variants clustered according to type 
and geographical location with a couple of exceptions that could be attributed 
to animal migrations (Maree et al., 2011).  
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The high antigenic diversity of SAT viruses places a limitation on the 
effectiveness of vaccination as a means of FMD control (Barnett et al., 1998). 
Infection or vaccination with one virus will either not provide immune 
protection or it may only confer partial protection (Bolwell et al., 1989; Grazioli 
et al., 2012; OIE, 2012; Sobrino et al., 2001). This antigenic variation 
accordingly raises the need for cross-reactive vaccines or the use of multiple 
vaccines that recognize the heterogeneous strains within the southern African 
FMDV serotypes (Bolwell et al., 1989; Brehm et al., 2008; Ferris & Donaldson, 
1992; Rweyemamu et al., 1978).  
 
Identification of the specific amino acids on a virus that are capable of eliciting 
a protective immune response is the key to designing more effective vaccines 
with the desired antigenic properties (Aggarwal & Barnett, 2002; Mateu et al., 
1990). Alternatively, protein subunits with the structural and immunogenic 
properties of their whole antigens may be designed and used as therapeutic 
and diagnostic tools (Meloen et al., 1987; Rubinstein et al., 2009; Usherwood 
& Nash, 1995). Knowing the epitopes that are conserved among the field 
FMDV strains that are in circulation will enable the rational design of a vaccine 
that is able to afford broad spectrum immune protection (Aggarwal & Barnett, 
2002; Mateu et al., 1990).  
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Figure 6: Minimum evolution tree illustrating the topotype concept using 
SAT virus strains 
The sequences of the P1 gene, that encodes the structural proteins of the 
SAT1, SAT2 and SAT3 viruses were used to build this minimum evolution 
tree. Virus isolates used were from southern Africa (Kruger National Park 
(KNP), South Africa (SAR), Zimbabwe (ZIM) or (RHO), Mozambique (MOZ), 
Namibia (NAM), Zambia (ZAM), Angola (ANG), western Africa (Nigeria (NIG), 
Senegal (SEN), Ghana (GHA)), eastern Africa (Uganda (UGA), Rwanda 
(RWA), Democratic Republic of Congo (ZAI), Kenya (KEN), Tanzania (TAN), 
Eritrea (ERI), Sudan (SUD)) and the Middle East (Saudi Arabia (SAU)). 
The major topotypes are labeled 1-8 for SAT1, I-XII for SAT2 and I-VI for 
SAT3. No representative isolates of SAT1 topotype 6 and SAT2 topotypes III, 
IV, X, XIII and XIV were included. Bootstrap support values ≥ 65 are based on 
1000 replicates and these are indicated next to the respective nodes. 
From: (Maree et al., 2011) 
 39 
1.1.7 Classical Experimental Epitope Determination Methods 
 
Antigenic sites and epitopes on viruses are typically determined by 
monoclonal antibody (MAb)-resistant variant studies, also known as virus 
neutralization tests (Aktas & Samuel, 2000), peptide scanning (Bittle et al., 
1982; Meloen et al., 1987; Thomas et al., 1988) and MAb-antigen contact 
studies (Aktas & Samuel, 2000). The sequencing of MAb-resistant mutants 
played an important role in the early identification of epitopes in the Euro-
Asiatic types A, C and O. Furthermore, experimentally resolved 3-D structures 
of FMDVs (Acharya et al., 1989; Lea et al., 1994) helped in the 
characterization of epitope topography (Barnett et al., 1998).  
 
Despite the successes of experimental epitope determination methods, they 
are laborious and not feasible when searching for epitopes on a genome-wide 
scale (Larsen et al., 2006). MAb-antigen contact studies, which is deemed the 
most reliable of the epitope determination strategies, is curbed by the limited 
availability of X-ray crystal structures of MAb-antigen complexes (Kuroda et 
al., 2012). There are for example currently no published crystallographic 
structures of any of the SAT viruses in complex with a MAb and only two of 
type C-Ab complexes (PDB IDs: 1QGC and 1EGO). Computational epitope 
prediction methods have therefore been proposed as a cost and time-effective 
alternative to the laborious and resource-intensive classical experimental 
methods (Hunter, 2006). 
 
1.1.8 Computational Epitope Prediction Methods  
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Continuous advances in software and high-performance computers have the 
potential to ameliorate the limitations of experimental epitope determination 
methods. High performance computers are able to execute algorithms of 
increasing complexity at decreasing costs and in a time-effective manner. 
Computational methods also have the potential ability to predict epitopes on a 
genome-wide scale (Larsen et al., 2006). Furthermore, they can reduce 
epitope prediction time by as much as 95% (De Groot et al., 2001). 
 
Computational epitope prediction methods exploit the inherent 
physicochemical properties of epitopes in their algorithms (Rubinstein et al., 
2009). Epitopes tend to be more exposed to solvent than their surrounding 
surface-exposed residues (Andersen et al., 2006; Novotny et al., 1986; 
Thornton et al., 1986). The high surface-exposure of antigenic regions also 
makes them highly flexible, which is necessary in order to accommodate the 
conformational changes that take place upon binding with Abs (Novotny et al., 
1986). Furthermore, it would be reasonable to assume that flexibility is a 
prerequisite of antigenic sites when one takes into consideration the plasticity 
of the complementarity determination regions (CDRs) of Abs. 
 
In silico epitope prediction methods are broadly divided into sequence and 
structure-based methods as well as into continuous/linear and discontinuous 
epitope prediction methods. What all these methods essentially have in 
common is that they provide a way of correlating the physico-chemical 
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properties of the respective amino acids to their probable location in the 
protein structure (Hopp & Woods, 1981; Larsen et al., 2006). 
 
Propensity scale methods are the most common way by which linear epitopes 
are predicted and they are entirely dependent on the primary structure of the 
proteins (Greenbaum et al., 2007; Lo et al., 2013). The original propensity 
scale methods make use of hydrophilicity (Parker et al., 1986), secondary 
structure (Chou & Fasman, 1974; Garnier et al., 1978) and side-chain solvent 
accessibility (Janin et al., 1978) in their algorithms (Lo et al., 2013). Modern 
linear epitope algorithms make use of a combination of propensity scale 
methods, but have been shown to only be marginally better at predicting 
linear epitopes (Larsen et al., 2006; Pellequer et al., 1991). In a similar 
manner to the experimental peptide scanning methods, propensity scales are 
not highly successful for discontinuous epitope prediction unless a given 
reading frame contains the amino acids that are the major determinants of the 
conformation of the epitope (Lin et al., 2013). Alternatively, structure-based 
methods are more ideally suited for the prediction of discontinuous epitopes 
(Greenbaum et al., 2007). 
 
Discontinuous epitope prediction methods employ various algorithms that 
mostly exploit a combination of structural and propensity scale-based 
information (Greenbaum et al., 2007). It has been shown that the most 
successful integrated methods consider amino acid composition, secondary 
structure and surface exposure in their algorithms (Kringelum et al., 2012). 
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Borley et al. (2013) devised a computational method for the identification of 
discontinuous epitopes on the outer surface of intact virus capsids, which is 
an extension of existing epitope prediction methods. This was necessary 
because viral structural proteins differ from globular proteins in shape as well 
as the arrangement of the repeated elements (Borley et al., 2013). They 
optimised the parameters for five programmes, Discotope2.0 (Kringelum et 
al., 2012), Seppa (Sun et al., 2009), Epitopia (Rubinstein et al., 2009), BEPro 
(Sweredoski & Baldi, 2008) and Ellipro (Ponomarenko et al., 2008), using an 
independent training dataset. The parameters turned out to be different from 
those that were defined as optimal by the respective programme developers 
(Borley et al., 2013). It was shown that when used individually, the respective 
algorithms performed poorly when it came to predicting experimentally 
resolved viral capsid epitopes. However, when a consensus of results among 
the top performing methods was considered, the reliability of predicted 
epitopes increased (Borley et al., 2013). Borley et al. (2013)’s method was 
able to predict novel FMDV epitopes across the serotypes as well as a 
previously uncharacterised putative antigenic site. 
 
Discontinuous epitope prediction methods require the 3-D structure of the 
antigen as input (Sun et al., 2013). In cases where no structure is available, 
some of the programmes build homology models of the antigens and then 
proceed to predict epitopes from the models (Ponomarenko et al., 2008). 
 
There is currently only one experimentally resolved structure of a SAT virus 
(PDB ID: 2WZR) and none of SAT viruses in complex with their antibodies. 
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This consequently raises the need to generate more structures of the various 
SAT viruses in order to carry out epitope predictions.  
 
1.1.9 Limitations of Experimental Structure Elucidation Methods  
 
X-ray crystallography (Blundell & Johnson, 1993), nuclear magnetic 
resonance (NMR) spectroscopy (Bax, 1989) and cryo-electron microscopy 
(cryo-EM) (Adrian et al., 1984; Dubochet et al., 1988) are the three major 
methods used to experimentally determine protein structures (Forster, 2002). 
X-ray crystallography and cryo-EM are the methods of choice for the 
elucidation of complex macromolecules such as viruses (Guo & Wen, 2014). 
Advances in biophysical techniques in the past couple of decades led to a 
significant increase in the number of resolved protein structures (H. Liu & Hsu, 
2005). To date, there are approximately 100,000 structures in the Protein 
Data Bank (PDB) (www.rcsb.org/pdb/) but this represents less than 1% of the 
available protein sequences. 
 
Inherent limitations in the biophysical methods play a major role in the 
sequence-structure gap (Jacobson & Sali, 2004). Furthermore, genomic 
sequence data is being generated at a rate that far exceeds that at which 
protein structures can be experimentally determined (Simons et al., 2001). As 
the cost of high-throughput sequencing is expected to continue to decrease, 
the sequence-structure gap will only increase further (Soon et al., 2013). 
There is therefore a need for the use of computational methods to predict how 
proteins fold under native conditions (Liu & Hsu, 2005; Simons et al., 2001). 
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Computational protein structure prediction methods are significantly faster 
than experimental methods and it is accepted that most protein structures will 
be computationally modelled, and not experimentally resolved (Jacobson & 
Sali, 2004).  
 
1.1.10 Overview of Computational Protein Structure Prediction Methods  
 
There are, broadly speaking, three computational methods used to predict 
protein structure. These are comparative/homology modelling, threading/fold 
recognition and ab initio methods (Floudas et al., 2006). These methods are 
classified according to the type of information they use. Homology methods 
and threading make use of existing experimentally determined structural 
information (Zhang et al., 2003). Ab initio methods on the other hand, utilize 
physical principles and attempt to mimic the folding process (Sanchez & Sali, 
1997).  
 
The quality of computationally predicted structures, and consequently their 
usefulness in downstream applications depends on the method used 
(Jacobson & Sali, 2004). In the case of homology modelling and threading 
methods, the quality of models depends on the quality of the structures on 
which they are based. Homology modelling may produce structures that are of 
a relatively high quality and close to the native structure. Good quality 
homology modelled structures may be used in functional annotation, docking 
of small molecules and ligand-binding site prediction (T. Liu, Tang, & Capriotti, 
2011). Ab initio methods are however limited by size. They are most 
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successful when predicting the structures of small proteins, typically shorter 
than 200 amino acids. Ab initio methods are therefore useful for modelling 
short regions of large proteins that are not amenable to experimental 
elucidation such as loops (Shehu & Kavraki, 2012).  
 
This research project will employ a homology modelling method. There are 
several resources available for automated homology modelling, making 
homology modelling intelligible to both experts and amateurs (Forster, 2002). 
However, these methods often need human intervention in order to improve 
the accuracy of the models (Jacobson & Sali, 2004).  
 
1.2 AIMS 
 
The first aim of this project was to build homology models of 18 FMDV 
protomers of the SAT1, SAT2, and SAT3 serotypes. These structures are 
representative of topotypes found in southern and eastern Africa, as well as 
Saudi Arabia. 
 
The second aim of this project was to use in silico epitope prediction methods 
to predict B-cell epitopes on the FMDV capsid surfaces of the aforementioned 
18 homology models. The prediction programmes employed were 
Discotope1.0 (Andersen et al., 2006) and Ellipro (Ponomarenko et al., 2008). 
These predictive methods employ different algorithms and it was expected 
that a consensus of results would be deemed as reliable epitope predictions. 
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Chapter 2 
 
 
 
 
Homology Modelling 
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HOMOLOGY MODELLING 
 
2.1 HOMOLOGY MODELLING REVIEW 
 
2.1.1 Introduction to Homology Modelling  
 
Homology modelling methods construct all-atom 3-D models of target protein 
sequences on the basis of their alignments to at least one related, 
experimentally resolved protein structure (Aszodi & Taylor, 1996; Jacobson & 
Sali, 2004). Homology modelling is based on the notion that proteins that 
have evolved from a common ancestor will usually have similar amino acid 
sequences. In turn, a strong protein sequence similarity implies a strong 
structural similarity (Chothia & Lesk, 1986; Vyas et al., 2012). Though it 
should be noted that it is possible for proteins to adopt similar 3-D structures 
from a wide range of seemingly unrelated amino acid sequences (Floudas et 
al., 2006; Marti-Renom et al., 2000). Homology modelling exploits the fact that 
there are a limited number of protein folds that can be adopted (Chothia, 
1992; Zhang, 1997). Also, small substitutions in the amino acid sequences will 
result in small conformational changes in the proteins’ 3-D structures (Chothia 
& Lesk, 1986; Hubbard & Blundell, 1987; Liu, Tang, & Capriotti, 2011). 
 
A target protein’s structure is predicted by searching for one or more related 
proteins in a database of resolved structures. The homologues are then used 
as templates on which the folding pattern of the target protein can be modeled 
(Sali & Blundell, 1993; Vyas et al., 2012). The quality of the model is 
dependent on the quality of the template. That is, the target and template 
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sequences must be sufficiently homologous (Baker & Sali, 2001), which can 
be limiting given that not all protein families have experimentally derived 
representative structures to serve as templates (Sali & Blundell, 1993).  
 
There are four major steps in homology modelling (Figure 7); identification of 
a template, optimal alignment of target and template, modelling of the 
backbone and side chains and finally model refinement (Floudas et al., 2006; 
Jacobson & Sali, 2004; Marti-Renom et al., 2000). 
 
2.1.2 Template Identification 
 
The first step of homology modelling is to identify homologues of the target 
protein that will serve as templates on which the folding pattern of the target 
protein can be modeled ( Liu, Tang, & Capriotti, 2011; Sali & Blundell, 1993). 
There are three major classes of methods used to compare the target’s 
sequence to those of experimentally resolved protein structures in a database 
such as the PDB (Marti-Renom et al., 2000; Vyas et al., 2012).  
 
The first class is the pairwise sequence alignment methods that independently 
compare the target amino acid sequence with each database sequence. 
BLAST (Altschul et al, 1990) and FASTA (Pearson & Lipman, 1988) 
algorithms, which are the most commonly used of these methods are only 
recommended for sequences with at least 30% sequence identity (Marti-
Renom et al., 2000; Vyas et al., 2012). Below this threshold, a rapid decline in 
the accuracy of homology models is observed. Pairwise amino acid sequence 
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identity in the 20-30% range is known as the ‘twilight zone’ and this is 
accompanied by a sharp increase in alignment errors ( Liu, Tang, & Capriotti, 
2011; Rost, 1999).  
 
Multiple sequence alignment methods improve the sensitivity of the template 
search and are therefore most ideally suited to identify distantly related 
templates in the twilight zone. PSI-BLAST (Altschul et al., 1997) and Clustal 
Omega (ClustalO), formerly ClustalW (Sievers et al., 2011) are two popular 
examples of such methods.  
 
Threading forms the third class of template identification methods. It involves 
a pairwise comparison of the target’s sequence to a library of 3-D folds (Marti-
Renom et al., 2000). Instead of using sequence similarity, the sequence-
structure alignments in threading methods are evaluated by the free energy of 
the related coarse homology models (Baker & Sali, 2001; Jones et al., 1992). 
Free energy is a function of enthalpy and entropy. This final class of methods 
is therefore mostly used for target sequences that do not have any related 
sequences available to serve as templates (H. Liu & Hsu, 2005; Marti-Renom 
et al., 2000).  
 
2.1.3 Optimal Target-Template Alignments 
 
The alignments used to identify potential template structures are not the 
optimal alignments required for homology modelling. An optimal alignment 
between the target and template sequences is necessary so as to enable the 
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structure in conserved regions to be copied from the template to the target. 
Such an alignment highlights the amino acid matches, insertions or deletions 
(Vyas et al., 2012; Zhang, 2002). Those regions of the alignments that have 
the highest level of sequence conservation usually consist of well-defined 
conserved secondary structure elements. These conserved regions form the 
core framework of the modelled target protein (Forster, 2002). Multiple 
template alignments may improve the quality of the resultant homology model 
if used correctly, resulting in models that have the best features of each 
template (Zhang, 2002). Visualization of the alignments is advisable to enable 
human intervention in the correction of some errors (Marti-Renom et al., 2000; 
Zhang, 2002).  
 
Either of two popular dynamic programming techniques, the Needleman-
Wunsch (Needleman & Wunsch, 1970) or Smith-Waterman (Smith & 
Waterman, 1981) algorithms, forms the basis of all optimal target-template 
alignment methods to date ( Liu, Tang, & Capriotti, 2011).  
 
2.1.4 Model Building 
 
Once optimal target-template alignments have been constructed, building of 
the target protein’s polypeptide backbone can begin (Forster, 2002; Vyas et 
al., 2012) (Figure 7). The first step in constructing the backbone is modelling 
of the conserved core regions ( Liu, Tang, & Capriotti, 2011). The modelled 
core regions then serve as scaffolds on which the loop regions can be added 
(Jacobson & Sali, 2004). Loop regions are difficult to model because their 
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sequences and structures are less conserved within protein families as a 
result of substitutions, insertions and deletions (Fiser et al., 2000; Marti-
Renom et al., 2000; Moult & James, 1986). Additionally, they tend to adopt 
disordered and flexible conformations (Fiser et al., 2000; Floudas et al., 
2006). Once loops have been added to the core regions, the modelling of the 
protein backbone is complete. The next step is the addition of side-chains 
(Jacobson & Sali, 2004). Side-chains in high-resolution X-ray crystallographic 
structures have been shown to adopt a limited number of stereochemically 
and energetically favourable conformations that are called rotational isomers 
(rotamers) (Janin et al., 1978; Ponder & Richards, 1987). The application of 
rotamer libraries for side-chain modelling reduces the search time of sampling 
the entire side-chain conformational space (Jacobson & Sali, 2004).  
 
2.1.5 Homology Modelling Methods 
 
There are three main groups of automated methods that are used to build the 
atomic models of target proteins (Marti-Renom et al., 2000). The rigid-body 
assembly methods build homology models from a small number of core 
region segments, loops and side chains derived from the templates (Browne 
et al., 1969; Greer, 1990). In the segment matching methods, a subset of 
conserved atomic positions derived from the template structures are used to 
guide the assembly of matching positions in the target structure (Levitt, 1992; 
Unger et al., 1989). The third group of methods is the satisfaction of spatial 
restraints, and it employs distance geometry or optimization techniques to 
satisfy spatial restraints derived from the target-template alignments (Aszodi & 
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Taylor, 1996; Havel & Snow, 1991; Sali & Blundell, 1993; Srinivasan et al., 
1993). 
 
2.1.5.1 MODELLER 
 
The satisfaction of spatial restraints is applied in the homology-modelling 
programme MODELLER (Sali & Blundell, 1993). The restrained structural 
features included CD-CD distances, main-chain N-O distances, main-chain 
and side-chain dihedral angles (Sali & Blundell, 1993). These geometrical 
features are expressed as probability density functions (PDFs). A PDF 
describes the conditional probability of a structural feature taking up a specific 
value given a range of associated features. For example, the range of values 
that a dihedral angle can take can be calculated based on the residue type 
and the main-chain phi and psi angles. An assumption is made that equivalent 
residues in the alignments have similar properties (Havel & Snow, 1991; 
Marti-Renom et al., 2000). A satisfactory number of strong restraints need to 
be specified for the structure to be well resolved (Sali & Blundell, 1993). This 
is followed by the minimization of violations on all the restraints. A force field 
is incorporated in the algorithm so as to enforce proper stereochemistry 
(Marti-Renom et al., 2000).  
 
2.2 REFINING THE MODELS USING ENERGY MINIMIZATION 
 
The side chains of homology-built models tend to have steric clashes and the 
models are of a low resolution in comparison to the templates on which they 
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were modelled (Selwyne et al., 2011). Since proteins need to adopt stable, 
low free-energy conformations in order to be functional, steps need to be 
taken to improve the quality of homology models (Melo & Feytmans, 1997; 
Selwyne et al., 2011; Zhang, 2002). 
 
 
Figure 7: Flowchart illustrating steps in homology modelling  
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Energy minimization is a strategy that is used to minimize the potential energy 
of a biological molecule’s structure. It resolves steric clashes between atoms 
and distorted bond angles and bond lengths (Adcock & Mccammon, 2006). 
Energy minimization finds the closest local energy minimum of a given 
structure, which is an optimal arrangement of its non-covalent interactions 
(Selwyne et al., 2011). 
 
Algorithms employed for energy minimization use simple potential-energy 
functions that are based on Newtonian mechanics (VanGunsteren & 
Brendsen, 1977). Force fields, which are integrated potential energy functions 
contain information on how to simulate chemical structures and their motion 
(Eichinger et al., 1999; VanGunsteren & Brendsen, 1977).  
 
2.2.1 AMBER 
 
Assisted Model Building With Energy Refinement (AMBER) is a widely used 
suite of force fields for the simulation of proteins, nucleic acids and other 
biologically important molecules possessing related functional groups (Cornell 
et al., 1995; Forster, 2002; Selwyne et al., 2011). The AMBER model is 
considered to be “minimalist” in its form and it is deemed that its 
uncomplicated bond and angle energy representations are sufficient for 
modelling most unrestrained systems (Equation 1) (Cornell et al., 1995).  
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Equation 1: Amber functional form 
From: (Cornell et al., 1995) 
 
 
The meanings of the right-hand side terms of Equation 1 are as follows: 
The first term is a summation of the energy between covalently bonded 
atoms. This harmonic force is a good approximation when the bond length is 
close to its equilibrium and less so as the atoms separate. The summation of 
energy values resulting from the geometry of electron orbitals involved in 
covalent bonding is represented by the second term. The energy increases as 
the bond angles diverge from the equilibrium value Teq.. The third term, which 
sums over torsions, represents the energy for the intramolecular rotations 
around bonds. The last term describes the non-bonded energy between all 
atom pairs, and can be decomposed into Van der Waals and electrostatic 
energies (the first and second terms of summation respectively) (Cornell et 
al., 1995; Selwyne et al., 2011).  
 
2.3 HOMOLOGY MODEL EVALUATIONS 
 
It is inevitable for homology models to have errors due to inaccuracies or gaps 
in the target-template alignments. The errors found in homology models are 
usually in the packing of side-chains, small distortions in the folding of the 
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main-chain atoms and larger errors within the loops (Baker & Sali, 2001). 
Errors in functionally important regions of the homology models result in 
protein structures that are of no use in downstream applications (Melo et al., 
1997). It is thereby important to apply methods that are capable of identifying 
poor quality models (Melo et al., 1997) so that the erroneous regions can 
subsequently be refined (Benkert et al., 2009).  
 
PROCHECK is a collection of programmes that is used for the assessment of 
the stereochemical quality of protein structures (Laskowski et al., 1993). The 
stereochemical properties of the protein in question are compared to those of 
well-refined structures of a similar resolution. The overall quality of a protein 
structure can therefore be determined in addition to being able to identify 
those regions that may be amenable to refinement (Laskowski et al., 1993).  
 
Atomic Non-Local Environment Assessment (ANOLEA) is an algorithm that 
assesses the quality of a protein structure by carrying out energy calculations 
at the atomic level in protein structures (Melo et al., 1997). ANOLEA 
calculates the energy of the non-local interactions between the heavy atoms 
of the 20 natural amino acids in the protein structure being evaluated. High-
energy zones (HEZs) can be identified, which correspond to erroneous 
regions or potential protein-protein binding sites (Melo et al., 1997).  
The Qualitative Model Energy Analysis (QMEAN) algorithm evaluates both 
the local and global quality of protein structures independently of protein size 
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and whether or not the structures are multimeric (Benkert et al., 2009). The 
scoring function compares the statistical properties of the models to those of 
similarly sized high-resolution experimentally resolved structures (Benkert et 
al., 2011). The resultant QMEAN Z-score is therefore an indicator of the 
quality and “degree of nativeness” of the structural features in the model 
(Benkert et al., 2011). 
 
The root mean square deviation (RMSD) is an overall measure of how similar 
the backbones of multiple structures are. An accurate structure is one whose 
RMSD falls within the range of RMSD values observed for the template 
structures on which it was modelled (Jacobson & Sali, 2004). Homology 
models that share a sequence identity of at least 50% with their templates 
have a main-chain RMSD of approximately 1Å (10-10metre) (Baker & Sali, 
2001). This level of accuracy is comparable to an NMR structure of medium 
resolution and an X-ray crystallography structure of low resolution (Baker & 
Sali, 2001). Sequence identities of between 30 and 50% among the target 
and template structures typically result in medium quality models with RMSD 
values of approximately 1.5Å (Baker & Sali, 2001).  
 
If it is found that the homology model is of an unsatisfactory quality, then 
alternative templates may be used or the target and template sequences may 
be re-aligned until a reliable model is built (Zhang, 2002) (Figure 7).  
 
2.4 METHODS 
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2.4.1 Preparation of Structural Viral Protein Sequences 
 
18 nucleotide sequences that encode the FMDV P1 polyprotein were obtained 
from Dr Francois Maree. The P1 gene encodes the FMDV capsid structural 
proteins (VP1, VP2, VP3 and VP4) (Belsham, 1993). These nucleotide 
sequences represent FMDV strains from seven countries, namely South 
Africa (SAR and KNP), Zimbabwe (ZIM), Zambia (ZAM), Namibia (NAM), 
Uganda (UGA), Kenya (KEN) and Saudi Arabia (SAU) (Table 2). The 18 
strains are representative of the SAT topotypes found in southern and eastern 
Africa, as well as one from Saudi Arabia. Strains were chosen for which 
complete P1/capsid coding sequences are available. Cattle and buffalo 
isolates were used because transmission of FMD follows two epidemiological 
patterns in southern Africa: from persistently infected buffalo to cattle, and 
vice versa. Furthermore, cattle and buffalo isolates within a serotype 
genetically group together.  
 
The P1 nucleotide sequences were translated into amino acid sequences 
using the CLC Bio Genomics Workbench v7.0.3 (CLC Bio). In order to 
delineate the discrete VP sequences from the polyproteins, the individual VP 
sequences from the SAT1 X-ray structure (PDB ID: 2WZR) were aligned to 
the SAT1, SAT2 and SAT3 amino acid sequences respectively. CLC Bio was 
used to carry out the alignments and visualize them. The individual VP 
sequences for the 18 sequences were extracted from the polyprotein 
sequence.  
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2.4.2 Identification of Templates for Modelling 
 
A BLASTP search of the PDB for structural homologs of SAT1, SAT2 and 
SAT3 sequences was carried out using CLC Bio. Three sequences were 
used, one representing each of the SAT serotypes. A Blosum65 matrix was 
employed because it is reported that the SAT1 serotype has a sequence 
identity of 65% with the O, A and C serotypes (Borley et al., 2013). Other 
parameters used in the BLASTP search were as follows: ‘word size = 3; 
expect = 10; gap cost (existence = 10, extension = 2); filter low complexity’.  
 
2.4.3 Multiple Alignments of Candidate Template Structures 
 
A Python script (seq_extra.py) (Appendix) was used to extract the amino acid 
sequences from PDB files of the top scoring structures from the BLASTP 
search of the PDB database. A multiple sequence alignment of these 
sequences was then carried out to aid in the identification of the best 
templates. The alignment programme ClustalO was used to carry out the 
alignment.  
 
2.4.4 Sequence Identities of Template Structures 
 
Pairwise sequence alignments of the template structures were carried out 
using ClustalO. These were then used to calculate the sequence identities of 
the template structures using CLC Bio.  
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Table 2: The names of 18 P1 foot-and-mouth disease virus nucleotide 
sequences used in this study 
SAR - South Africa: KNP - Kruger National Park (South Africa): ZIM- 
Zimbabwe: ZAM- Zambia: NAM – Namibia: UGA – Uganda: KEN – Kenya: 
SAU - Saudi Arabia. 
SAT Serotype SAT Strain Genbank Accession 
Number 
SAT1 (2232nt) KNP/196/91  JQ692596.1 
 NAM/307/98 DQ009717.1 
 SAR/9/81  DQ009715.1 
 UGA/1/97/1 AY043300.1 
 UGA/3/99 DQ009722.1 
 ZAM/2/93 DQ009719.1 
 ZIM/25/90 GU194499.1 
SAT2 (2220nt) ANG/04/74/2 DQ009736.1 
 KEN/3/57/2 AJ251473.1 
 KNP/2/89/2 GU194488.1 
 KNP/19/89 DQ009735.1 
 SAU/6/00 AY297948.1 
 UGA/02/02 DQ009731.1 
 ZIM/01/88 GU194491.1 
 ZIM/7/83/2 DQ009726.1 
SAT3 (2220nt) KNP/01/08 Unpublished 
 ZIM/05/91/3 DQ009740.1 
 ZAM/04/96/3 DQ009741.1 
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2.4.5 Building Homology Models 
 
2.4.5.1 Multiple Alignments for Homology Modelling 
 
The VP sequences of the target SAT sequences were rearranged to 
correspond to the order in the PDB files, which is VP1-4 as opposed to the 
natural polyprotein order of VP4, 2, 3, 1. Separate multiple alignments 
between each of the target sequences and the templates were built using 
default parameters in ClustalO. The output FASTA alignment file was 
manually converted into PIR format for use in homology modelling.  
 
2.4.5.2 Building Homology Models of the SAT VPs 
 
A standalone version of the homology modelling software MODELLER v9.12 
(MODELLER) was used to build homology models of the FMDV structural 
proteins of all 18 viruses. Five Python scripts (SAT1model_SS.py, 
SAT2model_SS.py, SAT2model_no_SS.py, SAT3model_SS.py, 
SAT3model_no_SS.py) (Appendix) were used to build all-hydrogen homology 
models of the protomers of the respective serotypes. These scripts employ 
the dopehr_loopmodel class, which automatically refines the loops after 
model building. They also specify any intra-protomer disulfide bonds in the 
respective structures. Furthermore, the bonds between SAT1 (LEU302-
PRO303); SAT2 (LEU297-PRO298) and SAT3 (LEU299-PRO300) were 
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designated as being in the cis conformation as specified in the template SAT1 
2WZR PDB file.  
 
2.4.6 Energy Minimization of SAT Homology Models 
 
All preparations and simulations were performed with the AMBER v12 suite of 
programmes.  
 
2.4.6.1 System Preparation  
 
The programme tleap was used to prepare the coordinate and parameter files 
that are needed to carry out the energy minimizations of the 18 SAT 
homology models. The Amberff12SB force field (Case et al., 2012) for 
proteins was used along with the TIP3P water model (Jorgensen et al., 1983). 
A truncated octahedron simulation box was generated. Na+ ions were used to 
neutralize the system by the addIons2 programme. Furthermore the saltcon 
parameter was used to obtain systems with a physiological salt concentration 
of 0.15M. Any intra-protomer disulfide bonds were built in the respective 
viruses. The tleap scripts used are in the Appendix.  
 
2.4.6.2 Energy Minimization of SAT Homology Models 
 
12,500 steps of conjugate gradient minimization were carried out on each of 
the systems. Firstly the water and Na+ molecules were minimized with the 
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protein backbone restrained. This was then followed by the minimization of 
the entire system.  
 
2.4.7 Homology Model Evaluation 
 
2.4.7.1 Structure Preparation for Homology Model Evaluation 
 
Prior to quality assessments of the homology models, the PDB files of the 
energy-minimised models were edited to remove the water, Na+ and Cl- ions.  
 
2.4.7.2 Homology Model Evaluation of SAT Homology Models 
 
The PDB files of all the homology models were uploaded to the SWISS-
MODEL server (“SWISS-MODEL,” 2006) (Arnold et al., 2006) for the 
stereochemical, energy and global quality evaluations. The PROCHECK and 
ANOLEA programmes were used to evaluate the stereochemical properties 
and energy profiles respectively of the homology models. QMEAN was used 
to assess the global quality of the models.  
 
For the RMSD calculations, the programme UCSF CHIMERA (Petterson et 
al., 2004) superimposed the respective homology models on each of the two 
templates (PDB ID: 2WZR and 1FOD) (Adams, n.d.; Logan et al., 1993).  
 
2.4.8 Generation of Pentamer Structures 
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Pentamer structures were generated using BIOMT transformations from the 
SAT1 PDB file (2WZR). 2WZR was chosen because it was the only template 
whose starting orientations were identical to those of the homology models. A 
script (Mono2poly.tcl) (Appendix) that reads BIOMT records and builds the 
corresponding biological units was used in the Tcl console of the programme 
VMD (Humphrey et al., 1996). The BIOMT transformations 1-5 were used to 
generate the pentamers of all the 18 SAT viruses. 
 
2.5 RESULTS and DISCUSSION 
 
2.5.1 Preparation of Structural Viral Protein Sequences 
 
The multiple sequence alignments between the SAT1, SAT2 and SAT3 
sequences with the discrete VP sequences obtained from the experimentally 
resolved SAT1 virus 2WZR (Figures 8, 9, 10 and 11), provided the 
coordinates of the respective VPs (Table 3). The four amino acid differences 
in sequence length between SAT1 and the other two serotypes are due to 
insertions in VP1 of SAT1 as highlighted in Table 3.  
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Figure 8: The delineation of the SAT1 polyproteins into the respective 
viral proteins (VP) 
The individual VP sequences obtained from the SAT1 X-ray crystal structure 
(PDB ID: 2WZR) were aligned to the SAT1 amino acid sequences used in this 
study. 
Matching residues are shown as periods (.) and ambiguous residues as 
hyphens (-).  
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Figure 9: The delineation of the SAT2 P1 polyproteins into the respective 
viral proteins (VP) 
The individual VP sequences obtained from the SAT1 X-ray crystal structure 
(PDB ID: 2WZR) were aligned to the SAT2 amino acid sequences used in this 
study. 
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Figure 10: The delineation of the SAT3 P1 polyproteins into the 
respective viral proteins (VP) 
The individual VP sequences obtained from the SAT1 X-ray crystal structure 
(PDB ID: 2WZR) were aligned to the SAT3 amino acid sequences used in this 
study.  
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Figure 11: The delineation of the SAT1, SAT2 and SAT3 P1 polyproteins 
into the respective viral proteins (VP) 
The individual VP sequences obtained from the SAT1 X-ray crystal structure 
(PDB ID: 2WZR) were aligned to the SAT1, SAT2 and SAT3 amino acid 
sequences respectively.  
 
 
Table 3: Viral protein coordinates deduced from alignments of the P1 
polyprotein sequences of SAT1, SAT2 and SAT3 sequences to that of 
the SAT1 X-ray crystal structure (PDB ID: 2WZR) 
 VP4 VP2 VP3 VP1 
SAT1 residue number 1 - 85 86 – 304 305 – 525 526 - 744 
SAT2 residue number 1 - 85 86 – 304 305 – 526 527 - 740 
SAT3 residue number 1 – 85 86 – 303 304 – 524 525 - 740 
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2.5.2 Identification of Templates for Homology Modelling 
 
A BLASTP search of the PDB database for homologues of the SAT1, SAT2 
and SAT3 viruses returned a list of structures, from which those that were in 
complex with a ligand were excluded from being templates. This left 2WZR 
(type SAT1) (Adams, n.d.), 4GH4 (type A22 Iraq) (Curry et al., 1996), 1BBT 
(type O1 BFS 1860) (Fry et al., 1993) and 1FOD (type O) (Logan et al., 1993) 
as the top four candidate templates. 
 
The multiple sequence alignment of the candidate templates with one of the 
SAT target sequences (Figure 12) revealed a gap in the homologues that 
corresponds to the region of the large and immunogenic GH loop of VP1 in 
the all structures, with the exception of 1FOD (Figure 13). The GH loop is 
highly flexible and therefore not resolved in X-ray crystal structures. 
Resolution of this loop was attained in 1FOD by the chemical reduction of the 
disulfide bond that anchors the GH loop in type O viruses. There is another 
structure referred to in the literature that is type O1 Kaufbeuren, which has a 
resolved GH loop but its structure is not in the PDB database (Borley et al., 
2013).  
 
Another major gap in the template multiple sequence alignment corresponded 
to the C-terminal end of VP1 (Figure 12), which is a disordered loop, and a 
known antigenic site (Kitson et al., 1990). Furthermore, two gaps are found on 
regions corresponding to VP4 of all templates (Figure 12). These gaps are 
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attributed to the fact that the internally located VP4 has a primarily disordered 
structure (Acharya et al., 1989).  
 
Two X-ray crystal structures, namely 2WZR and 1FOD were chosen as the 
final templates on which to build homology models of the SAT viruses. The 
former was chosen because it has the highest average sequence identity with 
the SAT sequences of 69.64%. The latter structure was selected as an 
additional template, despite its lower average sequence identity with the SAT 
viruses of 51.42%, to aid in modelling the GH loop. The quality of homology 
models was expected to be equal to that of low-resolution X-ray crystal 
structures due to the high sequence identities above 50% between the 
template and target sequences (Forrest et al., 2006). Comparison statistics of 
the two templates are highlighted in Table 4. The resolutions of the templates 
are 2.6Å for 1FOD and 3Å for 2WZR. These resolutions imply that the side-
chain atoms are resolved with an accuracy of ± 0.4Å and the templates are of 
good enough quality to use in homology modelling (Forrest et al., 2006). 
 
Table 4: Quality assessment of the two foot-and-mouth disease virus X-
ray crystal template structures used in building homology models of the 
SAT1, SAT2 and SAT3 viruses 
  2WZR  
(type SAT 1) 
1FOD 
(type O) 
Sequence identity with SAT sequences 69.64% 51.42% 
Resolution of X-ray structures 3Å 2.6Å 
QMEAN (Z-score) -1.61 -0.59 
PROCHECK Ramachandran plot  
(Disallowed region) 
1.2% 0.2% 
Resolved amino acids  669aa 691aa 
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Figure 12: Multiple sequence alignment of the top scoring homologues 
from the BLASTP search of the PDB database and a SAT1 P1 sequence 
The gap that corresponds to the GH loop in VP1 is highlighted with a shaded 
blue box; the C-terminal end of VP1 is highlighted with a shaded green box;  
the gaps in VP4 are highlighted with a shaded yellow box. 
The homologues are 1BBT (type O1); 1FOD (type C); 1FMD (type O); 4GH4 
(type A); 2WZR (type SAT1). 
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1BBT 
1FOD 
2WZR 
4GH4 
 
Figure 13: Comparison of four candidate template structures (PD IDs: 
1FOD, 4GH4, 1BBT, 2WZR) highlighting the presence of a resolved GH 
loop in only one X-ray crystal structure 
VP1 is shown as a blue ribbon. 
VP2, 3 and 4 are shown as dark grey ribbons. 
The location of the GH loop of VP1 is highlighted with a shaded blue oval and 
it is noticeably absent from all templates except 1FOD. 
The templates are 1FOD (type C); 4GH4 (type A); 1BBT (type O1); 2WZR 
(type SAT1). 
Image was generated using UCSF Chimera (Petterson et al., 2004). 
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2.5.3 Building Homology Models of the SAT protomers 
 
2.5.3.1 Multiple Alignments for Homology Modelling 
 
Examples of the multiple sequence alignments between the two templates 
2WZR and 1FOD and representative target sequences of the three serotypes 
are illustrated in Figures 14, 15 and 16. The rest of the multiple sequence 
alignments are in the Appendix.  
 
2.5.3.2 Building the homology models 
 
The protomers of the 18 SAT homology models built using MODELLER are 
shown in Figure 16. On visual inspection, the structures of the different SAT 
strains show a high degree of similarity within the core regions, and larger 
variations occur on the surface exposed loops and termini.  
 
The surface exposed VP1, VP2 and VP3 across all the strains were void of 
gross errors because they largely consist of highly conserved and ordered E-
barrels. However, four of the strains (ZAM/02/93/2, ZAM/04/96/3, ZIM/05/91/3 
and ZIM/25/90) had some gross errors in the orientation adopted by VP4. 
Parts of VP4 were tangled in either one of the surface exposed proteins, VP1 
or VP2 (Figure 17). Inspection of the respective VP4s revealed that there are 
large variations in the conformations adopted by the disordered protein 
among these four homology models (Figure 18). These errors may be 
attributed to the fact that VP4 is 38.8% unresolved in the X-ray crystal 
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structures of the two templates 1FOD and 2WZR. This is coupled with the 
limitations of homology modelling in building models of proteins with no 
suitable template. A search of the PDB for alternative templates for VP4 was 
unsuccessful as all homologous proteins are internal capsid proteins of 
various viral families and are similarly poorly resolved.  
 
The errors of VP4 on the ZAM/02/93/2, ZAM/04/96/3, ZIM/05/91/3 and 
ZIM/25/90 strains were ignored because they do not appear to affect the 
structure of the surface exposed VPs. In further studies it may be worth 
attempting to build models of VP4 using ab initio methods.  
 
2.5.4 Energy Minimization of SAT Homology Models 
 
Prior to energy minimizations, the SAT1, SAT2 and SAT3 systems consisted 
of approximately 141,000, 130,000 and 147,000 atoms respectively (Figure 
19). The 12,500 steps of conjugate gradient energy minimization were 
sufficient to stabilize the energy and RMSDs of the protomer backbones 
(Table 5). These results suggest that the protomers adopted stable 
conformations.  
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Figure 14: Multiple sequence alignment of a SAT1 target (SAR/09/81) and 
two template sequences (PDB IDs: 1FOD and 2WZR) for input in 
homology modelling programme MODELLER 
 76 
 
Figure 15: Multiple sequence alignment of a SAT2 (ANG/04/74/2) target 
and two template sequences (PDB IDs: 1FOD and 2WZR) for input in 
homology modelling programme MODELLER  
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Figure 16: Multiple sequence alignment of a SAT3 target (ZAM/04/96/3) 
and two template sequences (PDB IDs: 1FOD and 2WZR) for input in 
homology modelling programme MODELLER 
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ZAM/02/93/2   ZAM/04/96/3   ZIM/05/91/3 
 
   
ZIM/25/90   ANG/04/74/2 
 
   
2WZR (template)  1FOD (template) 
Figure 18: Comparison of the orientations adopted by the VP4 protein among 
the SAT homology models and the templates on which it was modelled 
The VP4 homology models were built as part of 18 SAT virus protomer models using 
the type SAT1 and O templates (PDB IDs: 2WZR and 1FOD) as templates.  
The orientation of VP4 in the ZAM/02/93/2, ZAM/04/96/3, ZIM/05/91/3 and ZIM/25/90 
is incorrect. 
The orientation of VP4 in ANG/04/74/2 is correct. 
 82 
 
Figure 19: Example of a SAT2 (ANG/04/74/2) homology model protomer 
in an octahedron box of water prior to energy minimizations 
18 SAT protomer homology models were prepared for energy minimization 
using the tleap programme of AMBER (Case et al., 2012).   
The water molecules are shown in light grey. 
The Na+ ions are illustrated as purple spheres. 
VP1 is illustrated as a blue ribbon. 
VP2 is illustrated as a green ribbon. 
VP3 is illustrated as a red ribbon. 
VP4 is illustrated as a yellow ribbon. 
Image was generated using UCSF Chimera (Petterson et al., 2004). 
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Table 5: Example of energy and root mean square (RMS) values of a 
SAT1 protomer (SAR/09/81) following 12,500 steps of conjugate gradient 
minimization 
Minimization of water with restrained protein backbone 
NSTEP 
1 
ENERGY 
-3.2011E+05 
RMSD 
1.0896E+03 
NSTEP 
5000 
ENERGY 
-5.0579E+05 
RMS 
1.3315E-01 
Minimization of water and protein backbone 
NSTEP 
1 
ENERGY 
-5.3887E+05 
RMSD 
1.1263E+00 
NSTEP 
7500 
ENERGY 
-5.9657E+05 
RMS 
1.2879E-01 
18 SAT protomer homology models were subjected to energy minimization 
using the tleap programme of AMBER (Case et al., 2012). 
 
 
2.5.5 Homology Model Evaluations 
 
2.5.5.1 PROCHECK Analysis 
 
The Ramachandran Plot analyses of the 18 SAT homology models revealed 
that on average 98.5% of all the residues were in sterically allowed regions, 
which is comparable to the X-ray crystal template structures 1FOD and 2WZR 
(Figure 20). Approximately 1.5% of the residues in the homology models were 
assigned in the disallowed regions. Those residues marked as having a bad 
conformation are located in the loop regions and disordered N- and C-terminal 
ends and therefore do not need to be corrected as they do not affect the core 
regions of the models. It may therefore be concluded that the homology 
models were of good quality.  
 
2.5.5.2 ANOLEA Analysis 
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The ANOLEA analyses of the homology models showed that the energy 
profiles of the homology models are comparable to, and better than those of 
their templates (Figure 21). The high-energy zones correspond to large loops 
and disordered regions such as the N- and C-terminal ends of VP1 and VP4 
and can therefore be ignored. Furthermore, high-energy zones may 
correspond to potential protein-protein binding sites (Melo et al., 1997), which 
in this case would be the antigenic sites. As previously mentioned, antigenic 
sites tend to be located on protruding, disordered loop regions (Acharya et al., 
1990). 
2.5.5.3 QMEAN Analysis 
 
The Z-scores of the homology models following energy minimization are 
shown in Table 6, where they are compared to those of their template 
structures. The lower scores of the homology models may be attributed to the 
GH loop and the disordered regions of VP4 that were unresolved in the 
templates but are present in the homology models. These regions are not 
expected to adopt favourable conformations and are therefore expected to 
lower the Z-scores of the homology models. Despite the fact that the Z-scores 
of the homology models are lower than that of the templates, they fall within 
the range that is expected for experimentally resolved protein structures 
(Benkert et al., 2011) (Figure 22).  
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Figure 20: PROCHECK Ramachandran plot analyses of template 
structures (PDB IDs: 2WZR and 1FOD) and a SAT2 KNP/02/89/2 
homology model 
The PROCHECK programme was used to evaluate the stereochemical 
properties of 18 SAT protomer homology models and their template structures 
in the form of a Ramachandran plot. 
The most favoured region is coloured red.  
The additional allowed region is coloured yellow.  
The generously allowed region is coloured light yellow. The disallowed region 
is coloured white. 
98% of the residues fell in the favourable regions. 
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2.5.5.4 Root Mean Square Deviation 
 
The average RMSD of each of the serotypes from the 2WZR and 1FOD 
templates is 1Å (Table 7), and the median and mode RMSD values are 0.9Å 
respectively. Therefore the homology models, with over 50% sequence 
identity are comparable to their template structures (Baker & Sali, 2001). Five 
of the homology models have RMSD values above 1.5Å (Table 7), which is 
the threshold for medium quality models (Baker & Sali, 2001). However, it 
should be noted that the RMSD gives an overall measure of structural 
variability and averages out any highly variable regions over the entire 
structure (Cristobal et al., 2001). For FMDVs, the RMSD of the core regions 
can be less than 1Å, while the loop regions can vary by as much as 12Å 
(Curry et al., 1995).  
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1FOD (type O) 
 88 
 
    2WZR (type SAT1) 
 89 
 
KNP/01/08 (SAT1 homology model) 
Figure 21: ANOLEA profile of template structures (PDB IDs: 2WZR and 
1FOD) and a SAT3 homology model KNP/01/08 
The ANOLEA programme was used to evaluate the energy profiles of 18 SAT 
protomer homology models. 
The energy values and the residue numbers are plotted on the y- and x-axes 
respectively. 
The green bars corespond to low-energy,  favourable regions. 
The red bars correspond to high-energy, unfavourable regions. 
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Table 6: The QMEAN Z-scores of the 18 SAT protomer homology models 
and the template structures (PDB IDs: 2WZR and 1FOD) 
FMDV Structure QMEAN  
Z-score 
 FMDV Structure QMEAN 
Z-score 
ANG/04/74/2 -2.28  UGA/01/97 -2.59 
KEN/03/57/2 -2.34  UGA/02/02/2 -2.51 
KNP/01/08 -2.03  UGA/03/99 -2.00 
KNP/02/89/2 -2.03  ZAM/02/93 -2.63 
KNP/19/89/2 -2.38  ZAM/04/96/3 -2.54 
KNP/196/91  -2.20  ZIM/01/88/2 -2.26 
NAM/307/98 -2.34  ZIM/05/91/3 -2.69 
SAR/09/81  -2.03  ZIM/07/83/2 -2.26 
SAU/06/00/2 -2.66  ZIM/25/90  -2.32 
1FOD (template) -0.59  2WZR (template) -1.61 
The QMEAN (Benkert et al., 2009) programme was used to evaluate the 
global quality of 18 SAT protomer homology models and their template 
structures. 
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1FOD (type O)   2WZR (type SAT1) 
     
ANG/04/74/2 (SAT2 homology model) 
Figure 22: QMEAN plot illustrating the Z-scores of template structures 
(PDB IDs: 2WZR and 1FOD) and a SAT2 ANG/04/74/2 homology model in 
comparison to experimentally resolved structures 
The QMEAN programme was used to evaluate the global quality of 18 SAT 
protomer homology models and their template structures. 
The respective structures under investigation are marked with a red X. 
The red and grey cricles correspond to experimentally resolved structures in 
the Protein Databank. The normalised QMEAN scores of these experimental 
structures are plotted according to protein size.  
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Table 7: Root mean square deviations of the 18 SAT protomer homology 
models in comparison to two template structures (PDB IDs: 2WZR and 
1FOD) 
SAT1 Strain RMSD (Å) relative to 
2WZR Template 
 RMSD (Å) relative to 
1FOD Template 
KNP/196/91 1,3  1,0 
NAM/307/98 1,1  0,9 
SAR/09/81 1,6  0,8 
UGA/01/97 2,4  0,8 
UGA/03/99 1,2  0,9 
ZAM/02/93 0,8  0,9 
ZIM/25/90 1,6  0,9 
SAT2 Strain RMSD (Å) relative to 
2WZR Template 
 RMSD (Å) relative to 
1FOD Template 
ANG/04/74/2 1,0  2,9 
KEN/03/57/2 0,5  2,2 
KNP/02/89/2 0.9  0,9 
KNP/19/89/2 1,0  0,8 
SAU/06/00/2 0,9  0,9 
UGA/02/02/2 1,0  1,0 
ZIM/01/88/2 0,9  0,9 
ZIM/07/83/2 0,7  0,6 
SAT3 Strain RMSD (Å) relative to 
2WZR Template 
 RMSD (Å) relative to 
1FOD Template 
KNP/01/08 1,3  0,7 
ZIM/05/91/3 1,1  0,6 
ZAM/04/96/3 1,5  0,7 
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2.5.6 Generation of Pentamer Structures 
 
A representative pentamer of a SAT virus is illustrated in Figure 23.  
 
 
Figure 23: Example pentamer of a SAT2 strain (ANG/04/74/2) 
18 SAT protomer homology models were built using SAT1 and O foot-and-
mouth disease virus structures (PDB IDs: 2WZR and 1FOD) as templates. 
The pentamers were generated using BIOMT transformations from 2WZR. 
VP1 is illustrated in blue. 
VP2 is illustrated in green. 
VP3 is illustrated in red. 
Image was generated using UCSF Chimera (Petterson et al., 2004). 
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2.5.7 Insights From the Homology Models 
 
2.5.7.1 Tertiary Structure of the Capsid Proteins 
 
The VP1 in the SAT strains lies in a different plane to the rest of the surface 
exposed VPs as it is canted towards the five-fold axis of symmetry (Figure 
24). This is a conserved feature in Picornaviruses, but it is exaggerated in 
FMDVs (Acharya et al., 1989).  
 
The cores of the surface exposed proteins VP1, VP2 and VP3 of the SAT viral 
protomers (Figure 16) all possess an eight-stranded anti-parallel E-barrel that 
is characteristic of Picornaviruses (Figure 4) (Acharya et al., 1989; Larsson, 
2012). On the other hand, most of VP4 has a disordered structure and a well-
defined helix comprising three turns (Figure 25). This helix is a novel feature 
of FMDVs among the Picornaviruses (Acharya et al., 1989). 
 
2.5.7.2 Intra-Protomer Disulfide Bonds 
 
All the SAT1 models have a disulfide bond at the base of the VP1 GH loop 
(Figure 26) that is between residues 135 of VP1 and 130 of VP2. All the SAT2 
models, except the SAU/06/00/2 strain, have a similar disulfide bond 
anchoring the GH loop of VP1 between residues 134 of VP1 and 130 of VP2 
(Figure 26). In SAU/06/00/2, the mutation at residue 130 VP2 is CysÆSer. 
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Figure 24: Example of sectional view of a SAT2 (ANG/04/74/2) foot-and-
mouth disease virus pentamer 
18 SAT protomer homology models were built using SAT1 and O foot-and-
mouth disease virus structures (PDB IDs: 2WZR and 1FOD) as templates. 
The pentamers were generated using BIOMT transformations from 2WZR. 
VP1 is illustrated in blue. 
VP2 is illustrated in green. 
VP3 is illustrated in red. 
VP4 is illustrated in yellow. 
Image was generated using UCSF Chimera (Petterson et al., 2004). 
 
 
 96 
 
Figure 25: Example of the fold of VP4 on SAT foot-and-mouth disease 
viruses 
VP4 among the SAT viruses has a largely disordered structure with a three-
turn helix unique to foot-and-mouth disease viruses among the 
Picornaviruses. 
Image was generated using UCSF Chimera (Petterson et al., 2004). 
 
 
This disulfide bond is characteristic of several Picornaviruses and typically 
occurs between residue 135 of VP2 and a residue on VP1 (Hogle et al., 1985; 
Luo et al., 1987; Rossmann et al., 1985). On the SAT3 strains, there is a 
CysÆHis mutation at residue 130 of VP2 that prevents the formation of a 
disulfide bond. Interestingly, on two of the SAT3 strains ZIM/05/91/3 and 
ZAM/04/96/3, a unique disulfide bond may be present at the base of the GH 
loop, between two VP1 residues 134 and 163 (Figure 26). The CD atoms of 
Cys 134 and Cys 163 of VP1 are at a close enough proximity of 9Å to 
theoretically form a bond. This is comparable to a distance of 8.9Å, which is 
found between the CD atoms involved in the disulfide bond of the 
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experimental SAT1 structure (PDB ID: 2WZR). It would be of interest to 
investigate whether this putative bond found on some of the SAT3 viruses 
alters the dynamics of the GH loop relative to the other SAT serotypes. The 
disulfide bond that anchors the GH loop is the main determinant of the 
conformation adopted by the loop and it aids in its flexibility (Lea et al., 1994). 
Structural studies have revealed that despite the highly flexible nature of the 
GH loop, it adopts conformations that can be distinguished among the 
different FMDV serotypes (Acharya et al., 1989; Curry et al., 1995; Lea et al., 
1994). 
 
Amongst the FMDVs, only serotype O was previously known to possess this 
disulfide bond at the base of the GH loop (Acharya et al., 1990). The 
presence of this bond is thought to account for the tendency of monoclonal 
antibodies against the type O strains to recognise discontinuous epitopes and 
whereas the ones against type A strains without this bond recognise linear 
epitopes (Acharya et al., 1990; Bolwell et al., 1989; Parry et al., 1990).  
 
The GH loops in this study were modelled using that of the X-ray crystal 
structure of the type O virus, 1FOD because it is the only FMDV structure in 
which the GH loop has been resolved. Resolution of the loop was achieved by 
chemically reducing the disulfide bond at its base. It would therefore stand to 
reason that the conformations adopted by the GH loops in the SAT homology 
models are not necessarily in the correct orientation. For this reason, the GH 
loop was excluded from the epitope prediction study.  
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SAU/06/00/2       ANG/04/74/2  
(SAT2 no disulfide bond)    (SAT2 disulfide bond) 
 
ZAM/04/96/3 
(SAT3 disulfide bond) 
 
Figure 26: Highlighting the absence and presence of a disulfide bond at 
the base of the GH loop of VP1 
18 SAT protomer homology models were built using SAT1 and O foot-and-
mouth disease virus structures (PDB IDs: 2WZR and 1FOD) as templates.  
VP1 is illustrated as a light blue ribbon. 
VP2 is illustrated as a light green ribbon. 
VP3 is illustrated as a salmon ribbon. 
VP4 is illustrated as a yellow ribbon. 
The Cys residues involved in the disulfide bond are highlighted as spheres.  
Image was generated using UCSF Chimera (Petterson et al., 2004). 
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2.5.7.3 E-Annulus 
 
The E-annulus is an opening in all Picornaviruses that leads from the surface 
of the capsid to the interior, and it is located at the five-fold axis of symmetry 
(Figure 27). It is made up of the N-termini of five VP3 molecules (Hogle et al., 
1985; Luo et al., 1987; Rossmann et al., 1985). The hole is 11Å in diameter at 
the surface and narrows to 6Å on the O serotype (Acharya et al., 1989).  
 
There are five Cys residues surrounding the E-annulus in types SAT2 and 
SAT3, one from each of the protomers. However, the X-ray crystal structure of 
type O revealed that only four of the Cys residues are involved in disulfide 
bonds (Acharya et al., 1990). The disulfide bonds are between Cys 7 of VP3 
in SAT2 and SAT3. The exceptions are the SAT2 strain SAU/06/00/2, whose 
residue 440 is mutated to the small hydrophobic Ala and all the SAT1 strains, 
whose residue 445 is mutated to the small hydrophobic Val or Ala. These 
mutations are not expected to have an effect on the integrity of the pentamers 
because it has been shown that the absence of these disulfide bonds does 
not have an effect on pentamer stability or infectivity (Acharya et al., 1990).  
 
2.6 CONCLUSIONS 
 
Homology models of the 18 SAT topotypes were successfully built. The 
internally located VP4 on four of the strains showed some gross errors, which 
can be attributed to the largely disordered nature of this protein and its poor 
resolution in the X-ray crystal structures. However, stereochemical and 
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energy analyses proved that the models were of a good quality. The surface 
exposed capsid proteins consist of a jelly-roll fold that is characteristic of 
Picornaviruses. Most of the SAT1 and SAT2 viruses possess a disulfide bond 
at the base of the GH loop that among the FMDVs was only previously 
described in type O viruses. A unique version of this disulfide bond was 
identified among two of the SAT3 strains that is between two VP1 Cys 
residues as opposed to between a VP1 and VP2 residue.  
 
 
Figure 27: E-annulus at five-fold axis of symmetry on a foot-and-mouth 
disease virus pentamer 
The pentamer surface is illustrated in grey. 
The conserved residues at the E-annulus are illustrated as spheres. 
Cys 7 of VP3 is shown as magenta spheres. 
Phe 3 of VP3 is shown as cyan spheres. 
Val 5 of VP3 is shown as black spheres. 
Image was generated using UCSF Chimera (Petterson et al., 2004). 
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IN SILICO EPITOPE PREDICTION 
 
3.1 IN SILICO EPITOPE PREDICTION METHODS REVIEW 
 
3.1.1 Devising a Discontinuous Epitope Prediction Method  
 
3.1.1.1 Training Dataset Construction   
 
The first step to devising any epitope prediction algorithm is the definition of a 
training dataset. Discontinuous epitope prediction methods use X-ray 
crystallographic information of Ab-antigen complexes to train their algorithms 
(Greenbaum et al., 2007). Redundancy is removed from the training datasets 
by generally allowing protein families to have equal representation (Andersen 
et al., 2006). To avoid over-fitting the algorithm, different parts of the dataset 
are used for training and evaluation (Andersen et al., 2006).  
  
3.1.1.2 Epitope Definition and Benchmark Dataset Annotation 
 
In order to train the prediction algorithms, an epitope needs to be defined 
(Greenbaum et al., 2007) and the various epitope prediction methods 
describe epitopes differently. In the Discotope2.0 (Kringelum et al., 2012) 
dataset, epitopes were defined as those antigen amino acids that are a 
distance of at most 4Å from any of the Ab atoms (Andersen et al., 2006). In 
the BEPro training dataset, an epitope is any antigen residue that is no further 
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than 6Å from the CDRs of the antibody chains, thereby excluding incidental 
contacts (Schlessinger et al., 2006; Sweredoski & Baldi, 2008). 
 
Surface exposure is another measure incorporated in the epitope prediction 
algorithms in order to aid in the definition of epitopes. In Epitopia, a surface 
amino acid is defined as any residue on a 3-D structure with a relative 
accessible surface area (relative ASA) greater than 0.05 (Rubinstein et al., 
2009). For SEPPA, a residue was defined as surface exposed if it had at least 
1Å2 of ASA (Sun et al., 2009). Furthermore, a surface exposed residue was 
an epitope if it lost at least 1Å2 of ASA upon binding with its antibody (Sun et 
al., 2009). In Discotope2.0 the upper half-sphere neighbour count measure 
(Hamelryck, 2005) was used as a measure of surface exposure (Hamelryck, 
2005; Kringelum et al., 2012),.  
 
An additional epitope definition that is part of Ellipro’s algorithm is that of the 
protrusion index (Ponomarenko et al., 2008). The protrusion index provides a 
simplistic way of detecting those parts of the protein that protrude from the 
protein’s surface. Residues with high protrusion index values are often 
associated with antigenic sites (Thornton et al., 1986).  
 
Most epitope prediction methods allow for the annotation of only one epitope 
per antigen in their training datasets (Andersen et al., 2006; Rubinstein et al., 
2009; Sweredoski & Baldi, 2008). This does not take into consideration the 
fact that not all epitopes on any particular antigen have been experimentally 
identified (Kringelum et al., 2012; Rubinstein et al., 2009; Sweredoski & Baldi, 
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2008). Improper benchmark annotation has a direct influence on the 
predictive abilities of the algorithms as well as the performance measures of 
the methods (Greenbaum et al., 2007; Kringelum et al., 2012; Sweredoski & 
Baldi, 2008).   
 
3.1.2 Discontinuous Epitope Prediction Machine-Learning Algorithms 
 
Five epitope prediction algorithms are discussed, namely Discotope 
(Andersen et al., 2006; Kringelum et al., 2012), BEPro (Sweredoski & Baldi, 
2008), Ellipro (Ponomarenko et al., 2008), Epitopia (Rubinstein et al., 2009) 
and Seppa (Sun et al., 2009) (Table 8). These are among the most widely 
used and freely available epitope prediction algorithms to date, as well as the 
ones suitable for the analysis of multimeric structures such as virus capsid 
proteins (Borley et al., 2013). 
 
3.1.2.1 Discotope  
 
Discotope (versions 1.0 and 2.0) integrates amino acids statistics expressed 
as log-odds ratios, spatial information and surface exposure in its algorithm 
(Andersen et al., 2006; Kringelum et al., 2012). It is notable in that it was the 
first epitope prediction method (as Discotope1.0) to make use of both 
propensity scale scores and structural information in its algorithm (Andersen 
et al., 2006). During execution of the Discotope algorithm, a 10Å radial sphere 
around each residue along the antigen chain is explored for intra-molecular 
contact residues. The total number of residues within the sphere is subtracted 
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from the sum of propensity scores of those ‘contact’ residues’ (Kringelum et 
al., 2012).  
 
3.1.2.2 BEPro  
 
BEPro, formerly known as PEPITO was initially conceived as an alternative 
method to Discotope. BEPro, like Discotope combines propensity scales with 
surface exposure information, namely the upper half sphere neighbour count 
measure. BEPro utilizes the Discotope amino acid propensity scale (Andersen 
et al., 2006) in its algorithm, side-chain orientation as well as solvent 
accessibility data (Sweredoski & Baldi, 2008). BEPro is available online as a 
part of the SCRATCH suite of programmes (Cheng et al., 2005).  
 
3.1.2.3 Ellipro 
 
Ellipro differs from other epitope prediction methods in that it does not require 
training (Ponomarenko et al., 2008). It is based on the notion that residues 
that protrude from the protein surface are more accessible for antibody 
binding (Atassi, 1984) and that these protruding residues can be identified by 
treating the protein as an ellipsoid (Taylor et al., 1983). Ellipro uses 
Thornton’s method (Thornton et al., 1986) in combination with a residue-
clustering algorithm to predict epitopes (Ponomarenko et al., 2008).  
 
3.1.2.4 Epitopia  
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Epitopia applies two machine learning based algorithms for the prediction of 
epitopes from either the tertiary structure of the antigen or directly from its 
sequence (Rubinstein et al. (a), 2009). A total of 44 physico-chemical and 
structural-geometrical properties for structure-based prediction and 41 for 
sequence-based prediction were used to train the Epitopia algorithm 
(Rubinstein et al. (b), 2009). The immunogenic properties used to predict 
epitopes from sequences naturally do not include some of the structural-
geometrical properties used for structure-based prediction (Rubinstein et al. 
(b), 2009). These properties included previously used as well as novel amino 
acid propensity scales. 
 
3.1.2.5 SEPPA  
 
SEPPA employs the concept of the ‘unit patch of residue triangle’ to describe 
the local spatial context of a protein’s surface amino acids (Sun et al., 2009). 
The novel concept of ‘unit patch of residue’ is used by SEPPA to give an 
improved description of the local spatial context on the antigen surface. The 
unit patch of residue triangle is made up of any three surface residues whose 
respective side-lengths is less than 4Å (Sun et al., 2009). Those unit patches 
containing at least two epitopes were defined as epitope unit patches, and 
those containing less than two epitopes were defined as non-epitope patches 
(Sun et al., 2009). Epitope propensity scores are summed up for all unit 
patches within a 15Å radius of each residue in the antigen (Bublil et al., 2007). 
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Table 8: A summary of the features of some widely used epitope 
prediction methods 
Epitope 
Prediction 
Method 
Online Server  Brief Notes (Features 
used in prediction  
method)  
Discotope1.0 
Discotope2.0 
www.cbs.dtu.dk/services/DiscoTope/ 
 
Amino acid statistics, 
spatial context, surface 
accessibility 
BEPro http://pepito.proteomics.ics.uci.edu  
 
Half sphere exposure 
values 
Ellipro http://tools.immuneepitope.org/ellipro  
 
Protrusion index 
Epitopia http://epitopia.tau.ac.il  
 
Based on Naïve Bayes 
classifier with 
physicochemical and 
structural geometrical 
properties 
SEPPA http://lifecenter.sgst.cn/seppa/ 
 
Unit patch of residue 
triangle 
Adapted from (Sun et al., 2013) 
 
3.2.1.6 Use of Consensus Results to Improve Predictive Ability  
 
As previously mentioned, a comparative study was carried out on the 
predictive abilities of five of the top epitope prediction programmes on intact 
virus capsids. It showed that Discotope, Ellipro and Epitopia are the best 
predictors of epitopes on intact FMDV capsid proteins, whereas BEPro and 
SEPPA performed poorly (Borley et al., 2013). Furthermore, using a 
consensus of the three best performing methods results in increased 
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specificity and accuracy. However, when it comes to predicting novel 
epitopes, a consensus of any two of the top three performing methods is best 
as it provides an improvement in sensitivity and specificity (Borley et al., 
2013). It was therefore decided to employ the use of two epitope prediction 
methods in this study.  
 
3.2 METHODS 
 
3.2.1 Homology Model Preparation for Epitope Prediction 
 
3.2.1.1 Generation of Pentamer Dimer Structures 
 
In order to account for neotopes, which are inter-protomeric epitopes and the 
FMDV’s icosahedral symmetry, pentamer dimer structures were generated. 
BIOMT transformations were copied from the SAT1 PDB file (2WZR) and 
pasted into the PDB files of the homology models. 2WZR was chosen 
because it was the only template whose starting orientations were identical to 
those of the homology models. A script (Mono2poly.tcl) (Appendix) that reads 
BIOMT records and builds the corresponding biological units was used in the 
Tcl console of the programme VMD. The BIOMT transformations 1-5 and 41-
45 were used to generate the two adjoining pentamers of all the 18 SAT 
viruses.  
 
3.2.1.2 Addition of SEQRES Records to Homology Model PDBs 
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The computational epitope prediction programs require input PDB files to 
have a SEQRES record, which MODELLER-built homology models lack. The 
PDB files of the pentamer dimers were uploaded to the website www.igs.cnrs-
mrs.fr and as output, the same files were returned with a SEQRES record. 
The chains were also renumbered, so that each protomer was labelled as a 
super-chain (Figure 28).  
 
3.2.2 Epitope Prediction 
 
The PDB files of the pentamer dimers were used as input to the epitope 
prediction server of Ellipro and the standalone version of Discotope1.0. The 
chains that were selected for evaluation are as described in (b) of Figure 28. 
The threshold values employed for the respective programmes are as 
described in Table 9. The default threshold value of -7.7 for Discotope1.0 was 
employed. For Ellipro, a higher threshold of 0.8 was used.  
 
The predicted epitopes were mapped on to the respective protomers in order 
to filter the surface exposed residues from those that are internally located, as 
the programmes treat all structures as globular proteins. Those residues that 
were predicted as epitopes by both programmes were defined as epitopes.  
 
Furthermore consensus epitopes across the three SAT serotypes were 
determined. The presence on at least 15 out of the 18 SAT strains was 
required for an epitope to be defined as a consensus epitope. This threshold 
was chosen because the 15 SAT1 and SAT2 strains used in this study are the 
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predominant causes of FMD outbreaks in Africa amongst the three SAT 
serotypes. A rational vaccine designed on the basis of at least 15 strains 
would provide ideal cross-protection against the dominant topotypes. 
Furthermore some of the SAT1 and SAT2 predicted epitopes can be validated 
by published experimental data. Epitope mapping data using MAb virus 
escape mutants are available for SAT1 and SAT2 strains (Crowther et al., 
1993b; Grazioli et al., 2006; Opperman et al., 2012).  
 
Table 9: A comparison of the default threshold values to the optimal 
threshold values used in this study for epitope prediction by the 
Discotope 1.0 and Ellipro programmes 
Programme Default threshold 
value 
Threshold value used 
in this study 
Discotope1.0 -7.7 -7.7 
Ellipro 0.5 0.8 
 
 
3.2.3 Root Mean Square Deviation of Consensus Epitopes 
 
The programme UCSF Chimera was used to calculate the RMSD of the 
consensus epitopes between the SAT serotypes.  
 
3.2.4 Protein Variability Index of the SAT Viruses 
 
3.2.4.1 Multiple Alignments for Protein Variability Index 
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A multiple sequence alignment of the 18 SAT amino acid sequences was built 
using default parameters in ClustalO. The order of VPs in the amino acid 
sequences was VP1-4 as opposed to the natural polyprotein order of VP4, 2, 
3, and 1. The SAT multiple sequence alignment was visualised using CLC 
Bio.  
 
 
Figure 28: A schematic diagram of the foot-and-mouth disease virus 
icosahedral capsid illustrating the protomers to be used in the epitope 
prediction calculations 
(a) The individual outer viral protein chains are labelled VP1-3, thereby 
constituting the outer part of a protomer 
(b) The four protomers, which will be included in the epitope prediction 
analysis are labelled as Chain 1-4 
Adapted from: (Borley et al., 2013) 
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3.2.4.2 Protein Variability Index 
 
The SAT1, SAT2 and SAT3 multiple sequence alignment was used as input 
to the Protein Variability Server (PVS) (“Protein Variability Server,” 2008) 
(Garcia-Boronat et al., 2008), which then generated a protein variability plot of 
the SAT sequences. The variability coefficient employed was Wu-Kabat.  
 
3.3 RESULTS and DISCUSSION 
 
3.3.1 Generation of Pentamer Dimer Structures 
 
The outer surface and a sectional view of the joint pentamer dimers are 
illustrated in Figure 29.  
 
3.3.2 Annotation of Predicted Epitopes  
 
Since the FMDV serotypes have different annotation systems for antigenic 
sites, these methods of annotation were not used so as to allow for the 
comparison of epitopes between all serotypes. The epitopes that were 
predicted among the various SAT strains were grouped according to serotype 
and their relative locations on the virus protomer. The antigenic sites were 
described as being located on either the two-, three- or five-fold axis of 
symmetry, or on the centre of the protomer (Figure 3). The specific epitopes 
were further described according to the specific loops on which they are 
located (Tables 10, 11 and 12). The loops are annotated according to 
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Picornavirus convention of the jelly-roll fold (Figure 2). The epitopes for the 
respective serotypes, SAT1, SAT2 and SAT3 are illustrated in Figure 30.  
 
Predicted epitopes on the GH loop and C-terminal end of VP1 were excluded 
from analysis, because their orientations are known to vary among the various 
serotypes, and further studies to determine their dynamics are outside the 
scope of this project.  
 
3.3.3 Predicted Epitopes on SAT1 Homology Models 
 
3.3.3.1 SAT1 Five-Fold Axis 
 
A set of epitopes on the five-fold axis of symmetry were predicted on the EB-
EC loop of VP1, namely epitopes 46, 47, 48 and 50 (Table 10). These 
epitopes lie adjacent to and overlap known epitopes at the same site in types 
O (43, 44, 45, 48 ) (Kitson et al., 1990) and Asia 1 (48) (Grazioli et al., 2012). 
The SAT1 strains NAM/307/98, UGA/01/97 and ZAM/02/93 were not 
predicted as containing any epitopes on the EB-EC loop of VP1.  
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(a)    (b) 
Figure 29: Two joint pentamers, which form part of a SAT foot-and-
mouth disease virus capsid 
(a) The outer surface of two joint pentamers 
(b) Sectional view of two joint pentamers 
VP1 is illustrated as blue spheres. 
VP2 is illustrated as green spheres. 
VP3 is illustrated as red spheres. 
VP4 is illustrated as yellow spheres. 
Image was generated using UCSF Chimera (Petterson et al., 2004). 
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SAT1      SAT2 
 
SAT3 
Figure 30: SAT1, SAT2 and SAT3 epitopes predicted by both 
Discotope1.0 and Ellipro epitope prediction programmes 
Two epitope prediction programmes Discotope1.0 (Andersen et al., 2006) and 
Ellipro (Ponomarenko et al., 2008) were used to predict epitopes on 18 SAT1, 
SAT2 and SAT3 homology models. The predicted epitopes are highlighted on 
serotype-specific representative protomers, which are shown in grey.  
Novel predicted epitopes are shown in blue. 
Previously known epitopes across other serotypes and predicted epitopes on 
the same loops as known epitopes are shown in red.  
Image was generated using UCSF Chimera (Petterson et al., 2004). 
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Table 10: Comparison of known epitopes on various foot-and-mouth 
disease virus serotypes to predicted SAT1 epitopes  
 
Chain 
ID 
Type A Type 
Asia1 
Type C Type O Type SAT1 Type SAT2 Predicted Type SAT1 
VP1  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1981 
2092 
C-
terminus 
483  
bB-bC  
 
 
 
 
 
 
 
 
 
140, 141, 
1423  
bG-bH  
 
 
 
 
 
 
 
 
2073  
C-
terminus 
 
 
 
 
 
 
834  
bD-bE  
 
 
 
138, 139, 
146, 148, 
149, 1505  
bG-bH 
 
 
 
 
 
 
 
1981  
2045  
C-
terminus 
43, 44, 45, 
486  
bB-bC  
 
 
 
 
 
 
 
 
144, 148, 
1546–8  
bG-bH 
1499  
bG-bH  
 
 
 
 
 
 
2086,10  
C-
terminus 
46, 4711  
bB-bC  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
20011 
C-
terminus 
 
 
 
 
 
 
 
 
 
 
 
147, 148, 
149, 156, 
15812  
bG-bH  
15413  
bG-bH  
15914  
bG-bH 
 
 
  
21014  
C-
terminus 
46, 47, 48, 50  
bB-bC (SAR/09/81)  
 
46, 47, 48  
bB-bC (KNP/196/91) 
 
47  
bB-bC (UGA/03/99, ZIM/25/90)  
 
96, 97, 98, 99, 102, 103, 104, 105  
bE-bF (KNP/196/91) 
 
95, 97, 98, 99, 100, 102, 103, 104, 105  
bE-bF (UGA/03/99) 
 
95, 96, 97,98, 99, 101, 102, 103, 104  
bE-bF (UGA/01/97) 
 
96, 97, 98, 99, 100, 102, 103, 104, 105  
bE-bF (SAR/09/81, ZIM/25/90) 
 
99, 102, 103, 104, 105  
bE-bF (ZAM/02/93) 
 
103  
bE-bF (NAM/307/98) 
VP2  
 
 
 
721  
bB-bC 
791, 8015  
bC-aA  
 
 
 
 
 
 
 
 
 
 
 
19615  
bH-b I  
40-5016 
 
 
 
67, 72, 74, 
77, 793  
bB-bC  
 
 
 
 
705  
bB-bC  
7111 
72, 7417  
bB-bC  
 
 
 
13417  
bE-aB 
 
 
 
 
 
18811 
bH 
19611  
bH-b I 
3118  
 
 
 
70, 71, 72, 
73, 75, 776  
bB-bC  
 
 
 
 
 
131,  
bE-aB  
1346,19  
aB 
 
 
 
 
7211  
bB-bC 
 
 
 
 
 
 
13411 
aB 
 72  
bB-bC (KNP/196/91, NAM/307/98, 
SAR/09/81, UGA/03/99, ZIM/25/90) 
 
86, 87, 88, 89  
bC-aA (KNP/196/91, ZIM/25/90) 
 
85, 86, 87, 88, 89  
bC-aA (NAM/307/98, SAR/09/81, 
UGA/03/99, ZAM/02/93) 
 
81, 84, 85, 86, 87, 88, 89  
bC-aA (UGA/01/97) 
 
90, 93  
aA (UGA/03/99) 
  
90, 92, 93  
aA (KNP/196/91, ZAM/02/93) 
 
90, 92, 93, 96  
aA (NAM/307/98, SAR/09/81, 
UGA/01/97) 
 
90, 96  
aA (ZIM/25/90) 
 
217, 218 
C-terminus (NAM/307/98) 
 
218, 219 
C-terminus (KNP/196/91, SAR/09/81) 
 
214, 215, 216, 217, 218 
C-terminus (UGA/01/97, UGA/03/99) 
 
214, 215, 216, 217, 218, 219 
C-terminus (ZAM/02/93, ZIM/25/90) 
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Chain 
ID 
Type A Type 
Asia1 
Type C Type O Type SAT1 Type SAT2 Predicted Type SAT1 
VP3  
 
 
 
 
 
58, 59, 60, 
6115  
bB-bB  
 
 
 
69,7015  
bB-bC  
 
 
 
136, 13915  
bE-aB  
 
 
 
 
 
 
 
 
19515  
bH-b I  
 
 
 
 
 
 
58, 593  
bB-bB  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
2183  
C-
terminus 
9, 134  
N-
terminus 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1484  
bF 
 
 
 
19511  
bH-b I 
 
 
 
 
 
 
 
 
 
 
 
 
6911 
bB-bC 
 
 
 
 
 
 
58, 5911 
bB-bB 
 
 
 
 
69, 7011 
bB-bC 
 
 
 
13511 
bE-aB 
 53, 54  
bB-bB (UGA/01/97) 
 
58, 59  
bB-bB (KNP/196/91, NAM/307/98, 
SAR/09/81, UGA/03/99, ZAM/02/93, 
ZIM/25/90) 
 
63,64, 65  
bB-bC (UGA/01/97) 
 
67, 68  
bB-bC (UGA/03/99) 
 
67, 68, 69, 70, 71  
bB-bC (NAM/307/98, SAR/09/81, 
ZAM/02/93, ZIM/25/90) 
 
67, 68, 69, 70   
bB-bC (KNP/196/91) 
 
127, 128  
bE2-aB (UGA/01/97,  UGA/03/99) 
 
131, 132  
bE2-aB (KNP/196/91, SAR/09/81) 
 
129, 131, 132  
bE2-aB (NAM/307/98, ZAM/02/93, 
ZIM/25/90) 
  
178  
bG-bH (UGA/03/99, ZAM/02/93) 
 
177, 178  
bG-bH (KNP/196/91, SAR/09/81)  
 
174, 175, 176, 177, 178  
bG-bH (NAM/307/98, ZIM/25/90) 
 
196  
bH-b I (UGA/03/99) 
 
195, 196  
bH-b I (ZAM/02/93) 
 
193, 194, 195, 196  
bH-b I (KNP/196/91) 
 
193, 194, 195, 196, 197 
 bH-b I (NAM/307/98, SAR/09/81, 
ZIM/25/90)  
Two epitope prediction programmes Discotope1.0 (Andersen et al., 2006) and 
Ellipro (Ponomarenko et al., 2008) were used to predict epitopes on 18 SAT1, 
SAT2 and SAT3 homology models. 
Known epitopes are shown in orange. 
SAT1 epitopes predicted by both Discotope1.0 and Ellipro are shown in 
green. 
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Another set of epitopes 95, 96, 97, 98, 99, 100, 101, 102, 103, 104, 105 were 
predicted on the EE-EF loop, which is in close proximity to the EB-EC loop of 
VP1. Predicted epitopes 95, 96, 97, 98 and 99 are novel across all serotypes.  
 
3.3.3.2 SAT1 Three-Fold Axis 
 
Known epitope 72 on the EB-EC loop of VP2 (Aktas & Samuel, 2000; Grazioli 
et al., 2012; Kitson et al., 1990; Lea et al., 1994; Saiz et al., 1991) was 
predicted on all the SAT1 strains, with the exception of UGA/01/97 and 
ZAM/02/93, and it is located on the three-fold axis of symmetry (Table 10).  
 
Another set of epitopes that is located on the three-fold axis of symmetry 
consists of residues 67, 68, 69, 70 and 71 on the EB-EC of VP3 (Table 10). 
Epitopes 67 and 68 are novel while 69 is known in type O (Borley et al., 2013) 
and both 69 and 70 are known in types A (Thomas et al., 1988) and SAT1 
(Borley et al., 2013). The SAT1 strain KNP/196/91 was not predicted as 
possessing epitope 71 on VP3, while UGA/03/99 only possessed the novel 
epitopes 67 and 68. UGA/01/97 on the other hand, had its own set of unique 
and novel pedicted epitopes on the EB-EC loop of VP3, namely 63, 64 and 65. 
This unique set of epitopes lies adjacent to the known epitopes 69 and 70.  
 
Also on the three-fold axis, and on the EH-EI loop of VP3, epitopes 193, 194, 
195, 196 and 197 were predicted on all SAT1 strains except UGA/01/97 
(Table 10). The EH-EI loop of VP3 is known to be antigenic in types A 
(Thomas et al., 1988) and C (Borley et al., 2013).  
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A feature known as the EB-EB knob on VP3 was predicted to be antigenic in 
the SAT1 strains, with epitopes 58 and 59 (Table 10). Strain UGA/01/97 was 
the exception, as the predicted epitopes are 53 and 54. The EB-EB knob is 
known to contain epitopes in types A (Thomas et al., 1988), Asia1 (Grazioli et 
al., 2012) and SAT1 (Borley et al., 2013). Due to its close proximity to the 
antigenic site at the three-fold axis, they may both be considered as forming a 
single antigenic site.  
 
3.3.3.3 SAT1 Protomer Centre 
 
The EG-EH loop of VP3, which is located at the centre of the protomer was 
predicted to be antigenic with epitopes 174, 175, 176, 177 and 178. 
KNP/196/91 was the only SAT1 strain to not possesss any predicted epitopes 
on this loop. The EG-EH loop of VP3 is thought to interact with the GH loop of 
VP1, thereby forming a single discontinuous epitope. These predicted 
epitopes on the EG-EH loop of VP3 may constitute part of what is antigenic 
site five of the O serotype (Crowther et al. (a), 1993). 
 
3.3.3.4 SAT1 Two-Fold Axis 
 
There are two sets of discontinuous epitopes located on the two-fold axis of 
symmetry among the SAT1 strains. The first comprises epitopes on the EC-
DA loop and DA helix of VP2 and this is a known antigenic site on type A 
(Thomas et al., 1988). Its predicted epitopes are 81, 84, 85, 86, 87, 88, 89 on 
 120 
the EC-DA loop; and 90, 92, 93 and 96 on the DA helix (Table 10). The 
predicted epitopes on the DA helix are novel across all serotypes.  
 
Residues on the C-terminal end of VP2 in contact with the EE2-DB loop of 
VP3 make up the second set of discontinuous epitopes on the two-fold axis of 
symmetry, which is novel across all serotypes (Table 10). The C-terminal 
predicted epitopes are 214, 215, 216, 217, 218, 219; and those on the EE2-
DB loop are 127, 128, 129, 131 and 132.  
 
3.3.4 Predicted Epitopes on SAT2 Homology Models 
 
3.3.4.1 SAT2 Five-Fold Axis 
 
On four of the SAT2 viruses (KNP/19/89/2, KNP/02/89/2, ANG/04/74/2, 
SAU/06/00/2), epitopes 43, 45 and 46 were predicted on the EB-EC loop of 
VP1 (Table 11), which lies at the five-fold axis of symmetry. This region 
contains known epitopes, namely 48 in type Asia1 (Grazioli et al., 2012); 43, 
44, 45, 48 in type O (Kitson et al., 1990); and 46 and 47 in type SAT1 (Borley 
et al., 2013).  
 
Adjacent to the EB-EC loop, novel epitopes were predicted on the EE-EF loop 
of VP1, forming a single antigenic site at the five-fold axis of symmetry. The 
the EE-EF loop does not contain any known epitopes. The predicted epitopes 
on this loop and EF strand are 95-99 and 101-105 (Table 11).  
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Table 11: Comparison of known epitopes on various foot-and-mouth 
disease virus serotypes to predicted SAT2 epitopes 
 
 
Chain 
ID 
Type A Type 
Asia1 
Type C Type O Type SAT1 Type SAT2 Predicted 
Type SAT2 
VP1  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1981 
2092 
 C-
terminus 
483  
bB-bC  
 
 
 
 
 
 
 
 
 
140, 141, 
1423  
bG-bH  
 
 
 
 
 
 
 
 
2073  
C-
terminus 
 
 
 
 
 
 
834  
bD-bE  
 
 
 
138, 139, 
146, 148, 
149, 1505  
bG-bH 
 
 
 
 
 
 
 
1981  
2045  
C-
terminus 
43, 44, 45, 
486  
bB-bC  
 
 
 
 
 
 
 
 
 
144, 148, 
1546–8  
bG-bH 
1499  
bG-bH  
 
 
 
 
 
2086,10  
C-
terminus 
46, 4711  
bB-bC  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
20011 
C-
terminus 
 
 
 
 
 
 
 
 
 
 
 
147, 148, 
149, 156, 
15812  
bG-bH  
15413  
bG-bH  
15914  
bG-bH 
 
 
 
21014  
C-
terminus 
43, 45, 46  
bB-bC (SAU/06/00/2) 
 
45, 46  
bB-bC (KNP/19/89/2) 
 
46  
bB-bC (KNP/02/89/2; 
ANG/04/74/2) 
 
95, 96, 97, 98, 99, 101, 102, 103, 
104, 105  
bE-bF (ANG/04/74/2, KEN/03/57/2, 
KNP/02/89/2, KNP/19/89/2, 
ZIM/01/88/2, ZIM/07/83/2) 
 
95, 96, 97, 98, 99, 102, 103, 104  
bE-bF (SAU/06/00/2) 
 
95, 96,97, 98, 99, 101, 102, 103, 
104  
bE-bF (UGA/02/02/2) 
 
VP2  
 
 
 
721  
bB-bC 
791, 8015  
bC-aA  
 
 
 
 
 
 
 
 
 
 
 
19615  
bH-b I  
40-5016 
 
 
 
67, 72, 74, 
77, 793  
bB-bC  
 
 
 
 
705  
bB-bC  
7111 
72, 7417  
bB-bC  
 
 
 
13417  
bE-aB 
 
 
 
 
 
18811 
bH 
19611  
bH-b I 
3118  
 
 
 
70, 71, 72, 
73, 75, 776  
bB-bC  
 
 
 
 
 
131,  
bE-aB  
1346,19  
aB 
 
 
 
 
7211  
bB-bC 
 
 
 
 
 
 
13411 
aB 
 72  
bB-bC (ANG/04/74/2, KEN/03/57/2, 
KNP/02/89/2, KNP/19/89/2,  
SAU/06/00/2, UGA/02/02/2, 
ZIM/01/88/2, ZIM/07/83/2) 
 
85, 86, 87, 88, 89  
bC-aA (SAU/06/00/2, ZIM/01/88/2, 
ZIM/07/83/2) 
 
86, 87, 88, 89  
bC-aA (KEN/03/57/2, KNP/02/89/2, 
KNP/19/89/2) 
 
87, 88, 89  
bC-aA (ANG/04/74/2,  
UGA/02/02/2) 
 
90, 92, 93  
aA (ANG/04/74/2, KEN/03/57/2, 
KNP/02/89/2, KNP/19/89/2,  
SAU/06/00/2, 
UGA/02/02/2, 
ZIM/01/88/2, ZIM/07/83/2) 
 
218, 219  
C-terminus (KEN/03/57/2, 
KNP/02/89/2, KNP/19/89/2) 
 
219  
C-terminus (SAU/06/00/2, 
UGA/02/02/2) 
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Chain 
ID 
Type A Type 
Asia1 
Type C Type O Type SAT1 Type SAT2 Predicted 
Type SAT2 
VP3  
 
 
 
 
 
58, 59, 60, 
6115  
bB-bB  
 
 
 
69,7015  
bB-bC  
 
 
 
136, 13915  
bE-aB  
 
 
 
 
 
 
 
 
19515  
bH-b I  
 
 
 
 
 
 
58, 593  
bB-bB  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
2183  
C-
terminus 
9, 134  
N-
terminus 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1484  
bF 
 
 
 
19511  
bH-b I 
 
 
 
 
 
 
 
 
 
 
 
 
6911 
bB-bC 
 
 
 
 
 
 
58, 5911 
bB-bB 
 
 
 
 
69, 7011 
bB-bC 
 
 
 
13511 
bE-aB 
 58, 59  
bB-bB (ANG/04/74/2, KEN/03/57/2, 
KNP/02/89/2, KNP/19/89/2, 
SAU/06/00/2, UGA/02/02/2, 
ZIM/01/88/2, ZIM/07/83/2) 
 
67, 68, 69, 70  
bB-bC (ANG/04/74/2, KEN/03/57/2, 
KNP/02/89/2, KNP/19/89/2, 
UGA/02/02/2, ZIM/01/88/2, 
ZIM/07/83/2) 
 
68, 69, 70  
bB-bC (SAU/06/00/2) 
 
131, 132  
bE2-aB (ANG/04/74/2, 
KEN/03/57/2, KNP/02/89/2, 
KNP/19/89/2,  
SAU/06/00/2, UGA/02/02/2, 
ZIM/01/88/2, ZIM/07/83/2) 
 
176  
bG-bH (UGA/02/02/2, 
SAU/06/00/2) 
 
176, 177  
bG-bH (KNP/19/89/2) 
 
175, 176, 177, 179  
bG-bH (ZIM/01/88/2, ZIM/07/83/2) 
 
175, 176, 177, 178, 179  
bG-bH (KEN/03/7/2, KNP/02/89/2) 
 
 
 
 
Two epitope prediction programmes Discotope1.0 (Andersen et al., 2006) and 
Ellipro (Ponomarenko et al., 2008) were used to predict epitopes on 18 SAT1, 
SAT2 and SAT3 homology models. 
Known epitopes are shown in orange. 
SAT2 Epitopes predicted by both Discotope1.0 and Ellipro are shown in 
green. 
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3.3.4.2 SAT2 Three-Fold Axis 
 
The EB-EC loop of VP2 is part of a known antigenic site in the Euro-Asiatic 
serotypes (Grazioli et al., 2012; Lea et al., 1994; Saiz et al., 1991) and it was 
predicted that residue 72 on this loop is an epitope across the SAT2 viruses in 
this study. Also forming part of the antigenic site at the three-fold axis are 
epitopes on the EB-EC loop of VP3 (Table 11). This loop is a known antigenic 
site among some of the Euro-Asiatic types. The known epitopes are 69, 70 on 
types A (Thomas et al., 1988) and SAT1 (Borley et al., 2013) and 69 on type 
O (Borley et al., 2013). The predicted epitopes on the EB-EC loop include the 
known epitopes and residue 68 on SAU/06/00/2 and 67 and 68 on all the 
other SAT2 viruses. 
 
Close to the three-fold axis of symmetry on VP3 is the EB-EB knob and it is 
known to be antigenic in types A (Thomas et al., 1988), Asia1 (Grazioli et al., 
2012) and SAT1 (Borley et al., 2013). Among the SAT2 viruses, residues 58 
and 59 were predicted as epitopes on the EB-EB knob with the exception of 
SAU/06/00/2 (Table 11).  
 
3.3.4.3 SAT2 Protomer Centre 
 
Located close to the centre of the protomer on the EG-EH loop of VP3 is a 
predicted antigenic site, which may interact with the immunodominant GH 
loop of VP1. The predicted epitopes at this antigenic site are 175, 176, 177, 
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178 and 179 with the exception of ANG/04/74/2, on which none of these 
epitopes was predicted (Table 11).  
 
3.3.4.4 SAT2 Two-Fold Axis 
 
At the two-fold axis of symmetry is a predicted discontinuous epitope on the 
EC-DA loop and DA helix of VP2 (Table 11). The predicted epitopes 85, 86, 
87, 88, 89 on the EC-DA loop correspond to a known antigenic site on type A, 
which comprises epitopes 79 and 80 (Thomas et al., 1988). On the DA helix, 
predicted epitopes 90, 92 and 93 are novel across across all serotypes.  
 
A second discontinuous epitope at the two-fold axis of symmetry involves 
residues on the C-terminal end of VP2 and the EE2-DB loop of VP3 (Table 
11). The respective predicted epitopes on this site are 218, 219 on VP2 and 
131, 132 on VP3. Among the SAT2 strains, ANG/04/74/2, ZIM/01/88/2 and 
ZIM/07/83/2 had no predicted epitopes on the C-terminal end of VP2. Though 
the EE2-DB loop contains known epitopes 136 and 139 in type A (Thomas et 
al., 1988), its interaction with the C-terminal end of VP2 represents a novel 
discontinuous epitope that was also predicted on the SAT1 strains.  
 
3.3.5 Predicted Epitopes on SAT3 Homology Models 
 
3.3.5.1 SAT3 Five-Fold Axis 
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ZIM/05/91/3 was the only SAT3 strain on which epitopes were predicted close 
to the five-fold axis of symmetry. Novel predicted epitopes 97, 98, and 102 on 
VP1 are located on the EE-EF loop (Table 12). These epitopes are located 
adjacent to a known antigenic site in other serotypes, which is on the EB-EC 
loop of VP1 (Borley et al., 2013; Grazioli et al., 2012; Kitson et al., 1990). 
 
3.3.5.2 SAT3 Three-Fold Axis 
 
On the EH-EI loop of VP2, residues 190, 191 and 192 were predicted as 
epitopes on the SAT3 strain KNP/01/08 (Table 12). These epitopes are 
located next to the known epitope 196 in types A (Thomas et al., 1988) and C 
(Borley et al., 2013) and are located on the three-fold axis of symmetry. These 
epitopes were not predicted on neither of the other two SAT serotypes. On the 
same axis, epitopes were predicted on the EB-EC loop of VP3, which is a 
known antigenic site. The predicted epitopes on this loop among the SAT3 
strains are 66, 67, 68, 69, 70 and 71. Another set of predicted epitopes on the 
three-fold axis are on EH-EI loop of VP3, namely 194, 195, 196 and 197 
(Table 12). These epitopes overlap and are adjacent to the known epitope 
195 in type A (Thomas et al., 1988) and type C (Borley et al., 2013). These 
epitopes on the EH-EI loop of VP3 were also predicted on the SAT1 
serotypes.  
 
The EB-EB knob, an antigenic feature that is know in types A (Thomas et al., 
1988), Asia1 (Grazioli et al., 2012) and SAT1 (Borley et al., 2013) was 
predicted to contain epitopes 58 and 59 on the SAT3 strains (Table 12).  
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Epitope 72 on the EB-EC loop of VP2, which was predicted across all the 
other serotypes was not predicted as being antigeinc on the SAT3 strains in 
this study.  
 
3.3.5.3 SAT3 Protomer Centre 
 
On two of the SAT3 strains, KNP/01/08 and ZAM/04/96/3, the EG-EH loop of 
VP3 at the centre of the protomer, was predicted to contain epitopes 177 and 
178 (Table 12). The EG-EH loops of VP3 and VP1 may interact with each 
other forming a discontinuous epitope as predicted in types SAT1 and SAT2.  
 
3.3.5.4 SAT3 Two-Fold Axis 
 
The antigenic site at the two-fold axis of symmetry in one of the SAT3 strains, 
KNP/01/08, comprises a single discontinuous epitope, which is two 
discontinuous epitopes in some of the SAT1 and SAT2 strains. On the DA 
helix of VP2, two novel epitopes 93 and 96 were predicted on the strain 
KNP/01/08. These are in contact with the predicted epitopes 131 and 132 on 
the EE2-DB loop of VP3. In contrast, the predicted epitopes on the two-fold 
axes of strains ZAM/04/96/3 and ZIM/05/91/3 are 87, 88, 89 and 90 of the EC-
DA loop of VP2 and 131 and 132 on the EE2-DB loop of VP3.  
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Table 12: Comparison of known epitopes on various foot-and-mouth 
disease virus serotypes to predicted SAT3 epitopes  
 
Chain 
ID 
Type A Type 
Asia1 
Type C Type O Type SAT1 Type SAT2 Predicted 
Type SAT3 
VP1  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1981 
2092 
 C-
terminus 
483  
bB-bC  
 
 
 
 
 
 
 
140, 141, 
1423  
bG-bH  
 
 
 
 
 
 
 
2073  
C-
terminus 
 
 
 
 
 
834  
bD-bE  
 
 
138, 139, 
146, 148, 
149, 1505  
bG-bH 
 
 
 
 
 
 
1981  
2045  
C-
terminus 
43, 44, 45, 
486  
bB-bC  
 
 
 
 
 
 
144, 148, 
1546–8  
bG-bH 
1499  
bG-bH  
 
 
 
 
 
2086,10  
C-
terminus 
46, 4711  
bB-bC  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
20011 
C-
terminus 
 
 
 
 
 
 
 
 
 
147, 148, 
149, 156, 
15812  
bG-bH  
15413  
bG-bH  
15914  
bG-bH 
 
 
21014  
C-
terminus 
97, 98, 102 
bE-bF (ZIM/05/91/3) 
 
 
VP2  
 
 
721  
bB-bC 
791, 8015  
bC-aA  
 
 
 
 
 
 
 
 
 
19615  
bH-b I  
40-5016 
 
 
67, 72, 74, 
77, 793  
bB-bC  
 
 
 
705  
bB-bC  
7111 
72, 7417  
bB-bC  
 
 
13417  
bE-aB 
 
 
 
 
18811 
bH 
19611  
bH-b I 
3118  
 
 
70, 71, 72, 
73, 75, 776  
bB-bC  
 
 
 
 
131,  
bE-aB  
1346,19  
aB 
 
 
 
7211  
bB-bC 
 
 
 
 
 
13411 
aB 
 87, 88, 89, 90  
bC-aA (ZIM/05/91/3, ZAM/04/96/3) 
 
93, 96  
aA (KNP/01/08) 
 
133  
bE2-aB (ZIM/05/91/3,  
ZAM/04/96/3) 
 
133, 134  
bE2-aB (KNP/01/08) 
 
190, 191, 192  
bH-b I (KNP/01/08) 
 
VP3  
 
 
 
 
58, 59, 60, 
6115  
bB-bB  
 
 
69,7015  
bB-bC  
 
 
136, 13915  
bE-aB  
 
 
 
 
 
 
 
19515  
bH-b I  
 
 
 
 
 
58, 593  
bB-bB  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
2183  
C-
terminus 
9, 134  
N-
terminus 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1484  
bF 
 
 
19511  
bH-b I 
 
 
 
 
 
 
 
 
 
 
6911 
bB-bC 
 
 
 
 
 
58, 5911 
bB-bB 
 
 
 
69, 7011 
bB-bC 
 
 
13511 
bE-aB 
 58, 59  
bB-bB (KNP/01/08, ZIM/05/91/3, 
ZAM/04/96/3) 
 
66, 67, 68, 69, 70, 71  
bB-bC (KNP/01/08, ZIM/05/91/3, 
ZAM/04/96/3) 
 
 
131, 132  
bE2-aB (KNP/01/08, ZIM/05/91/3, 
ZAM/04/96/3) 
 
177, 178  
bG-bH (KNP/01/08, ZAM/04/96/3) 
 
194, 195, 196, 197 bH-bI 
(KNP/01/08, ZIM/05/91/3, 
ZAM/04/96/3) 
 
 
Two epitope prediction programmes Discotope1.0 (Andersen et al., 2006) and 
Ellipro (Ponomarenko et al., 2008) were used to predict epitopes on 18 SAT1, 
SAT2 and SAT3 homology models. 
Known epitopes are shown in orange. 
SAT3 epitopes predicted by both Discotope1.0 and Ellipro are shown in 
green. 
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3.3.5.5 SAT3 Novel Antigenic Site 
 
A possible antigenic site that comprises an interaction between the EE2-DB 
loop of VP2 and the C-terminal end of VP1 was predicted. The predicted 
epitopes involved in this interaction are 133 and 134 on the EE2-DB loop and 
residues on the C-terminal end of VP1. Residue 134 of VP2 is a known 
epitope in types C (Mateu et al., 1994) and O (Acharya et al., 1989; Kitson et 
al., 1990). Another known epitope in this locale is 131 in type O (Acharya et 
al., 1989; Kitson et al., 1990).  
 
3.3.6 Consensus Epitopes Among the SAT Strains 
 
Following the prediction of SAT epitopes, a consensus set of epitopes that are 
common among the SAT strains was collated (Table 13) (Figure 31). A 
threshold of at least 15 out of 18 strains in possession of a specific epitope, 
was applied for that epitope to be considered a “consensus epitope”. The only 
consensus epitope on VP1 is 102, and it is found across all the SAT 
serotypes with the exception of the SAT1 strain NAM/307/98 and and the two 
SAT3 strains KNP/01/08 and ZAM/04/96/3 (Table 13). On VP2, predicted 
epitopes 87, 88 and 89 were found on all the SAT1 and SAT2 strains, but not 
on any of the SAT3 viruses (Table 13). Epitope 90 was predicted on all strains 
with the exception of KNP/01/08, which is a SAT3 virus (Table 13). 
Consensus epitopes 58 and 59 on VP3 are common amongst all the SAT 
strains with the exception of the SAT1 strain UGA/01/97 (Table 13). Residues 
67 and 68 are also predicted to be epitopes across all the SAT serotypes 
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except for UGA/01/97 (Table 13). Finally 69 and 70 on VP3 are consensus 
epitopes among the SAT strains, with the exclusion of UGA/01/97 and 
UGA/03/99 (Table13). With the exception of epitope 102 on VP1, the 
consensus epitopes are located on the same loops as known binding sites of 
neutralizing Abs among the Euro-Asiatic serotypes.  
 
The subset of consensus epitopes may form part of the binding sites for 
neutralizing Abs that are capable of providing cross-protection from a wide 
range of SAT strains. Furthermore, knowing these consensus epitopes will aid 
in the rational design of vaccines that are capable of neutralizing otherwise 
immunologically distinct SAT strains and SAT serotypes. The identification of 
neutralizing Abs that bind to known epitopes on the same loops as these 
consensus epitopes, will provide a platform for the reverse engineering of 
cross-reactive peptide vaccines.  
 
There are consensus epitopes present on the two-, three-, and five-fold axes 
of symmetry. It can be surmised that the Abs that bind to these epitopes have 
different mechanisms of action. It is known that neutralization by Abs is a 
complex set of events involving various mechanisms of action, and it is largely 
dependent on the structure of the antigen (Dimmock, 1993; Hewat et al., 
1997; McCullough et al., 1992). Abs that bind to the two- and three-fold axes 
of symmetry may change the stability of the viruses by crosslinking 
pentamers, thereby interfering with the release of the viral genome (Dimmock, 
1993). The function of the E annulus is unknown (Acharya et al., 1990), and 
therefore the mechanism of neutralisation of Abs that bind to the five-fold axis 
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of symmetry may not be easily deduced. It is most likely that these Abs will be 
involved in aggregation of viruses.  
 
 
 
Figure 31: Consensus epitopes among the 18 SAT1, SAT2 and SAT3 
viruses 
Two epitope prediction programmes Discotope1.0 (Andersen et al., 2006) and 
Ellipro (Ponomarenko et al., 2008) were used to predict epitopes on 18 SAT1, 
SAT2 and SAT3 homology models. A consensus epitope was defined as one 
that was predicted on at least 15 out of the 18 SAT strains in this study. The 
predicted epitopes are shown as spheres on a SAT representative protomer. 
VP1 is illustrated in blue. 
VP2 is illustrated in green. 
VP3 is illustrated in red. 
VP4 is illustrated in yellow. 
Image was generated using UCSF Chimera (Petterson et al., 2004). 
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Table 13: Identity of consensus epitopes among the 18 SAT1, SAT2 and 
SAT3 viruses 
Chain 
ID 
Consensus 
epitope 
identity 
SAT1 strain SAT2 strain SAT3 strain 
VP1 102 KNP/196/91 
SAR/09/81 
UGA/01/97 
UGA/03/99 
ZAM/02/93 
ZIM/25/90 
(Gly) 
(Gly) 
(Gly) 
(Gly) 
(Gly) 
(Gly) 
 
ANG/04/74/2  
KEN/03/57/2   
KNP/02/89/2   
KNP/19/89/2 
SAU/06/00/2   
UGA/02/02/2 
ZIM/01/88/2    
ZIM/07/83/2  
(Asp) 
(Asp) 
(Asp) 
(Asp) 
(Asp) 
(Asp) 
(Asp) 
(Asp) 
ZIM/05/91/3  (Asp) 
VP2 87, 88, 89 
 
 
 
KNP/196/91   
NAM/307/98 
SAR/09/81     
UGA/01/97 
UGA/03/99 
ZAM/02/93 
ZIM/25/90        
, 
(His, Lys, Gly) 
(His, Lys, Gly) 
(His, Lys, Gly) 
(His, Lys, Gly) 
(His, Lys, Gly) 
(His, Lys, Gly) 
(His, Lys, Gly) 
ANG/04/74/2 
KEN/03/57/2 
KNP/02/89/2 
KNP/19/89/2 
SAU/06/00/2   
UGA/02/02/2  
ZIM/01/88/2    
ZIM/07/83/2 
(His, Lys, Gly) 
(His, Lys, Gly) 
(His, Lys, Gly) 
(His, Lys, Gly) 
(His, Lys, Gly) 
(His, Lys, Gly) 
(His, Lys, Gly) 
(His, Lys, Gly) 
 
VP2 90 KNP/196/91 
NAM/307/98 
SAR/09/81 
UGA/01/97 
UGA/03/99 
ZAM/02/93 
ZIM/25/90 
(Ile) 
(Ile) 
(Ile) 
(Ile) 
(Ile) 
(Ile) 
(Ile) 
 
ANG/04/74/2 
KEN/03/57/2 
KNP/02/89/2 
KNP/19/89/2 
SAU/06/00/2 
UGA/02/02/2 
ZIM/01/88/2  
ZIM/07/83/2 
(Ile) 
(Ile) 
(Ile) 
(Ile) 
(Ile) 
(Ile) 
(Ile) 
(Ile) 
ZIM/05/91/3 
ZAM/04/96/3 
(Ile) 
(Ile) 
VP3 58, 59 
 
KNP/196/91 
NAM/307/98 
SAR/09/81 
UGA/03/99 
ZAM/02/93 
ZIM/25/90 
(Asn, Gly) 
(Asn, Gly) 
(Asn, Gly) 
(Asn, Gly) 
(Asn, Gly) 
(Asn, Gly) 
 
ANG/04/74/2 
KEN/03/57/2 
KNP/02/89/2 
KNP/19/89/2 
SAU/06/00/2 
UGA/02/02/2 
ZIM/01/88/2 
ZIM/07/83/2 
(Asp, Gly) 
(Asp, Gly) 
(Asp, Gly) 
(Asp, Gly) 
(Asp, Gly) 
(Asp, Gly) 
(Asp, Gly) 
(Asp, Gly) 
KNP/01/08 
ZIM/05/91/3 
ZAM/04/96/3 
(Asp, Gly) 
(Asn, Gly) 
(Asp, Gly) 
 
VP3 67,68 
 
KNP/196/91 
NAM/307/98 
SAR/09/81 
UGA/03/99 
ZAM/02/93  
ZIM/25/90 
 
(Ala, Asn) 
(Asn, Asn) 
(Ser, Asn) 
(His, Glu) 
(Asn, Asn) 
(Asn, Asn) 
 
 
ANG/04/74/2 
KEN/03/57/2  
KNP/02/89/2 
KNP/19/89/2 
SAU/06/00/2 
UGA/02/02/2 
ZIM/01/88/2 
ZIM/07/83/2 
(Asn, Ser) 
(Asn, Asn) 
(Asn, Asn) 
(Asn, Asn) 
(Asn, Asn) 
(Asn, Asn) 
(Asn, Asn) 
(Asn, Asn) 
KNP/01/08  
ZIM/05/91/3  
ZAM/04/96/3 
(His, Asn) 
(His, Asn) 
(His, Asn) 
 
VP3 69, 70 KNP/196/91  
NAM/307/98 
SAR/09/81  
ZAM/02/93 
ZIM/25/90 
(Ser,.Gly) 
(Ser,.Gly) 
(Ser,.Gly) 
(Ser,.Gly) 
(Ser,.Gly) 
ANG/04/74/2  
KEN/03/57/2  
KNP/02/89/2  
KNP/19/89/2  
SAU/06/00/2 
UGA/02/02/2 
ZIM/01/88/2 
ZIM/07/83/2 
(Gly, Asn)  
(Gly, Asp)  
(Gly, Asp) 
(Gly, Asp) 
(Gly, Asp) 
(Gly, Asp) 
(Gly, Asp) 
(Gly, Asp) 
KNP/01/08 
ZIM/05/91/3 
ZAM/04/96/3  
(Ser,.Gly) 
(Ser,.Gly) 
(Ser,.Gly) 
   
Two epitope prediction programmes Discotope1.0 (Andersen et al., 2006) and 
Ellipro (Ponomarenko et al., 2008) were used to predict epitopes on 18 SAT1, 
SAT2 and SAT3 homology models. A consensus epitope was defined as one 
that was predicted on at least 15 out of the 18 SAT strains in this study 
Negatively charged amino acids are highlighted in turquoise. 
Positively charged amino acids are highlighted in green. 
Polar uncharged amino acids are highlighted in red. 
Hydrophobic amino acids are highlighted in pink. 
Special amino acids are highlighted in grey. 
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3.3.6.1 Properties of Consensus Epitopes 
 
Out of the 177 consensus epitopic residues, 30.5% were Gly; 19.2% Asn; 
14.7% Asp; 10.7% His; 9.6% Ile; 8.5% Lys; 5.6% Ser; 0.6% Glu and Ala 
respectively (Table 13). Furthermore, the consensus epitopes can be grouped 
according to their chemical properties, namely charged, polar uncharged and 
non-polar (Table 13). The complement of interactions between Ab-antigen 
complexes varies depending on the binding partners involved. It has however 
been shown that only a few residues are critical for Ab-antigen binding, and 
these may be defined as epitopes (Janeway et al., 2001; Kringelum et al., 
2012; Schlessinger et al., 2006; Sweredoski & Baldi, 2008). The surrounding 
amino acids within the interface provide structural complementarity and 
augment the Ab-antigen interactions (Virella, 2001). 
 
Non-polar amino acids, which were the most abundant consensus epitopes at 
40.7%, are generally responsible for a large proportion of the binding energy 
in some antigens (Janeway et al., 2001). It is reported that hydrophobic 
interactions may contribute as much as 50% of the total strength of the Ab-
antigen bond (Virella, 2001). The non-polar Gly is typically found in loop 
regions (Krieger et al., 2005), and was individually the most abundant 
consensus epitope at 30.5% (Table 13). The resultant hydrophobic-
hydrophobic interactions between non-polar amino acids exclude water, 
operate over short ranges and are largely involved in binding surfaces that are 
complementary in shape (Janeway et al., 2001).  
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Electrostatic interactions on the other hand, which involve charged amino 
acids and hydrogen bonds between oxygen and/or nitrogen atoms (Virella, 
2001), operate over longer ranges and accommodate specific features that 
are not necessarily complementary (Janeway et al., 2001). Mutations of 
charged amino acids at Ab-antigen interfaces have been shown to disrupt the 
affinity of Abs to their antigens (Janeway et al., 2001; Virella, 2001). Among 
the consensus epitopes in this study, the charged amino acids were the 
second most abundant at 34.5% (Table 13).  
 
The least abundant consensus epitopes were the polar uncharged amino 
acids at 24.8% (Table 13). Hydrogen bonds may form between the side 
chains of polar residues thereby trapping water molecules, which in turn 
contribute to the binding energy (Janeway et al., 2001; Virella, 2001).  
 
3.3.6.2 Identity of Consensus Epitopes 
 
Consensus epitope 102 on SAT1 viruses is the small hydrophobic Gly 
residue, which is typically located at the turn of a loop (Krieger et al., 2005). 
On the SAT2 and SAT3 strains, this epitope is Asp, which is a negatively 
charged amino acid (Table 13).  
 
Consensus epitope 87 on VP2 is a His across all the strains (Table 13). His is 
a large basic amino acid with an imidazole ring. It is neutral at physiological 
pH because it has a pKa value of 6.04. His is commonly found on binding 
surfaces because it gains and loses its proton relatively easily depending on 
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the local protein environment. It therefore has a similar preference for being 
surface exposed or being buried. Epitope 88 is a Lys for all strains. It is also a 
large positively charged amino acid. Gly is the residue at position 89. Epitope 
90 is an Ile, which is a small hydrophobic amino acid that is conserved across 
all the strains.  
 
Consensus epitope 58 of VP3 on one SAT3, ZIM/05/91/3 and all the SAT1 
strains, is the large polar uncharged amino acid, Asn (Table 13). The same 
epitope on the SAT2 and two of the SAT3 strains, KNP/01/08 and 
ZAM/04/96/3 is the negatively charged Asp. Asn and Asp residues are the 
same size and differ with respect to the negative charge on the R-group of 
Asp. Epitope 59 is a Gly that is conserved across all the SAT strains (Table 
13).  
 
Epitope 67 of VP3 is highly variable on SAT1 (Table 13). The amino acids 
found at this locus are Asn, Ser, Ala and His. Asn and Ser are both polar and 
uncharged, and Ala is a small hydrophobic amino acid. On the SAT2 and 
SAT3 viruses, epitope 67 is Asn and His respectively. Only two strains of the 
SAT serotypes do not have Asn at epitope 68. One is SAT1 strain, 
UGA/03/99, which is the negatively charged and large Glu. The second is the 
SAT2 strain ANG/04/74/2, which is a Ser. 
 
Ser is the amino acid of epitope 69 in all the SAT1 and SAT3 strains (Table 
13). Among the SAT2 viruses it is Gly. Epitope 70 is highly conserved among 
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the SAT1 and SAT3 viruses as Gly, and it is Asp in all the SAT2 strains 
besides ANG/04/74/2. For ANG/04/74/2, epitope 70 is Asn. 
 
The EC-DA loop on which the consensus epitopes of VP2 are located has 
known neutralizing Abs in serotype A. The consensus epitopes of VP3, which 
are found on the EB-EB knob have been characterised across three 
serotypes, namely A, Asia1 and SAT1. Adjacent to the EB-EB knob are 
consensus epitopes on the EB-EC loop that are known to be antigenic in A, O 
and SAT1. Since these consensus epitopes have known neutralizing 
antibodies across various serotypes, they have the potential to form the basis 
for the design of cross-reactive SAT vaccines through site-directed 
mutagenesis. 
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3.3.6.3 Root Mean Square Deviation of Consensus Epitopes 
 
An average RMSD of 5.7Å was observed between consensus epitopes of the 
respective serotypes, while one of 3.5Å was observed within each of the serotypes 
(Tables 14, 15 and 16). The greater structural variation of epitopes between the 
different serotypes than that between epitopes within the same serotype is expected. 
Furthermore, the average RMSD values of the consensus epitopes are higher than that 
of the entire virus protomers, which was 1Å (Table 7). The large RMSD values illustrate 
that even though consensus epitopes may have been predicted across the serotypes, 
there is still varying degrees of structural variation at these loci. This is because 
epitopes are located on loop regions, which are known to be flexible in comparison to 
the conserved core regions. As mentioned earlier, the RMSD of the core regions can be 
less than 1Å, while the loop regions can vary by as much as 12Å (Curry et al., 1995).  
 
3.3.7 Protein Variability Index of the SAT Viruses 
 
The Wu-Kabat plot was used to evaluate the sequence variability of the SAT strains 
used in this study, and it can be seen that the predicted epitopes fall within the highly 
variable regions, as reported in literature for experimentally characterised epitopes 
(Figure 32) (Acharya et al., 1989, 1990; Aktas & Samuel, 2000; Hogle et al., 1985). As 
stated earlier, it is this same sequence variability that is responsible for the low 
efficiency of single strain vaccines in providing adequate immune protection against the 
various FMDV strains in circulation.  
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 Table 14: The R
M
SD
 of consensus epitope 102 of VP1 betw
een the SA
T serotypes 
 
  
K
N
P
 
/196/91 
S
A
R
 
/09/81 
U
G
A
 
/01/97 
U
G
A
 
/03/99 
ZA
M
 
/02/93 
ZIM
 
/25/90 
A
N
G
 
/04/74/2 
K
E
N
 
/03/57/2 
K
N
P
 
/02/89/2 
K
N
P
 
/19/89/2 
 
S
A
U
 
/06/00/2 
U
G
A
 
/02/02/2 
ZIM
 
/01/88/2 
ZIM
 
/07/83/2 
K
N
P
 
/01/08 
SA
T1 Strains 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
K
N
P
/196/91 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
S
A
R
/09/81 
2.8 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
U
G
A
/01/97 
3.7 
6.2 
 
 
 
 
 
 
 
 
 
 
 
 
 
U
G
A
/03/99 
3.0 
1.9 
5.1 
 
 
 
 
 
 
 
 
 
 
 
 
ZA
M
/02/93 
2.3 
2.8 
4.4 
3.3 
 
 
 
 
 
 
 
 
 
 
 
ZIM
/25/90 
3.2 
2.2 
5.2 
2.9 
1.6 
 
 
 
 
 
 
 
 
 
 
SA
T2 Strains 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
A
N
G
/04/74/2 
8.8 
5.9 
10.1 
7.3 
6.6 
7.1 
 
 
 
 
 
 
 
 
 
K
E
N
/03/57/2 
9.6 
7.6 
10.8 
8.1 
8.4 
9.0 
3.7 
 
 
 
 
 
 
 
 
K
N
P
/02/89/2 
8.5 
5.9 
9.6 
7.2 
6.3 
6.9 
1.0 
3.7 
 
 
 
 
 
 
 
K
N
P
/19/89/2 
 
8.9 
6.2 
10.1 
7.3 
7.0 
7.5 
1.3 
2.5 
1.4 
 
 
 
 
 
 
S
A
U
/06/00/2 
8.7 
6.4 
10.1 
7.2 
7.4 
7.6 
2.5 
1.4 
2.6 
1.3 
 
 
 
 
 
U
G
A
/02/02/2 
8.5 
6.0 
9.8 
7.1 
6.6 
7.2 
1.1 
2.9 
1.0 
0.6 
1.7 
 
 
 
 
ZIM
/01/88/2 
8.0 
5.3 
9.2 
7.1 
5.7 
6.3 
1.2 
4.2 
0.8 
1.8 
3.0 
1.4 
 
 
 
ZIM
/07/83/2 
8.3 
5.8 
9.5 
7.0 
6.3 
6.9 
1.0 
3.3 
0.4 
1.1 
2.2 
0.7 
0.9 
 
 
SA
T3 Strains 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
K
N
P
/01/08 
6.3 
5.6 
6.7 
5.8 
5.2 
6.3 
4.7 
4.4 
3.9 
4.1 
4.0 
3.9 
4.0 
3.8 
 
The R
M
S
D
 values w
ere calculated using U
C
S
F C
him
era (P
etterson et al., 2004). 
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Table 15: The R
M
SD
 of consensus epitopes 87, 88 and 89 of VP2 betw
een the SAT serotypes 
 
  
K
N
P
 
/196/91 
N
A
M
 
/307/98 
S
A
R
 
/09/81 
U
G
A
 
/01/97 
U
G
A
 
/03/99 
ZA
M
 
/02/93 
ZIM
 
/25/90 
A
N
G
 
/04/74/2 
K
E
N
 
/03/57/2 
K
N
P
 
/02/89/2 
K
N
P
 
/19/89/2 
 
S
A
U
 
/06/00/2 
U
G
A
 
/02/02/2 
ZIM
 
/01/88/2 
SA
T1 Strains 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
K
N
P
/196/91 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
N
A
M
/307/98 
2.4 
 
 
 
 
 
 
 
 
 
 
 
 
 
S
A
R
/09/81 
2.2 
1.8 
 
 
 
 
 
 
 
 
 
 
 
 
U
G
A
/01/97 
2.7 
3.0 
2.9 
 
 
 
 
 
 
 
 
 
 
 
U
G
A
/03/99 
1.8 
1.0 
2.1 
3.2 
 
 
 
 
 
 
 
 
 
 
ZA
M
/02/93 
3.3 
3.0 
2.2 
2.0 
3.5 
 
 
 
 
 
 
 
 
 
ZIM
/25/90 
6.7 
7.8 
6.1 
7.0 
7.9 
6.0 
 
 
 
 
 
 
 
 
SA
T2 Strains 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
A
N
G
/04/74/2 
6.8 
4.6 
4.7 
6.9 
6.9 
5.8 
10.1 
 
 
 
 
 
 
 
K
E
N
/03/57/2 
7.9 
6.8 
6.3 
8.8 
7.6 
7.4 
9.3 
4.3 
 
 
 
 
 
 
K
N
P
/02/89/2 
7.5 
6.7 
5.7 
7.4 
8.1 
5.3 
7.7 
4.2 
4.4 
 
 
 
 
 
K
N
P
/19/89/2 
 
7.5 
6.7 
6.0 
7.6 
8.5 
5.5 
8.6 
3.6 
4.2 
2.9 
 
 
 
 
S
A
U
/06/00/2 
7.0 
6.3 
5.5 
7.7 
7.0 
6.2 
7.7 
4.3 
2.8 
3.5 
4.0 
 
 
 
U
G
A
/02/02/2 
6.6 
6.5 
5.2 
7.4 
7.3 
6.0 
6.2 
5.2 
3.9 
4.2 
4.5 
2.3 
 
 
ZIM
/01/88/2 
6.4 
5.7 
4.7 
6.2 
7.8 
4.6 
7.5 
3.5 
4.6 
3.0 
2.2 
4.1 
4.0 
 
ZIM
/07/83/2 
5.9 
5.0 
4.1 
5.8 
7.1 
4.3 
7.7 
3.1 
4.4 
3.0 
2.5 
3.9 
3.9 
0.8 
The R
M
S
D
 values w
ere calculated using U
C
S
F C
him
era (P
etterson et al., 2004). 
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Table 16: The R
M
SD
 of consensus epitopes 58 and 59 of VP3 betw
een the SA
T serotypes 
 
  
K
N
P
 
/196/91 
N
A
M
 
/307/98 
S
A
R
 
/09/81 
U
G
A
 
/03/99 
ZA
M
 
/02/93 
ZIM
 
/25/90 
A
N
G
 
/04/74/2 
K
E
N
 
/03/57/2 
K
N
P
 
/02/89/2 
K
N
P
 
/19/89/2 
 
S
A
U
 
/06/00/2 
U
G
A
 
/02/02/2 
ZIM
 
/01/88/2 
ZIM
 
/07/83/2 
K
N
P
 
/01/08 
ZIM
 
/05/91/3 
ZA
M
 
/04/96/3 
SA
T1 Strains 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
K
N
P
/196/91 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
N
A
M
/307/98 
3.6 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
S
A
R
/09/81 
3.9 
2.4 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
U
G
A
/03/99 
2.9 
2.3 
3.1 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
ZA
M
/02/93 
3.7 
2.3 
3.0 
3.8 
 
 
 
 
 
 
 
 
 
 
 
 
 
ZIM
/25/90 
5.0 
5.0 
3.3 
5.4 
4.6 
 
 
 
 
 
 
 
 
 
 
 
 
SA
T2 Strains 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
A
N
G
/04/74/2 
4.8 
5.8 
4.6 
5.1 
4.3 
6.9 
 
 
 
 
 
 
 
 
 
 
 
K
E
N
/03/57/2 
3.5 
2.6 
3.5 
3.3 
3.0 
3.0 
5.3 
 
 
 
 
 
 
 
 
 
 
K
N
P
/02/89/2 
3.7 
4.2 
4.3 
3.9 
2.8 
5.9 
3.1 
4.0 
 
 
 
 
 
 
 
 
 
K
N
P
/19/89/2 
 
2.3 
3.2 
3.1 
2.2 
1.9 
3.9 
3.4 
4.0 
0.7 
 
 
 
 
 
 
 
 
S
A
U
/06/00/2 
2.2 
4.1 
2.6 
2.2 
2.6 
3.8 
4.8 
2.5 
3.2 
3.3 
 
 
 
 
 
 
 
U
G
A
/02/02/2 
2.1 
3.0 
2.5 
2.1 
2.0 
3.1 
4.4 
2.4 
3.0 
2.9 
1.8 
 
 
 
 
 
 
ZIM
/01/88/2 
2.3 
4.0 
2.5 
2.4 
2.6 
3.9 
3.1 
2.4 
1.4 
1.1 
3.6 
2.9 
 
 
 
 
 
ZIM
/07/83/2 
2.3 
4.0 
2.5 
2.4 
2.6 
3.9 
3.1 
4.0 
0.7 
0.9 
3.1 
2.8 
1.2 
 
 
 
 
SA
T3 Strains 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
K
N
P
/01/08 
2.7 
3.0 
2.5 
2.5 
2.5 
3.1 
5.9 
5.1 
4.8 
5.0 
8.0 
6.0 
5.7 
4.9 
 
 
 
ZIM
/05/91/3 
2.7 
3.5 
3.6 
3.2 
2.1 
4.9 
3.2 
4.1 
2.3 
2.8 
3.3 
3.1 
3.1 
3.1 
3.5 
 
 
ZA
M
/04/96/3 
3.0 
2.0 
3.3 
2.8 
2.0 
3.4 
7.2 
7.4 
6.7 
6.9 
8.0 
8.2 
7.5 
6.7 
2.4 
3.4 
 
The R
M
S
D
 values w
ere calculated using U
C
S
F C
him
era (P
etterson et al., 2004). 
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Table 17: The R
M
SD
 of consensus epitopes 67, 68, 69 and 70 of VP3 betw
een the SA
T serotypes 
  
K
N
P
 
/196/91 
N
A
M
 
/307/98 
S
A
R
 
/09/81 
U
G
A
 
/03/99 
ZA
M
 
/02/93 
ZIM
 
/25/90 
A
N
G
 
/04/74/2 
K
E
N
 
/03/57/2 
K
N
P
 
/02/89/2 
K
N
P
 
/19/89/2 
 
S
A
U
 
/06/00/2 
U
G
A
 
/02/02/2 
ZIM
 
/01/88/2 
ZIM
 
/07/83/2 
K
N
P
 
/01/08 
ZIM
 
/05/91/3 
ZA
M
 
/04/96/3 
SA
T1 Strains 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
K
N
P
/196/91 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
N
A
M
/307/98 
3.4 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
S
A
R
/09/81 
4.4 
3.8 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
U
G
A
/03/99 
3.3 
1.6 
3.3 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
ZA
M
/02/93 
3.8 
1.9 
5.3 
2.8 
 
 
 
 
 
 
 
 
 
 
 
 
 
ZIM
/25/90 
8.8 
6.7 
8.3 
7.4 
7.2 
 
 
 
 
 
 
 
 
 
 
 
 
SA
T2 Strains 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
A
N
G
/04/74/2 
8.9 
5.6 
7.3 
8.2 
7.0 
8.0 
 
 
 
 
 
 
 
 
 
 
 
K
E
N
/03/57/2 
7.4 
6.8 
5.8 
6.6 
7.6 
6.2 
7.0 
 
 
 
 
 
 
 
 
 
 
K
N
P
/02/89/2 
6.7 
5.9 
5.9 
6.9 
6.5 
5.8 
6.4 
3.3 
 
 
 
 
 
 
 
 
 
K
N
P
/19/89/2 
 
7.1 
5.7 
5.7 
7.2 
6.8 
6.6 
5.7 
3.8 
1.5 
 
 
 
 
 
 
 
 
S
A
U
/06/00/2 
9.3 
8.6 
7.7 
8.1 
8.6 
6.6 
9.1 
3.9 
3.5 
4.1 
 
 
 
 
 
 
 
U
G
A
/02/02/2 
7.7 
6.9 
6.2 
7.1 
7.6 
5.1 
7.4 
3.0 
1.9 
2.4 
2.9 
 
 
 
 
 
 
ZIM
/01/88/2 
6.2 
4.9 
5.0 
6.3 
6.3 
5.6 
5.6 
3.3 
1.6 
1.5 
4.5 
2.4 
 
 
 
 
 
ZIM
/07/83/2 
6.0 
4.9 
5.0 
5.9 
5.8 
5.2 
6.0 
3.7 
1.3 
1.6 
4.3 
2.4 
1.0 
 
 
 
 
SA
T3 Strains 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
K
N
P
/01/08 
3.8 
3.0 
3.9 
2.6 
3.7 
5.4 
5.4 
5.4 
5.6 
5.6 
7.9 
6.2 
4.6 
4.8 
 
 
 
ZIM
/05/91/3 
5.4 
3.7 
5.9 
3.7 
3.2 
4.5 
6.9 
6.9 
6.8 
6.7 
9.5 
7.7 
6.0 
6.3 
3.0 
 
 
ZA
M
/04/96/3 
5.3 
3.8 
6.3 
3.9 
2.5 
5.6 
9.0 
9.0 
8.6 
8.4 
11.5 
9.6 
7.6 
7.8 
4.4 
2.9 
 
The R
M
S
D
 values w
ere calculated using U
C
S
F C
him
era (P
etterson et al., 2004)
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Figure 32: Wu-Kabat plot illustrates that the predicted epitopes are located on 
highly variable regions of the FMDV capsid 
A multiple sequence alignment of 18 P1 polyprotein sequences from SAT1, SAT2 and 
SAT3 viruses was created. The alignment was used to generate a Wu-Kabat (Wu & 
Kabat, 1970) plot. 
The Wu-Kabat variability index is plotted on the y-axis and the consensus capsid 
protein sequences of all 18 SAT strains is on the x-axis. 
Predicted epitopes on VP1 are highlighted with shaded blue boxes. 
Predicted epitopes on VP2 are highlighted with shaded green boxes. 
Predicted epitopes on VP3 are highlighted with shaded orange boxes. 
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3.3.8 Limitations of In Silico Epitope Prediction Methods 
 
Despite significant advances made in devising in silico epitope prediction methods, 
there are still limitations to the predictive powers of their algorithms and there are 
therefore continued efforts to improve their performance. One of the most widely used 
performance evaluators for machine learning algorithms is the area under the receiver 
operating characteristic curve, also known as (AUC) or (ROC) curve (Fawcett, 2006; 
Spackman, 1989; Swets, 1988). The true positive rate (TPR) is plotted on the y-axis 
and the false positive rate (FPR) is plotted on the x-axis. The TPR is also called 
sensitivity or recall (Fawcett, 2006). The AUC relates how sensitivity is dependent on 1-
specificity or how the TPR depends on the FPR (Fawcett, 2006). AUC values range 
between zero and one (Swets, 1988). A method that scores 0.5 is deemed a random 
discriminator and one that scores a value of one has a perfect predictive capability 
(Fawcett, 2006; Greenbaum et al., 2007). Currently, the top performing epitope 
prediction methods, namely Discotope, Epitopia, Ellipro, Seppa and BEpro have 
average AUC values ranging between 0.6 and 0.7, depending on the evaluation dataset 
used (Kringelum et al., 2012; Rubinstein et al., 2009; Sun et al., 2009; Sweredoski & 
Baldi, 2008).  
 
One of the major limitations to the improved performance of in silico epitope prediction 
methods is improper benchmark annotation. Most epitope prediction methods allow for 
the annotation of only one epitope per antigen in their training datasets (Andersen et al., 
2006; Rubinstein et al., 2009; Sweredoski & Baldi, 2008). This does not take into 
consideration the fact that not all epitopes on any particular antigen have been 
experimentally identified (Kringelum et al., 2012; Rubinstein, Mayrose, & Pupko, 2009; 
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Sweredoski & Baldi, 2008). Improper benchmark annotation not only has a direct 
influence on the predictive abilities of the algorithms but also on the performance 
measures of the methods (Greenbaum et al., 2007; Kringelum et al., 2012; Sweredoski 
& Baldi, 2008). 
 
A limitation of the AUC for epitope prediction methods is that it underestimates the 
predictive power of the algorithm as long as the training datasets are under-annotated 
(Kringelum et al., 2012; Rubinstein et al., 2009). Otherwise good predictors 
consequently call a number of false negatives (Kringelum et al., 2012; Ponomarenko & 
Bourne, 2007; Rubinstein et al., 2009). Another form of improper benchmark annotation 
is that most of the X-ray crystal structures in the training datasets consist of Abs bound 
to single antigen chains, yet Abs in vivo are raised against whole biological units 
(Kringelum et al., 2012). A negative consequence of this is that several antigen contacts 
that are predicted as being available for binding to an antibody are in fact involved in 
long-range intra-molecular interactions (Kringelum et al., 2012). 
 
Another limitation of the epitope prediction methods that was shown with respect to 
Picornaviruses is that they are not able to predict all the known epitopes. Discotope and 
Ellipro were able to predict 61% and 58% respectively of the known FMDV epitopes 
(Borley et al., 2013).  
 
In spite of the limited predictive powers of the respective epitope prediction methods, 
using a consensus of the results of the top performing methods can ameliorate these 
limitations (Liang et al., 2010). When predicting putative novel epitopes, consensus 
results reduce the likelihood of false positive results (Borley et al., 2013). 
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3.4 CONCLUSIONS 
 
3.4.1 Novel Epitopes 
 
The epitope prediction programmes Discotope and Ellipro predicted both known and 
novel epitopes on the SAT strains. Some of the novel epitopes are located on the same 
loops as experimentally derived epitopes, while others are located on a putative novel 
antigenic site, which is located close to the five-fold axis of symmetry. The set of 
epitopic amino acids predicted on the novel antigenic site comprises residues 95 to 105 
on the EE-EF loop of VP1 on the SAT1 and SAT2 serotypes.  
 
One putative novel epitope that falls within a known antigenic site comprises residues 
190 to 192 on the VP2 EH-EI loop of the SAT3 strain, KNP/01/08 only. Borley et al. 
(2013) also predicted this epitope across several Euro-Asiatic serotypes. The EH-EI loop 
contains the known epitope 196 on types A and C (Borley et al., 2013).  
 
Novel epitopes 66 to 71 on the EB-EC loop of VP3 were predicted across the three SAT 
serotypes. This loop is known to contain epitopes 60 and 70 on the A, O and SAT1 
serotypes (Borley et al., 2013). Novel epitopes 193 to 197 on the EH-EI loop of VP3 
were predicted on the SAT1 and SAT3 serotypes. These epitopes are novel except for 
epitope 196, which is known in types A and C (Borley et al., 2013). The epitopes on the 
EB-EC and EH-EI loops of VP3 are located on the three-fold axis of symmetry at the 
inter-pentamer interface.  
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It was of interest to note that the SAT viruses had more predicted epitopes in common 
with known epitopes on the type A viruses than any of the other serotypes.  
 
3.4.2 Consensus Epitopes 
 
A consensus set of predicted epitopes was compiled that comprises epitopes predicted 
on at least 15 out of 18 strains. These epitopes are 102 of VP1; 87-90 of VP2; 58 and 
59 of VP3; and 67-70 of VP3. The consensus epitopes on VP2 and VP3 are known to 
possess neutralizing Abs across three other serotypes, O, A and Asia1. These 
consensus epitopes among the SAT serotypes are therefore potential targets for the 
rational design of cross-reactive vaccines. FMDV capsids can be designed through 
mutagenesis in order to possess a set of epitopes that are shared by the strains in 
circulation.  
 
 174 
REFERENCES  
Acharya, R., Fry, E., Stuart, D., Fox, G., Rowlands, D., & Brown, F. (1989). The three-
dimensional structure of foot-and-mouth-disease virus at 2.9 A resolution. Nature, 
337, 709–716. 
Acharya, R., Fry, E., Stuart, D., Fox, G., Rowlands, D., & Brown, F. (1990). The 
structure of foot-and-mouth disease virus: implications for its physical and 
biological properties. Veterinary Microbiology, 23, 21–34. 
Adams, P., Lea, S., Newman, J., Blakemore, W., King, A., Stuart, D. & Fry, E. (n.d.). 
The Structure of Foot-and-Mouth Disease Virus Serotype Sat1. To Be Published. 
Retrieved from http://www.rcsb.org/pdb/explore/explore.do?structureId=2WZR 
 
Adcock, S. A., & Mccammon, J. A. (2006). Molecular dynamics: Survey of methods for 
simulating the activity of proteins. Chemical Reviews, 106(5), 1589–1615. 
Adrian, M., Dubochet, J., LePault, J., & McDowall, A. (1984). Cryo-electron microscopy 
of viruses. Nature, 308, 32–36. 
Aggarwal, N., & Barnett, P. V. (2002). Antigenic sites of foot-and-mouth disease virus 
(FMDV) : an analysis of the specificities of anti-FMDV antibodies after vaccination 
of naturally susceptible host species. Journal of General Virology, 83(4), 775–782. 
Aktas, S., & Samuel, A. R. (2000). Identification of antigenic epitopes on the foot and 
mouth disease virus isolate O1/Manisa/Turkey/ 69 using monoclonal antibodies. 
Review of Science and Technology International Office of Epizootics, 19(3), 744–
753. 
Altschul, S., Gish, W., Miller, W., Myers, W., & Lipman, E. W. (1990). Basic local 
alignment search tool. Journal of Molecular Biology, 215, 403–410. 
Altschul, S., Madden, T., Schaffer, A., Zhang, J., Zhang, Z., Miller, W., & Lipman, D. 
(1997). Gapped BLAST and PSI-BLAST: A new generation of protein database 
search programs. Nucleic Acids Research, 25, 3899–3402. 
Andersen, P. H., Nielsen, M., & Lund, O. L. E. (2006). Prediction of residues in 
discontinuous B-cell epitopes using protein 3D structures. Protein Engineering, 15, 
2558–2567. doi:10.1110/ps.062405906 
Ao, D., Guo, H.-C., Sun, S.-Q., Sun, D.-H., Fung, T. S., Wei, Y.-Q., … Liu, X.-T. (2015). 
Viroporin activity of the foot-and-mouth disease virus non-structural 2B protein. 
Plos One, 10(5), e0125828. doi:10.1371/journal.pone.0125828 
Arnold, K., Bordoli, L., Kopp, J., & Schwede, T. (2006). The SWISS-MODEL workspace: 
a web-based environment for protein structure homology modelling. Bioinformatics, 
22(2), 195–201. 
Aszodi, A., & Taylor, W. R. (1996). Homology modelling by distance geometry. Folding 
 175 
and Design, 1, 325–334. 
Atassi, Z. (1984). Antigenic structures of proteins. European Journal of Biochemistry, 
145, 1–20. doi:10.1111/j.1432-1033.1984.tb08516.x 
Bablanian, G. M., & Grubman, M. J. (1993). Characterization of the foot-and-mouth 
disease virus 3C protease expressed in Escherichia coli. Virology, 197, 320–327. 
Bachrach, H. L., Moore, M. D., McKercher, P. D., & Polatnick, J. (1975). Immune and 
antibody responses to an isolated capsid protein of foot-and-mouth disease virus. 
The Journal of Immunology, 115(6), 1636–1641. 
Baker, D., & Sali, A. (2001). Protein structure prediction and structural genomics. 
Science, 294, 93–96. 
Barnett, P. V, Samuel, A. R., Pullen, L., Ansell, D., Butcher, R. N., & Parkhouse, R. M. 
E. (1998). Monoclonal antibodies, against O1 serotype foot-and-mouth disease 
virus, from a natural bovine host, recognize similar antigenic features to those 
defined by the mouse. Journal of General Virology, 79, 1687–1697. 
Bastos, A. D. S., Haydon, D. T., Forsberg, R., Knowles, N. J., Anderson, E. C., Bengis, 
R. G., … Thomson, G. R. (2001). Genetic heterogeneity of SAT-1 type foot-and-
mouth disease viruses in southern Africa. Archives of Virology, 146, 1537–1551. 
Bax, A. (1989). Two-dImensional NMR and protein structure. Annual Reviews in 
Biochemistry, 58, 223–256. 
Baxt, B., Vakharia, V., Moore, D. M., Franke, A. J., & Morgan, D. O. (1989). Analysis of 
neutralizing antigenic sites on the surface of type A12 foot-and-mouth disease 
virus. Journal of Virology, 63(5), 2143–2153. 
Belsham, G. J. (1993). Distinctive features of foot-and-mouth disease virus, a member 
of the Picornavirus family; Aspects of virus protein synthesis, protein processing 
and structure. Progress in Biophysical Molecular Biology, 60, 241–260. 
Belsham, G. J. (2013). Influence of the Leader protein coding region of foot-and-mouth 
disease virus on virus replication. The Journal of General Virology, 94(7), 1486–
1495. doi:10.1099/vir.0.052126-0 
Benkert, P., Biasini, M., & Schwede, T. (2011). Toward the estimation of the absolute 
quality of individual protein structure models. Bioinformatics, 27(3), 343–350. 
Benkert, P., Ku, M., & Schwede, T. (2009). QMEAN server for protein model quality 
estimation. Nucleic Acids Research, 37, W510–W514. 
Bittle, J. L., Houghten, R. A., Alexander, H., Shinnick, T. M., Sutcliffe, J. G., Lerner, R. 
A., … Brown, F. (1982). Protection against foot-and-mouth disease by 
immunization with a chemically synthesized peptide predicted from the viral 
nucleotide sequence. Nature, 298, 30–33. doi:10.1038/298030a0 
 176 
Blundell, T. L., & Johnson, M. S. (1993). Catching a common fold. Protein Science, 
2(6), 877–883. 
Bolwell, C., Clarke, B. E., Parry, N. R., Ouldridge, E. J., Brown, F., & Rowlands, D. J. 
(1989). Epitope mapping of foot-and-mouth disease virus with neutralizing 
monoclonal antibodies. Journal of General Virology, 70, 59–68. 
Borley, D. W., Mahapatra, M., Paton, D. J., Esnouf, R. M., Stuart, D. I., & Fry, E. E. 
(2013). Evaluation and Use of In-Silico Structure-Based Epitope Prediction with 
Foot-and-Mouth Disease Virus. PLoS ONE, 8(5), e61122. 
doi:10.1371/journal.pone.0061122 
Brehm, K. E., Kumar, N., Thulke, H. H., & Haas, B. (2008). High potency vaccines 
induce protection against heterologous challenge with foot-and-mouth disease 
virus. Vaccine, 26, 1681–1687. 
Browne, W. J., North, A. C. T., & Phillips, D. C. (1969). A possible three-dimensional 
structure of bovine α-lactalbumin based on that of hen’s egg-white lysozyme. 
Journal of Molecular Biology, 42, 65–86. 
Bublil, E. M., Freund, N. T., Mayrose, I., Penn, O., Roitburd-Berman, A., Rubinstein, N., 
… Gershoni, J. M. (2007). Stepwise prediction of conformational discontinuous B-
cell epitopes using the Mapitope algorithm. Proteins, 68, 294–304. 
doi:10.1002/prot.21387 
Carrillo, C. (2012). Foot and mouth disease virus. In M. Garcia (Ed.), Viral genomes - 
molecular structure, diversity, gene expression mechanisms and host-virus 
interactions (pp. 53–68). Intech. 
Case, D. A., Darden, T. A., Cheatham III, T. E., Simmerling, C. L., Wang, J., Duke, R. 
E., … Kollman, P. A. (2012). AMBER 12. San Francisco: University of California. 
Cheng, J., Randall, A. Z., Sweredoski, M. J., & Baldi, P. (2005). SCRATCH: a protein 
structure and structural feature prediction server. Nucleic Acids Research, 33, 72–
76. doi:10.1093/nar/gki396 
Chothia, C. (1992). One thousand families for the molecular biologist. Nature, 357, 543–
544. 
Chothia, C., & Lesk, A. M. (1986). The relation between the divergence of sequence 
and structure in proteins. The European Molecular Biology Organization Journal, 
5(4), 823–826. 
Chou, P. Y., & Fasman, G. D. (1974). Conformational parameters for amino acids in 
helical β-sheet and random coil regions calculated from proteins. Biochemistry, 
13(2), 211–222. doi:10.1021/bi00699a001 
Chow, M., Newman, J. F., Felman, D., Hogle, J. M., Rowland, D. J., & Brown, F. (1987). 
Myristylation of picornavirus capsid protein VP4 and its structural significance. 
 177 
Nature, 237, 482–486. 
Clarke, B. E., Brown, A. L., Curry, K. M., Newton, S. E., Rowlands, D. J., & Carroll, A. 
R. (1987). Potential secondary and tertiary structure in the genomic RNA of foot-
and-mouth disease virus. Nucleic Acids Research, 15, 7067–7079. 
Cooper, P. D., Agol, V. I., Bachrach, H. L., Brown, F., Ghendon, Y., Gibbs, A. J., … 
Tyrrell, D. A. J. (1978). Picornaviridae: Second report. Intervirology, 10, 165–180. 
Cornell, W. D., Cieplak, P., Bayly, C. I., Gould, I. R., Merz, K. M., Ferguson, D. M., … 
Kollman, P. A. (1995). A second generation force field for the simulation of 
proteins, nucleic acids and organic molecules. Journal of the American Chemical 
Society, 117, 5179–5197. 
Cristobal, S., Zemla, A., Fischer, D., Rychlewski, L., & Elofsson, A. (2001). A study of 
quality measure for protein threading models. BMC Bioinformatics, 2, 5. 
Crowther, J. R., Farias, S., Carpenter, W. C., & Samuel, A. R. (1993). Identification of a 
fifth neutralizable site on type 0 foot-and-mouth disease virus following 
characterization of single and quintuple monoclonal antibody escape mutants. 
Journal of General Virology, 74, 1547–1553. 
Crowther, J. R., Rowe, C. A., & Butcher, R. (1993). Characterization of monoclonal 
antibodies against a type SAT 2 foot-and-mouth disease virus. Epidemiology and 
Infection, 111, 391–406. 
Curry, S., Fry, E., Blakemore, W., Abu-ghazaleh, R., Jackson, T., King, A., … Stuart, D. 
(1995). Perturbations in the surface structure of A22 Iraq foot-and-mouth disease 
virus accompanying coupled changes in host cell specificity and antigenicity. 
Structure, 4, 135–145. 
Curry, S., Fry, E., Blakemore, W., Abu-Ghazaleh, R., Jackson, T., King, A., … Stuart, D. 
(1996). Perturbations in the surface structure of A22 Iraq foot-and-mouth disease 
virus accompanying coupled changes in host cell specificity and antigenicity. 
Structure, 4, 135–145. doi:8805520 
De Groot, A. S., Bosma, A., & Chinai, N. (2001). From genome to vaccine: in silico 
predictions, ex vivo verification. Vaccine, 19(31), 4385–4395. doi:10.1016/s0264-
410x(01)00145-1 
Dimmock, N. J. (1993). Neutralization of animal viruses. Current Topics in Microbiology 
and Immunology, 183, 1–149. 
Dubochet, J., Adrian, M., Chang, J.-J., Homo, J.-C., Le Pault, J., McDowall, A., & 
Schultz, P. (1988). Cryo-electron microscopy of vitrified specimens. Quarterly 
Review of Biophysics, 21(2), 129–228. 
Eichinger, M., Heymann, B., Heller, H., Grubmuller, H., & Tavan, P. (1999). 
Conformational dynamics simulations of proteins. In P. Deuflhard, J. Hermans, B. 
 178 
Leimkuhler, A. E. Mark, S. Reich, & R. Skeel (Eds.), Computational Molecular 
Dynamics: Challenges, Methods, Ideas (4th ed., pp. 78–97). Berlin: Springer Berlin 
Heidelberg. 
Fawcett, T. (2006). An introduction to ROC analysis. Pattern Recognition Letters, 27, 
861–874. doi:10.1016/j.patrec.2005.10.010 
Ferris, N. P., & Donaldson, A. I. (1992). The World Reference Laboratory for Foot and 
Mouth Disease : a review of thirty-three years of activity (1958-1991). Review of 
Science and Technology (International Office of Epizootics), 11(3), 657–684. 
Fiser, A., Do, R. K. G., & Sali, A. (2000). Modeling of loops in protein structures. Protein 
Science, 9, 1753–1773. 
Floudas, C. A., Fung, H. K., McAllister, S. R., Mönnigmann, M., & Rajgaria, R. (2006). 
Advances in protein structure prediction and de novo protein design: A review. 
Chemical Engineering Science, 61, 966–988. 
Forrest, L. R., Tang, C. L., & Honig, B. (2006). On the accuracy of homology modeling 
and sequence alignment methods applied to membrane proteins. Biophysical 
Journal, 91(2), 508–517. 
Forss, S., Strebel, K., & Schaller, H. (1984). Nucleotide sequence and genome 
organization of foot-and-mouth disease virus. Nucleic Acids Research, 12, 6587–
6601. 
Forster, M. J. (2002). Molecular modelling in structural biology. Micron, 33, 365–384. 
Fry, E., Acharya, R. & Stuart, D. (1993). Methods used in the structure determination of 
foot-and-mouth disease virus. Acta Crystallogr.,Sect.A, 49, 45–55. doi:8382928 
Fry, E., Logan, D., Acharya, R., Fox, G., & Rowlands, D. (1990). Architecture and 
topography of an aphthovirus. Seminars in Virology, 1, 439–451. 
Garcia-Boronat, M., Diez-Rivero, C. M., Reinherz, E. L., & Reche, P. A. (2008). PVS: a 
web server for protein sequence variability analysis tuned to facilitate conserved 
epitope discovery. Nucleic Acids Research, 36, W35–W41. 
Garnier, J., Osguthorpe, D. J., & Robson, B. (1978). Analysis of the accuracy and 
implications of simple methods for predicting the secondary structure of globular 
proteins. Journal of Molecular Biology, 120, 97–120. doi:10.1016/0022-
2836(78)90297-8 
Goodwin, S., Tuthill, T. J., Arias, A., Killington, R. a, & Rowlands, D. J. (2009). Foot-
and-mouth disease virus assembly: processing of recombinant capsid precursor by 
exogenous protease induces self-assembly of pentamers in vitro in a 
myristoylation-dependent manner. Journal of Virology, 83(21), 11275–11282. 
doi:10.1128/JVI.01263-09 
 179 
Grazioli, S., Fallacara, F., & Brocchi, E. (2013). Mapping of antigenic sites of foot-and-
mouth disease virus serotype Asia 1 and relationships with sites described in other 
serotypes. Journal of General Virology, 94(3), 559–569. doi:doi: 
10.1099/vir.0.048249-0 
Grazioli, S., Fallacara, F., & Brocchi, E. (2013). Mapping of antigenic sites of foot-and-
mouth disease virus serotype Asia 1 and relationships with sites described in other 
serotypes. Journal of General Virology, 94(3), 559–569. doi:10.1099/vir.0.048249-0 
Grazioli, S., Moretti, M., Barbieri, I., Crosatti, M., & Brocchi, E. (2006). Use of 
monoclonal antibodies to identify and map new antigenic determinants involed in 
neutralization of FMD viruses type SAT 1 and SAT 2. In European Commission for 
the control of Foot-and-Mouth Disease: International control of Foot-and-Mouth 
disease: Tools, Trends and perspectives. Paphos, Cyprus. 
Greenbaum, J. A., Andersen, P. H., Blythe, M., Bui, H., Cachau, R. E., Crowe, J., … 
Morrison, S. (2007). Towards a consensus on datasets and evaluation metrics for 
developing B-cell epitope prediction tools. Journal of Molecular Recognition, 20(2), 
75–82. doi:10.1002/jmr.815 
Greer, J. (1990). Comparative modeling methods: Application to the family of the 
mammalian serine proteases. Proteins: Structure, Function and Bioinformatics, 
7(4), 317–334. 
Grubman, M., & Baxt, B. (2004). Foot-and-mouth disease. Clinical Microbiology 
Reviews, 17(2), 465–493. doi:10.1128/CMR.17.2.465 
Guo, F., & Wen, J. (2014). Single particle cryo-electron microscopy and 3-D 
reconstruction of viruses. Methods in Molecular Biology, 1117, 401–443. 
doi:10.1007/978-1-62703-776-1_19 
Hamelryck, T. (2005). An amino acid has two sides: a new 2D measure provides a 
different view of solvent exposure. Proteins, 59, 38–48. doi:10.1002/prot.20379 
Harber, J. J., Bradley, J., Anderson, C. W., & Wimmer, E. (1991). Catalysis of polivirus 
VP0 maturation cleavage is not mediated by serine 10 of VP2. Journal of Virology, 
65, 326–334. 
Harris, T. J., & Brown, F. (1977). Biochemical analysis of a virulent and an avirulent 
strain of foot-and-mouth disease virus. Journal of General Virology, 34, 87–105. 
Havel, T. F., & Snow, M. E. (1991). A new method for building protein conformations 
from sequence alignments with homologues of known structure. Journal of 
Molecular Biology, 217, 1–7. 
Hewat, E. A., Verdaguer, N., Fita, I., Blakemore, W., Brookes, S., King, A., … Stuart, D. 
I. (1997). Structure of the complex of an Fab fragment of a neutralizing antibody 
with foot-and-mouth disease virus: positioning of a highly mobile antigenic loop. 
 180 
The European Molecular Biology Organization Journal, 16(7), 1492–1500. 
Hogle, J. M., Chow, M., & Filman, D. J. (1985). Three-dimensional structure of 
Poliovirus at 2.9A resolution. Science, 229, 1358–1365. 
Hopp, T. P., & Woods, K. R. (1981). Prediction of protein antigenic determinants from 
amino acid sequences. Proceedings of the National Academy of Sciences of the 
USA, 78(6), 3824–3828. doi:10.1073/pnas.78.6.3824 
Hubbard, T. J., & Blundell, T. L. (1987). Comparison of solvent-inaccessible cores of 
homologous proteins: definitions useful for protein modelling. Protein Engineering, 
1(3), 159–171. 
Humphrey, W., Dalke, A., & Schulten, K. (1996). VMD - ’Visual Molecular Dynamics. 
Journal of Molecular Graphics, 14(1), 33–38. 
Hunter, P. (2006). Into the fold. EMBO Reports, 7(3), 249–252. 
doi:10.1038/sj.embor.7400655 
Jacobson, M., & Sali, A. (2004). Comparative Protein Structure Modeling and its 
Applications to Drug Discovery. Annual Reports in Medicinal Chemistry, 39(4), 
259–276. doi:10.1016/S0065-7743(04)39020-2 
Jamal, S. M., & Belsham, G. J. (2013). Foot-and-mouth disease: past, present and 
future. Veterinary Research, 44(116), 1–14. doi:10.1186/1297-9716-44-116 
Janeway, C. A., Travers, P., & Walport, M. (2001). The interaction of the antibody 
molecule with specific antigen. In Immunobiology: The Immune System in Health 
and Disease (5th ed.). New York: Garland Science. 
Janin, J., Wodak, S., Levitt, M., & Maigret, B. (1978). Conformation of amino acid side-
chains in proteins. Journal of Molecular Biology, 125, 357–386. doi:10.1016/0022-
2836(78)90408-4 
Jones, D. T., Taylor, W. R., & Thornton, J. M. (1992). A new approach to protein fold 
recognition. Nature, 358, 86–89. 
Jorgensen, W. L., Chandrasekhar, J., Madura, J. D., Impey, R. W., & Klein, M. L. 
(1983). Comparison of simple potential functions for simulating liquid water. Journal 
of Chemical Physics, 79, 926–935. 
King, A. M. Q., Sangar, D. V., Harris, T. J., & Brown, F. (1980). Heterogeneity of the 
genome-linked protein of foot-and-mouth disease virus. Journal of Virology, 34, 
627–634. 
Kitson, J., McCahon, D., & Belsham, G. J. (1990). Sequence analysis of monoclonal 
antibody resistant mutants of type O foot-and-mouth disease virus: Evidence for 
the involvement of the three surface exposed capsid proteins in four antigenic sites. 
Virology, 179(1), 26–34. 
 181 
Krieger, F., Moglich, A., & Thomas, K. (2005). Effect of proline and glycine residues on 
dynamics and barriers of loop formation in polypeptide chains. Journal of the 
American Chemical Society, 127(10), 3346–3352. 
Kringelum, J. V., Lundegaard, C., Lund, O., & Nielsen, M. (2012). Reliable B-Cell 
epitope predictions: impacts of method development and improved benchmarking. 
Plos Computational Biology, 8(12), 1–10. doi:10.1371/journal.pcbi.1002829 
Kuroda, D., Shirai, H., Jacobson, M., & Nakamura, H. (2012). Computer-aided antibody 
design. Protein Engineering Design and Selection, 25(10), 507–521. 
doi:10.1093/protein/gzs024 
Larsen, J. E. P., Lund, O., & Nielsen, M. (2006). Improved method for predicting linear 
B-cell epitopes. Biomed Central Immunome Research, 2(2), 1–7. 
doi:10.1186/1745-7580-2-2 
Larsson, D. (2012). Exploring the molecular dynamics of proteins and viruses. Uppsala 
University. 
Laskowski, R. A., MacArthur, M. W., Moss, D., & Thornton, J. M. (1993). Procheck: a 
program to check the stereochemical quality of protein structures. Journal of 
Applied Crystallography, 26, 283–291. 
Lea, S., Blakemore, W., Brocchi, E., Domingo, E., Fry, E., King, A., … Mateu, M. G. 
(1994). The structure and antigenicity of a type C foot-and-mouth disease virus. 
Structure, 2, 123–139. 
Levitt, M. (1992). Accurate modeling of protein conformation by automatic segment 
matching. Journal of Molecular Biology, 226, 507–533. 
Liang, S., Zheng, D., Standley, D. M., Yao, B., Zacharias, M., & Zhang, C. (2010). 
EPSVR and EPMeta: prediction of antigenic epitopes using support vector 
regression and multiple server results. Biomed Central Bioinformatics, 11, 381–
387. doi:10.1186/1471-2105-11-381 
Lin, S. Y., Cheng, S., & Su, E. C. (2013). Prediction of B-cell epitopes using 
evolutionary information and propensity scales. Biomed Central Bioinformatics, 
14(Supplement 2), S10–19. doi:10.1186/1471-2105-14-s2-s10 
Liu, H., & Hsu, J. (2005). Recent developments in structural proteomics. Proteomics, 5, 
2056–2068. 
Liu, T., Tang, G. W., & Capriotti, E. (2011). Comparative modeling: the state of the art 
and protein drug target structure prediction. Combinatorial Chemistry & High 
Throughput Screening, 14(6), 532–547. doi:10.2174/138620711795767811 
Lo, Y., Pai, T., Wu, W., & Chang, H. (2013). Prediction of conformational epitopes with 
the use of a knowledge-based energy function and geometrically related 
neighboring residue characteristics. BMC Bioinformatics, 14(Suppl 4), S3. 
 182 
Logan, D., Abu-Ghazaleh, R., Blakemore, W., Curry, S., Jackson, T., King, A. M. Q., … 
Fry, E. (1993). Structure of a major immunogenic site on foot-and-mouth disease 
virus. Nature, 326, 566–568. 
Longjam, N., Deb, R., Sarmah,  a. K., Tayo, T., Awachat, V. B., & Saxena, V. K. (2011). 
A brief review on diagnosis of foot-and-mouth disease of livestock: conventional to 
molecular tools. Veterinary Medicine International, 2011, 1–17. 
doi:10.4061/2011/905768 
Luo, M., Vriend, G., Kamer, G., Arnold, E., Rossmann, M. G., Boege, U., … 
Palmenberg, A. C. (1987). The atomic structure of Mengo virus at 3.0Å resolution. 
Science, 235, 182–191. 
Maree, F. F., Blignaut, B., Esterhuysen, J. J., Beer, T. A. P. De, Theron, J., Neill, H. G. 
O., & Rieder, E. (2011). Predicting antigenic sites on the foot-and-mouth disease 
virus capsid of the South African Territories types using virus neutralization data. 
Journal of General Virology, 92, 2297–2309. doi:10.1099/vir.0.032839-0 
Marti-Renom, M. A., Stuart, A. C., Fiser, A., Sanchez, R., Melo, F., & Sali, A. (2000). 
Comparative protein structure modeling of genes and genomes. Annual Review of 
Biophysics and Biomolecular Structure, 29, 291–325. 
Mateu, M. G. (1995). Antibody recognition of picornaviruses and escape from 
neutralization: a structural view. Virus Research, 38, 1–24. 
Mateu, M. G., Hernandez, J., Martinez, M. A., Feigelstock, D., Lea, S., Perez, J. J., … 
Domingo, E. (1994). Antigenic heterogeneity of a foot-and-mouth disease virus 
serotype in the field Is mediated by very limited sequence variation at several 
antigenic sites. Journal of Virology, 68(3), 1407–1417. 
Mateu, M. G., Martinez, M. A., Capucci, L., Andreu, D., Giralt, E., Sobrino, F., … 
Domingo, E. (1990). A single amino acid substitution affects multiple overlapping 
epitopes in the major antigenic site of foot-and-mouth disease virus of serotype C. 
Journal of General Virology, 71, 629–637. doi:10.1099/0022-1317-71-3-629 
McCahon, D., Crowther, J. R., Belsham, G. J., Kitson, J., Duchesne, M., Have, P., … 
De Simone, F. (1989). Evidence for at least four antigenic sites on Type O foot-
and-mouth disease virus involved in neutralization; identification by single and 
multiple site monoclonal antibody-resistant mutants. Journal of General Virology, 
70, 639–645. 
McCullough, K. C., De Simone, F., Brocchi, E., Capucci, L., Crowther, J. R., & Kihm, U. 
(1992). Protective immune repsonse against foot-and-mouth disease virus. Journal 
of Virology, 66, 1835–1840. 
Melo, F., Devos, D., Depiereux, E., & Feytmans, E. (1997). ANOLEA: A www server to 
assess protein structures. In T. Gaasterland (Ed.), Fifth International Conference 
on Intelligence Systems for Molecular Biologu (p. 187). Michigan: Association for 
 183 
the Advancement of Artificial Intelligence Press. 
Melo, F., & Feytmans, E. (1997). Novel knowledge-based mean force potential at 
atomic level. Journal of Molecular Biology, 267, 207–222. 
Meloen, R. H., Puyk, W. C., Meijer, D. J. A., Lankhof, H., Posthumus, W. P. A., & 
Schaaper, W. M. M. (1987). Antigenicity and immunogenicity of synthetic peptides 
of foot-and-mouth disease virus. Journal of General Virology, 68, 305–314. 
doi:10.1099/0022-1317-68-2-305 
Monod, J., Wyman, J., & Changeux, J. (1965). On the nature of allosteric transitions: A 
plausible model. Journal of Molecular Biology, 12, 88–118. 
Moult, J., & James, M. N. G. (1986). An algorithm for determining the conformation of 
polypeptide segments in proteins by systematic search. Proteins: Structure, 
Function and Bioinformatics, 1(2), 146–163. 
Needleman, S. B., & Wunsch, C. D. (1970). A general method applicable to the search 
for similarities in the amino acid sequence of two proteins. Journal of Molecular 
Biology, 48, 443–453. 
Newman, J. F., Cartwright, B., Doel, T. R., & Brown, F. (1979). Purification and 
identification of the RNA-dependant RNA polymerase of foot-and-mouth disease 
virus. Journal of General Virology, 45, 497–507. 
Newton, S. E., Carroll, A. R., Campbell, R. O., Clarke, B. E., & Rowlands, D. (1985). 
The sequence of foot-and-mouth disease virus RNA to the 5’ side of the poly(C) 
tract. Gene, 40, 331–336. 
Novotny, J., Handschumacher, M., Haber, E., Bruccoleri, R. E., Carlson, W. B., 
Fanning, D. W., … Rose, G. D. (1986). Antigenic determinants in proteins coincide 
with surface regions accessible to large probes (antibody domains). Proceedings of 
the National Academy of Sciences of the USA, 83, 226–230. 
doi:10.1073/pnas.83.2.226 
OIE. (2012). Foot and mouth disease. In Manual of Diagnostic Tests and Vaccines for 
Terrestrial Animals (7th ed.). Paris: OIE. 
Opperman, P. A., Maree, F. F., Van Wyngaardt, W., Vosloo, W., & Theron, J. (2012). 
Mapping of antigenic determinants on a SAT2 foot-and-mouth disease virus using 
chicken single-chain antibody fragments. Virus Research, 167, 370–379. 
doi:doi:10.1016/j.virusres.2012.05.026 
Opperman, P. A., Rotherham, L. S., Esterhuysen, J., Charleston, B., Juleff, N., 
Capozzo, A. V, … Maree, F. F. (2014). Determining the epitope dominance on the 
capsid of a SAT2 foot-and-mouth disease virus by mutational analyses. Journal of 
Virology, 88(15), 8307–8318. 
Ouldridge, E. J., Barnett, P. V., Parry, N. R., Syred, A., Head, M., & Rweyemamu, M. M. 
 184 
(1984). Demonstration of neutralizing and non-neutralizing epitopes on the trypsin-
sensitive site of foot-and-mouth disease virus. Journal of General Virology, 65, 
203–207. 
Palmenberg, A. C. (1990). Proteolytic processing of picornaviral polyprotein. Annual 
Reviews in Microbiology, 44, 603–623. 
Parker, J. M., Guo, D., & Hodges, R. S. (1986). New hydrophilicity scale derived from 
high-performance liquid chromatography peptide retention data: correlation of 
predicted surface residues with antigenicity and X-ray-derived accessible sites. 
Biochemistry, 19, 5425–5432. doi:10.1021/bi00367a013 
Parry, N., Fox, G., Rowlands, D., Brown, F., Fry, E., Acharya, R., … Stuart, D. (1990). 
Structural and serological evidence for a novel mechanism of antigenic variation in 
foot-and-mouth disease virus. Nature, 347, 567–572. 
Paton, D. J., & Taylor, G. (2011). Developing vaccines against foot-and-mouth disease 
and some other exotic viral diseases of livestock. Philosophical Transactions of the 
Royal Society B: Biological Sciences, 366(1579), 2774–2781. 
doi:10.1098/rstb.2011.0107 
Pearson, W. R., & Lipman, D. (1988). Improved tools for biological sequence 
comparison. Proceedings of the National Academy of Sciences of the USA, 85, 
2444–2448. 
Pellequer, J., Westhof, E., & VanRegenmortel, M. (1991). Predicting the location of 
continuous epitopes in proteins from their primary strucutre. Methods in 
Enzymology, 203, 176–201. doi:10.1016/0076-6879(91)03010-e 
Peters, B., Sidney, J., Bourne, P., Bui, H. H., Buus, S., Doh, G., … Kubo, R. (2005). 
The immune epitope database and analysis resource: From vision to blueprint. 
Immunogenetics, 57(326-336). doi:10.1371/journal.pbio.0030091 
Petterson, E. F., Goddard, T. D., Huang, C. C., Couch, G. S., Greenblatt, D. M., Meng, 
E. C., & Ferrin, T. E. (2004). UCSF Chimera-a visualization system for exploratory 
research and analysis. Journal of Computational Chemistry, 25(13), 1605–1612. 
Pfaff, E., Mussgay, M., Bohm, H. O., Shulz, G. E., & Schaller, H. (1982). Antibodies 
against a preselected peptide recognise and neutralise foot-and-mouth disease 
virus. European Molecular Biology Organization Journal, 1, 869–874. 
Ponder, J. W., & Richards, F. M. (1987). Tertiary templates for proteins. Use of packing 
criteria in the enumeration of allowed sequences for different structural classes. 
Journal of Molecular Biology, 193(4), 775–791. 
Ponomarenko, J. V, & Bourne, P. E. (2007). Antibody-protein interactions: benchmark 
datasets and prediction tools evaluation. BMC Structural Biology, 7, 64. 
doi:10.4016/5328.01 
 185 
Ponomarenko, J. V, Bui, H., Li, W., Fusseder, N., Bourne, P. E., Sette, A., & Peters, B. 
(2008). Ellipro: a new structure-based tool for the prediction of antibody epitopes. 
BMC Bioinformatics, 9, 514–522. doi:10.1186/1471-2105-9-514 
Protein Variability Server. (2008). Retrieved February 6, 2015, from 
http://imed.med.ucm.es/PVS/ 
Rossmann, M. G., Arnold, E., Erickson, J. W., Frankenberger, E. A., Griffith, J. P., 
Hecht, H. J., … Vriend, G. (1985). Structure of a human common cold virus and 
functional relationship to other picornaviruses. Nature, 317, 145–153. 
Rost, B. (1999). Twilight zone of protein sequence alignments. Protein Engineering, 
12(2), 85–94. 
Rubinstein, N., Mayrose, I., Martz, E., & Pupko, T. (2009). Epitopia : a web-server for 
predicting B-cell epitopes. BMC Bioinformatics, 10, 287–293. doi:10.1186/1471-
2105-10-287 
Rubinstein, N., Mayrose, I., & Pupko, T. (2009). A machine-learning approach for 
predicting B-cell epitopes. Molecular Immunology, 46, 840–847. 
doi:10.1016/j.molimm.2008.09.009 
Rweyemamu, M. M., Booth, J. C., Head, M., & Pay, T. W. F. (1978). Microneutralization 
tests for serological typing and subtyping of foot-and-mouth disease virus strains. 
Journal of Hygiene Cambridge, 81, 107–123. 
Ryan, M. D., Belsham, G. J., & King, A. M. Q. (1989). Specificity of enzyme-substrate 
interactions in foot-and-mouth disease virus polyprotein processing. Journal of 
Virology, 173, 33–45. 
Ryan, M. D., King, A. M. Q., & Thomas, G. P. (1991). Cleavage of foot-and-mouth 
disease virus polyprotein is mediated by residues located within a 19 amino acid 
sequence. Journal of General Virology, 2727–2732. 
Saiz, J. C., Gonzalez, M. J., Borca, M. V, Sobrino, F., & Moore, D. M. (1991). 
Identification of neutralizing antigenic sites on VP1 and VP2 of Type A5 foot-and-
mouth disease virus, defined by neutralization- resistant variants. Journal of 
Virology, 65(5), 2518–2524. 
Sali, A., & Blundell, T. L. (1993). Comparative protein modelling by satisfaction of 
spatial restraints. Journal of Molecular Biology, 234(3), 779–815. 
Samuel, A. R., & Knowles, N. J. (2001). Foot-and-mouth disease type O viruses exhibit 
genetically and geographically distinct evolutionary lineages (topotypes). Journal of 
General Virology, 82, 609–621. 
Sanchez, R., & Sali, A. (1997). Evaluation of Comparative Protein Structure Modelling 
by Modeller-3. Proteins: Structure, Function and Genetics, (Supplement 1), 50–58. 
 186 
Sangar, D. V., Newton, S. E., Rowlands, D. J., & Clarke, B. E. (1987). All foot-and-
mouth disease virus serotypes initiate protein synthesis at two separate AUGs. 
Nucleic Acids Research, 15, 3305–3315. 
Sangar, D. V., Rowland, D. J., Harris, T. J., & Brown, F. (1977). A protein covalently 
linked to foot-and-mouth-disease virus RNA. Nature, 268, 648–650. 
Sangula, A. K., Siegismund, H. R., Belsham, G. J., Balinda, S. N., Masembe, C., & 
Muwanika, V. N. (2011). Low diversity of foot-and-mouth disease serotype C virus 
in Kenya: evidence for probable vaccine strain re-introductions in the field. 
Epidemiology and Infection, 139(2), 189–96. doi:10.1017/S0950268810000580 
Schlessinger, A., Ofran, Y., Yachdav, G., & Rost, B. (2006). Epitome: database of 
structure-inferred antigenic epitopes. Nucleic Acids Research, 34, D777–D780. 
doi:10.1093/nar/gkj053 
Selwyne, R. A., Kholmurodov, K. T., & Koltovaya, N. A. (2011). Homology modelling 
and molecular dynamics of cyclin-dependent protein kinases. In S. H. Rao (Ed.), IT 
for Real World Problems (pp. 1–72). University Press (India). 
Shehu, A., & Kavraki, L. E. (2012). Modeling structures and motions of loops in protein 
molecules. Entropy, 14, 252–290. 
Sievers, F., Wilm, A., Dineen, D., Gibson, T. J., Karplus, K., Li, W., … So, J. (2011). 
Fast, scalable generation of high-quality protein multiple sequence alignments 
using Clustal Omega. Molecular Systems Biology, 7(539). 
Simons, K. T., Strauss, C., & Baker, D. (2001). Prospects for ab initio protein structural 
genomics. Journal of Molecular Biology, 306, 1191–1199. 
Smith, T. F., & Waterman, M. S. (1981). Identification of common molecular 
subsequences. Journal of Molecular Biology, 147, 195–197. 
Sobrino, F., Saiz, M., Jimenez-Clavero, M. A., Nunez, J. I., Rosas, M. F., Baranowski, 
E., & Ley, V. (2001). Foot-and-mouth disease virus: a long known virus , but a 
current threat. Veterinary Research, 32, 1–30. 
Soon, W. W., Hariharan, M., & Snyder, M. P. (2013). High-throughput sequencing for 
biology and medicine. Molecular Systems Biology, 9, 640–654. 
Spackman, K. A. (1989). Signal detection theory: Valuable tools for evaluating inductive 
learning. In Sixth International Workshop on Machine Learning (pp. 160–163). San 
Mateo, California: Morgan Kaufman. doi:10.1016/b978-1-55860-036-2.50047-3 
Srinivasan, S., March, C. J., & Sudarsanam, S. (1993). An automated method for 
modeling proteins on known templates using distance geometry. Protein Science, 
2(2), 277–289. 
Stanway, G. (1990). Structure, function and evolution of Picornaviruses. Journal of 
 187 
Virology, 71, 2483–2501. 
Strebel, K., & Beck, E. (1986). A second protease of foot-and-mouth disease virus. 
Journal of Virology, 58(3), 893–899. 
Sun, J., Wu, D., Xu, T., Wang, X., Xu, X., Tao, L., … Cao, Z. W. (2009). SEPPA : a 
computational server for spatial epitope prediction of protein antigens. Nucleic 
Acids Research, 37, 612–616. doi:10.1093/nar/gkp417 
Sun, P., Ju, H., Liu, Z., Ning, Q., Zhang, J., Zhao, X., … Li, Y. (2013). Bioinformatics 
resources and tools for conformational B-Cell epitope prediction. Computational 
and Mathematical Methods in Medicine, 2013. doi:10.1155/2013/943636 
Sweredoski, M. J., & Baldi, P. (2008). PEPITO: improved discontinuous B-cell epitope 
prediction using multiple distance thresholds and half sphere exposure. Structural 
Bioinformatics, 24(12), 1459–1460. doi:10.1093/bioinformatics/btn199 
Swets, J. A. (1988). Measuring the accuracy of diagnostic systems. Science, 240, 
1285–1293. doi:10.1126/science.3287615 
SWISS-MODEL. (2006). Retrieved May 26, 2014, from http://swissmodel.expasy.org/ 
Taylor, W. R., Thornton, J. M., & Turnell, W. G. (1983). An ellipsoidal approximation of 
protein shape. Journal of Molecular Graphics, 1, 30–38. doi:10.1016/0263-
7855(83)80001-0 
Thomas, A. A. M., Woortmeijer, R. J., Puijk, W., & Barteling, S. J. (1988). Foot-and-
Mouth Disease Virus Type A10. Journal of General Virology, 62(8), 2782–2789. 
Thomson, G. R. (1995). Overview of foot-and-mouth disease in Southern Africa. Review 
of Science and Technology (International Office of Epizootics), 14(3), 503–520. 
Thornton, J. M., Edwards, M. S., Taylor, W. R., & Barlow, D. J. (1986). Location of 
“continuous” antigenic determinants in the protruding regions of proteins. European 
Molecular Biology Organization Journal, 5(2), 409–413. 
Unger, R., Harel, D., Wherland, S., & Sussman, J. L. (1989). A 3D building blocks 
approach to analyzing and predicting structure of proteins. Proteins, 5(4), 355–373. 
Usherwood, E. J., & Nash, A. A. (1995). Lymphocyte recognition of picornaviruses. 
Journal of General Virology, 76, 499–508. doi:10.1099/0022-1317-76-3-499 
Valdazo-González, B., Knowles, N. J., Hammond, J., & King, D. P. (2012). Genome 
sequences of SAT2 foot-and-mouth disease viruses from Egypt and Palestinian 
Autonomous Territories (Gaza Strip). Journal of Virologyirology, 86(16), 8901–
8902. doi:10.1128/JVI.01231-12 
VanGunsteren, W. F., & Brendsen, H. J. C. (1977). Algorithms for macromolecular 
dynamics and constraint dynamics. Molecular Physics, 34, 1311–1327. 
 188 
Virella, G. (2001). Antigen-antibody reactions. In G. Virella (Ed.), Medical Immunology 
(5th ed., pp. 140–160). CRC Press. 
Vosloo, W., Knowles, N. J., & Thomson, G. R. (1992). Genetic relationships between 
southern African SAT-2 isolates of foot-and-mouth-disease virus. Epidemiology and 
Infection, 109, 547–558. 
Vyas, V. K., Ukawala, R. D., Ghate, M., & Chintha, C. (2012). Homology modeling a fast 
tool for drug discovery: current perspectives. Indian Journal of Pharmaceutical 
Sciences, 74(1), 1–17. 
Weber, S., Granzow, H., Weiland, F., & Maruardt, O. (1996). Intracellular membrane 
proliferation in E. coli induced by foot-and-mouth disease virus 3A gene products. 
Virus Genes, 12, 5–14. 
Wu, T. T., & Kabat, E. A. (1970). An analysis of the sequences of the variable regions of 
Bence Jones proteins and myeloma light chains and their implications for antibody 
complementarity. Journal of Experimental Medicine, 132, 211–250. 
Xiang, W., Andino, A. V., & Wimmer, E. (1997). RNA signals in entero- and rhinovirus 
genome replication. Sem. Virology, 8, 256–273. 
Xie, Q. C., McCahon, D., Crowther, J. R., Belsham, G. J., & McCullough, K. C. (1987). 
Neutralization of foot-and-mouth disease virus can be mediated through any of at 
least three separate antigenic sites. Journal of General Virology, 68, 1637–1647. 
Zhang, C. (1997). Relations of the numbers of protein sequences, families and folds. 
Protein Engineering, 10(7), 757–761. 
Zhang, H. (2002). Protein Tertiary Structures : Prediction from Amino Acid Sequences. 
In Encyclopaedia of Life Sciences. 
Zhang, Y., Kolinski, A., & Skolnick, J. (2003). Touchstone II: A New Approach to Ab 
Initio Protein Structure Prediction. Biophysical Journal, 85(2), 1145–1164. 
Zhao, L., Wong, L., Lu, L., Hoi, S., & Jinyan, L. (2012). B-cell epitope prediction through 
a graph model. Biomed Central Bioinformatics, 13(Suppl 17). doi:10.1186/1471-
2105-13-S17-S20 
 
 189 
 
REFERENCES FOR TABLES 1, 10, 11, 12 
Acharya, R., Fry, E., Stuart, D., Fox, G., Rowlands, D., & Brown, F. (1989). The three-
dimensional structure of foot-and-mouth-disease virus at 2.9 A resolution. Nature, 
337, 709–716. 
Acharya, R., Fry, E., Stuart, D., Fox, G., Rowlands, D., & Brown, F. (1990). The 
structure of foot-and-mouth disease virus: implications for its physical and 
biological properties. Veterinary Microbiology, 23, 21–34. 
Adams, P., Lea, S., Newman, J., Blakemore, W., King, A., Stuart, D. & Fry, E. (n.d.). 
The Structure of Foot-and-Mouth Disease Virus Serotype Sat1. To Be Published. 
Retrieved from http://www.rcsb.org/pdb/explore/explore.do?structureId=2WZR 
 
Adcock, S. A., & Mccammon, J. A. (2006). Molecular dynamics: Survey of methods for 
simulating the activity of proteins. Chemical Reviews, 106(5), 1589–1615. 
Adrian, M., Dubochet, J., LePault, J., & McDowall, A. (1984). Cryo-electron microscopy 
of viruses. Nature, 308, 32–36. 
Aggarwal, N., & Barnett, P. V. (2002). Antigenic sites of foot-and-mouth disease virus 
(FMDV) : an analysis of the specificities of anti-FMDV antibodies after vaccination 
of naturally susceptible host species. Journal of General Virology, 83(4), 775–782. 
Aktas, S., & Samuel, A. R. (2000). Identification of antigenic epitopes on the foot and 
mouth disease virus isolate O1/Manisa/Turkey/ 69 using monoclonal antibodies. 
Review of Science and Technology International Office of Epizootics, 19(3), 744–
753. 
Altschul, S., Gish, W., Miller, W., Myers, W., & Lipman, E. W. (1990). Basic local 
alignment search tool. Journal of Molecular Biology, 215, 403–410. 
Altschul, S., Madden, T., Schaffer, A., Zhang, J., Zhang, Z., Miller, W., & Lipman, D. 
(1997). Gapped BLAST and PSI-BLAST: A new generation of protein database 
search programs. Nucleic Acids Research, 25, 3899–3402. 
Andersen, P. H., Nielsen, M., & Lund, O. L. E. (2006). Prediction of residues in 
discontinuous B-cell epitopes using protein 3D structures. Protein Engineering, 15, 
2558–2567. doi:10.1110/ps.062405906 
Ao, D., Guo, H.-C., Sun, S.-Q., Sun, D.-H., Fung, T. S., Wei, Y.-Q., … Liu, X.-T. (2015). 
Viroporin activity of the foot-and-mouth disease virus non-structural 2B protein. 
Plos One, 10(5), e0125828. doi:10.1371/journal.pone.0125828 
Arnold, K., Bordoli, L., Kopp, J., & Schwede, T. (2006). The SWISS-MODEL workspace: 
a web-based environment for protein structure homology modelling. Bioinformatics, 
 190 
22(2), 195–201. 
Aszodi, A., & Taylor, W. R. (1996). Homology modelling by distance geometry. Folding 
and Design, 1, 325–334. 
Atassi, Z. (1984). Antigenic structures of proteins. European Journal of Biochemistry, 
145, 1–20. doi:10.1111/j.1432-1033.1984.tb08516.x 
Bablanian, G. M., & Grubman, M. J. (1993). Characterization of the foot-and-mouth 
disease virus 3C protease expressed in Escherichia coli. Virology, 197, 320–327. 
Bachrach, H. L., Moore, M. D., McKercher, P. D., & Polatnick, J. (1975). Immune and 
antibody responses to an isolated capsid protein of foot-and-mouth disease virus. 
The Journal of Immunology, 115(6), 1636–1641. 
Baker, D., & Sali, A. (2001). Protein structure prediction and structural genomics. 
Science, 294, 93–96. 
Barnett, P. V, Samuel, A. R., Pullen, L., Ansell, D., Butcher, R. N., & Parkhouse, R. M. 
E. (1998). Monoclonal antibodies, against O1 serotype foot-and-mouth disease 
virus, from a natural bovine host, recognize similar antigenic features to those 
defined by the mouse. Journal of General Virology, 79, 1687–1697. 
Bastos, A. D. S., Haydon, D. T., Forsberg, R., Knowles, N. J., Anderson, E. C., Bengis, 
R. G., … Thomson, G. R. (2001). Genetic heterogeneity of SAT-1 type foot-and-
mouth disease viruses in southern Africa. Archives of Virology, 146, 1537–1551. 
Bax, A. (1989). Two-dImensional NMR and protein structure. Annual Reviews in 
Biochemistry, 58, 223–256. 
Baxt, B., Vakharia, V., Moore, D. M., Franke, A. J., & Morgan, D. O. (1989). Analysis of 
neutralizing antigenic sites on the surface of type A12 foot-and-mouth disease 
virus. Journal of Virology, 63(5), 2143–2153. 
Belsham, G. J. (1993). Distinctive features of foot-and-mouth disease virus, a member 
of the Picornavirus family; Aspects of virus protein synthesis, protein processing 
and structure. Progress in Biophysical Molecular Biology, 60, 241–260. 
Belsham, G. J. (2013). Influence of the Leader protein coding region of foot-and-mouth 
disease virus on virus replication. The Journal of General Virology, 94(7), 1486–
1495. doi:10.1099/vir.0.052126-0 
Benkert, P., Biasini, M., & Schwede, T. (2011). Toward the estimation of the absolute 
quality of individual protein structure models. Bioinformatics, 27(3), 343–350. 
Benkert, P., Ku, M., & Schwede, T. (2009). QMEAN server for protein model quality 
estimation. Nucleic Acids Research, 37, W510–W514. 
Bittle, J. L., Houghten, R. A., Alexander, H., Shinnick, T. M., Sutcliffe, J. G., Lerner, R. 
A., … Brown, F. (1982). Protection against foot-and-mouth disease by 
 191 
immunization with a chemically synthesized peptide predicted from the viral 
nucleotide sequence. Nature, 298, 30–33. doi:10.1038/298030a0 
Blundell, T. L., & Johnson, M. S. (1993). Catching a common fold. Protein Science, 
2(6), 877–883. 
Bolwell, C., Clarke, B. E., Parry, N. R., Ouldridge, E. J., Brown, F., & Rowlands, D. J. 
(1989). Epitope mapping of foot-and-mouth disease virus with neutralizing 
monoclonal antibodies. Journal of General Virology, 70, 59–68. 
Borley, D. W., Mahapatra, M., Paton, D. J., Esnouf, R. M., Stuart, D. I., & Fry, E. E. 
(2013). Evaluation and Use of In-Silico Structure-Based Epitope Prediction with 
Foot-and-Mouth Disease Virus. PLoS ONE, 8(5), e61122. 
doi:10.1371/journal.pone.0061122 
Brehm, K. E., Kumar, N., Thulke, H. H., & Haas, B. (2008). High potency vaccines 
induce protection against heterologous challenge with foot-and-mouth disease 
virus. Vaccine, 26, 1681–1687. 
Browne, W. J., North, A. C. T., & Phillips, D. C. (1969). A possible three-dimensional 
structure of bovine α-lactalbumin based on that of hen’s egg-white lysozyme. 
Journal of Molecular Biology, 42, 65–86. 
Bublil, E. M., Freund, N. T., Mayrose, I., Penn, O., Roitburd-Berman, A., Rubinstein, N., 
… Gershoni, J. M. (2007). Stepwise prediction of conformational discontinuous B-
cell epitopes using the Mapitope algorithm. Proteins, 68, 294–304. 
doi:10.1002/prot.21387 
Carrillo, C. (2012). Foot and mouth disease virus. In M. Garcia (Ed.), Viral genomes - 
molecular structure, diversity, gene expression mechanisms and host-virus 
interactions (pp. 53–68). Intech. 
Case, D. A., Darden, T. A., Cheatham III, T. E., Simmerling, C. L., Wang, J., Duke, R. 
E., … Kollman, P. A. (2012). AMBER 12. San Francisco: University of California. 
Cheng, J., Randall, A. Z., Sweredoski, M. J., & Baldi, P. (2005). SCRATCH: a protein 
structure and structural feature prediction server. Nucleic Acids Research, 33, 72–
76. doi:10.1093/nar/gki396 
Chothia, C. (1992). One thousand families for the molecular biologist. Nature, 357, 543–
544. 
Chothia, C., & Lesk, A. M. (1986). The relation between the divergence of sequence 
and structure in proteins. The European Molecular Biology Organization Journal, 
5(4), 823–826. 
Chou, P. Y., & Fasman, G. D. (1974). Conformational parameters for amino acids in 
helical β-sheet and random coil regions calculated from proteins. Biochemistry, 
13(2), 211–222. doi:10.1021/bi00699a001 
 192 
Chow, M., Newman, J. F., Felman, D., Hogle, J. M., Rowland, D. J., & Brown, F. (1987). 
Myristylation of picornavirus capsid protein VP4 and its structural significance. 
Nature, 237, 482–486. 
Clarke, B. E., Brown, A. L., Curry, K. M., Newton, S. E., Rowlands, D. J., & Carroll, A. 
R. (1987). Potential secondary and tertiary structure in the genomic RNA of foot-
and-mouth disease virus. Nucleic Acids Research, 15, 7067–7079. 
Cooper, P. D., Agol, V. I., Bachrach, H. L., Brown, F., Ghendon, Y., Gibbs, A. J., … 
Tyrrell, D. A. J. (1978). Picornaviridae: Second report. Intervirology, 10, 165–180. 
Cornell, W. D., Cieplak, P., Bayly, C. I., Gould, I. R., Merz, K. M., Ferguson, D. M., … 
Kollman, P. A. (1995). A second generation force field for the simulation of 
proteins, nucleic acids and organic molecules. Journal of the American Chemical 
Society, 117, 5179–5197. 
Cristobal, S., Zemla, A., Fischer, D., Rychlewski, L., & Elofsson, A. (2001). A study of 
quality measure for protein threading models. BMC Bioinformatics, 2, 5. 
Crowther, J. R., Farias, S., Carpenter, W. C., & Samuel, A. R. (1993). Identification of a 
fifth neutralizable site on type 0 foot-and-mouth disease virus following 
characterization of single and quintuple monoclonal antibody escape mutants. 
Journal of General Virology, 74, 1547–1553. 
Crowther, J. R., Rowe, C. A., & Butcher, R. (1993). Characterization of monoclonal 
antibodies against a type SAT 2 foot-and-mouth disease virus. Epidemiology and 
Infection, 111, 391–406. 
Curry, S., Fry, E., Blakemore, W., Abu-ghazaleh, R., Jackson, T., King, A., … Stuart, D. 
(1995). Perturbations in the surface structure of A22 Iraq foot-and-mouth disease 
virus accompanying coupled changes in host cell specificity and antigenicity. 
Structure, 4, 135–145. 
Curry, S., Fry, E., Blakemore, W., Abu-Ghazaleh, R., Jackson, T., King, A., … Stuart, D. 
(1996). Perturbations in the surface structure of A22 Iraq foot-and-mouth disease 
virus accompanying coupled changes in host cell specificity and antigenicity. 
Structure, 4, 135–145. doi:8805520 
De Groot, A. S., Bosma, A., & Chinai, N. (2001). From genome to vaccine: in silico 
predictions, ex vivo verification. Vaccine, 19(31), 4385–4395. doi:10.1016/s0264-
410x(01)00145-1 
Dimmock, N. J. (1993). Neutralization of animal viruses. Current Topics in Microbiology 
and Immunology, 183, 1–149. 
Dubochet, J., Adrian, M., Chang, J.-J., Homo, J.-C., Le Pault, J., McDowall, A., & 
Schultz, P. (1988). Cryo-electron microscopy of vitrified specimens. Quarterly 
Review of Biophysics, 21(2), 129–228. 
 193 
Eichinger, M., Heymann, B., Heller, H., Grubmuller, H., & Tavan, P. (1999). 
Conformational dynamics simulations of proteins. In P. Deuflhard, J. Hermans, B. 
Leimkuhler, A. E. Mark, S. Reich, & R. Skeel (Eds.), Computational Molecular 
Dynamics: Challenges, Methods, Ideas (4th ed., pp. 78–97). Berlin: Springer Berlin 
Heidelberg. 
Fawcett, T. (2006). An introduction to ROC analysis. Pattern Recognition Letters, 27, 
861–874. doi:10.1016/j.patrec.2005.10.010 
Ferris, N. P., & Donaldson, A. I. (1992). The World Reference Laboratory for Foot and 
Mouth Disease : a review of thirty-three years of activity (1958-1991). Review of 
Science and Technology (International Office of Epizootics), 11(3), 657–684. 
Fiser, A., Do, R. K. G., & Sali, A. (2000). Modeling of loops in protein structures. Protein 
Science, 9, 1753–1773. 
Floudas, C. A., Fung, H. K., McAllister, S. R., Mönnigmann, M., & Rajgaria, R. (2006). 
Advances in protein structure prediction and de novo protein design: A review. 
Chemical Engineering Science, 61, 966–988. 
Forrest, L. R., Tang, C. L., & Honig, B. (2006). On the accuracy of homology modeling 
and sequence alignment methods applied to membrane proteins. Biophysical 
Journal, 91(2), 508–517. 
Forss, S., Strebel, K., & Schaller, H. (1984). Nucleotide sequence and genome 
organization of foot-and-mouth disease virus. Nucleic Acids Research, 12, 6587–
6601. 
Forster, M. J. (2002). Molecular modelling in structural biology. Micron, 33, 365–384. 
Fry, E. . A. R. . S. D. (1993). Methods used in the structure determination of foot-and-
mouth disease virus. Acta Crystallogr.,Sect.A, 49, 45–55. doi:8382928 
Fry, E., Logan, D., Acharya, R., Fox, G., & Rowlands, D. (1990). Architecture and 
topography of an aphthovirus. Seminars in Virology, 1, 439–451. 
Garcia-Boronat, M., Diez-Rivero, C. M., Reinherz, E. L., & Reche, P. A. (2008). PVS: a 
web server for protein sequence variability analysis tuned to facilitate conserved 
epitope discovery. Nucleic Acids Research, 36, W35–W41. 
Garnier, J., Osguthorpe, D. J., & Robson, B. (1978). Analysis of the accuracy and 
implications of simple methods for predicting the secondary structure of globular 
proteins. Journal of Molecular Biology, 120, 97–120. doi:10.1016/0022-
2836(78)90297-8 
Goodwin, S., Tuthill, T. J., Arias, A., Killington, R. a, & Rowlands, D. J. (2009). Foot-
and-mouth disease virus assembly: processing of recombinant capsid precursor by 
exogenous protease induces self-assembly of pentamers in vitro in a 
myristoylation-dependent manner. Journal of Virology, 83(21), 11275–11282. 
 194 
doi:10.1128/JVI.01263-09 
Grazioli, S., Fallacara, F., & Brocchi, E. (2013). Mapping of antigenic sites of foot-and-
mouth disease virus serotype Asia 1 and relationships with sites described in other 
serotypes. Journal of General Virology, 94(3), 559–569. doi:doi: 
10.1099/vir.0.048249-0 
Grazioli, S., Fallacara, F., & Brocchi, E. (2013). Mapping of antigenic sites of foot-and-
mouth disease virus serotype Asia 1 and relationships with sites described in other 
serotypes. Journal of General Virology, 94(3), 559–569. doi:10.1099/vir.0.048249-0 
Grazioli, S., Moretti, M., Barbieri, I., Crosatti, M., & Brocchi, E. (2006). Use of 
monoclonal antibodies to identify and map new antigenic determinants involed in 
neutralization of FMD viruses type SAT 1 and SAT 2. In European Commission for 
the control of Foot-and-Mouth Disease: International control of Foot-and-Mouth 
disease: Tools, Trends and perspectives. Paphos, Cyprus. 
Greenbaum, J. A., Andersen, P. H., Blythe, M., Bui, H., Cachau, R. E., Crowe, J., … 
Morrison, S. (2007). Towards a consensus on datasets and evaluation metrics for 
developing B-cell epitope prediction tools. Journal of Molecular Recognition, 20(2), 
75–82. doi:10.1002/jmr.815 
Greer, J. (1990). Comparative modeling methods: Application to the family of the 
mammalian serine proteases. Proteins: Structure, Function and Bioinformatics, 
7(4), 317–334. 
Grubman, M., & Baxt, B. (2004). Foot-and-mouth disease. Clinical Microbiology 
Reviews, 17(2), 465–493. doi:10.1128/CMR.17.2.465 
Guo, F., & Wen, J. (2014). Single particle cryo-electron microscopy and 3-D 
reconstruction of viruses. Methods in Molecular Biology, 1117, 401–443. 
doi:10.1007/978-1-62703-776-1_19 
Hamelryck, T. (2005). An amino acid has two sides: a new 2D measure provides a 
different view of solvent exposure. Proteins, 59, 38–48. doi:10.1002/prot.20379 
Harber, J. J., Bradley, J., Anderson, C. W., & Wimmer, E. (1991). Catalysis of polivirus 
VP0 maturation cleavage is not mediated by serine 10 of VP2. Journal of Virology, 
65, 326–334. 
Harris, T. J., & Brown, F. (1977). Biochemical analysis of a virulent and an avirulent 
strain of foot-and-mouth disease virus. Journal of General Virology, 34, 87–105. 
Havel, T. F., & Snow, M. E. (1991). A new method for building protein conformations 
from sequence alignments with homologues of known structure. Journal of 
Molecular Biology, 217, 1–7. 
Hewat, E. A., Verdaguer, N., Fita, I., Blakemore, W., Brookes, S., King, A., … Stuart, D. 
I. (1997). Structure of the complex of an Fab fragment of a neutralizing antibody 
 195 
with foot-and-mouth disease virus: positioning of a highly mobile antigenic loop. 
The European Molecular Biology Organization Journal, 16(7), 1492–1500. 
Hogle, J. M., Chow, M., & Filman, D. J. (1985). Three-dimensional structure of 
Poliovirus at 2.9A resolution. Science, 229, 1358–1365. 
Hopp, T. P., & Woods, K. R. (1981). Prediction of protein antigenic determinants from 
amino acid sequences. Proceedings of the National Academy of Sciences of the 
USA, 78(6), 3824–3828. doi:10.1073/pnas.78.6.3824 
Hubbard, T. J., & Blundell, T. L. (1987). Comparison of solvent-inaccessible cores of 
homologous proteins: definitions useful for protein modelling. Protein Engineering, 
1(3), 159–171. 
Humphrey, W., Dalke, A., & Schulten, K. (1996). VMD - ’Visual Molecular Dynamics. 
Journal of Molecular Graphics, 14(1), 33–38. 
Hunter, P. (2006). Into the fold. EMBO Reports, 7(3), 249–252. 
doi:10.1038/sj.embor.7400655 
Jacobson, M., & Sali, A. (2004). Comparative Protein Structure Modeling and its 
Applications to Drug Discovery. Annual Reports in Medicinal Chemistry, 39(4), 
259–276. doi:10.1016/S0065-7743(04)39020-2 
Jamal, S. M., & Belsham, G. J. (2013). Foot-and-mouth disease: past, present and 
future. Veterinary Research, 44(116), 1–14. doi:10.1186/1297-9716-44-116 
Janeway, C. A., Travers, P., & Walport, M. (2001). The interaction of the antibody 
molecule with specific antigen. In Immunobiology: The Immune System in Health 
and Disease (5th ed.). New York: Garland Science. 
Janin, J., Wodak, S., Levitt, M., & Maigret, B. (1978). Conformation of amino acid side-
chains in proteins. Journal of Molecular Biology, 125, 357–386. doi:10.1016/0022-
2836(78)90408-4 
Jones, D. T., Taylor, W. R., & Thornton, J. M. (1992). A new approach to protein fold 
recognition. Nature, 358, 86–89. 
Jorgensen, W. L., Chandrasekhar, J., Madura, J. D., Impey, R. W., & Klein, M. L. 
(1983). Comparison of simple potential functions for simulating liquid water. Journal 
of Chemical Physics, 79, 926–935. 
King, A. M. Q., Sangar, D. V., Harris, T. J., & Brown, F. (1980). Heterogeneity of the 
genome-linked protein of foot-and-mouth disease virus. Journal of Virology, 34, 
627–634. 
Kitson, J., McCahon, D., & Belsham, G. J. (1990). Sequence analysis of monoclonal 
antibody resistant mutants of type O foot-and-mouth disease virus: Evidence for 
the involvement of the three surface exposed capsid proteins in four antigenic sites. 
 196 
Virology, 179(1), 26–34. 
Krieger, F., Moglich, A., & Thomas, K. (2005). Effect of proline and glycine residues on 
dynamics and barriers of loop formation in polypeptide chains. Journal of the 
American Chemical Society, 127(10), 3346–3352. 
Kringelum, J. V., Lundegaard, C., Lund, O., & Nielsen, M. (2012). Reliable B-Cell 
epitope predictions: impacts of method development and improved benchmarking. 
Plos Computational Biology, 8(12), 1–10. doi:10.1371/journal.pcbi.1002829 
Kuroda, D., Shirai, H., Jacobson, M., & Nakamura, H. (2012). Computer-aided antibody 
design. Protein Engineering Design and Selection, 25(10), 507–521. 
doi:10.1093/protein/gzs024 
Larsen, J. E. P., Lund, O., & Nielsen, M. (2006). Improved method for predicting linear 
B-cell epitopes. Biomed Central Immunome Research, 2(2), 1–7. 
doi:10.1186/1745-7580-2-2 
Larsson, D. (2012). Exploring the molecular dynamics of proteins and viruses. Uppsala 
University. 
Laskowski, R. A., MacArthur, M. W., Moss, D., & Thornton, J. M. (1993). Procheck: a 
program to check the stereochemical quality of protein structures. Journal of 
Applied Crystallography, 26, 283–291. 
Lea, S., Blakemore, W., Brocchi, E., Domingo, E., Fry, E., King, A., … Mateu, M. G. 
(1994). The structure and antigenicity of a type C foot-and-mouth disease virus. 
Structure, 2, 123–139. 
Levitt, M. (1992). Accurate modeling of protein conformation by automatic segment 
matching. Journal of Molecular Biology, 226, 507–533. 
Liang, S., Zheng, D., Standley, D. M., Yao, B., Zacharias, M., & Zhang, C. (2010). 
EPSVR and EPMeta: prediction of antigenic epitopes using support vector 
regression and multiple server results. Biomed Central Bioinformatics, 11, 381–
387. doi:10.1186/1471-2105-11-381 
Lin, S. Y., Cheng, S., & Su, E. C. (2013). Prediction of B-cell epitopes using 
evolutionary information and propensity scales. Biomed Central Bioinformatics, 
14(Supplement 2), S10–19. doi:10.1186/1471-2105-14-s2-s10 
Liu, H., & Hsu, J. (2005). Recent developments in structural proteomics. Proteomics, 5, 
2056–2068. 
Liu, T., Tang, G. W., & Capriotti, E. (2011). Comparative modeling: the state of the art 
and protein drug target structure prediction. Combinatorial Chemistry & High 
Throughput Screening, 14(6), 532–547. doi:10.2174/138620711795767811 
Lo, Y., Pai, T., Wu, W., & Chang, H. (2013). Prediction of conformational epitopes with 
 197 
the use of a knowledge-based energy function and geometrically related 
neighboring residue characteristics. BMC Bioinformatics, 14(Suppl 4), S3. 
Logan, D., Abu-Ghazaleh, R., Blakemore, W., Curry, S., Jackson, T., King, A. M. Q., … 
Fry, E. (1993). Structure of a major immunogenic site on foot-and-mouth disease 
virus. Nature, 326, 566–568. 
Longjam, N., Deb, R., Sarmah,  a. K., Tayo, T., Awachat, V. B., & Saxena, V. K. (2011). 
A brief review on diagnosis of foot-and-mouth disease of livestock: conventional to 
molecular tools. Veterinary Medicine International, 2011, 1–17. 
doi:10.4061/2011/905768 
Luo, M., Vriend, G., Kamer, G., Arnold, E., Rossmann, M. G., Boege, U., … 
Palmenberg, A. C. (1987). The atomic structure of Mengo virus at 3.0Å resolution. 
Science, 235, 182–191. 
Maree, F. F., Blignaut, B., Esterhuysen, J. J., Beer, T. A. P. De, Theron, J., Neill, H. G. 
O., & Rieder, E. (2011). Predicting antigenic sites on the foot-and-mouth disease 
virus capsid of the South African Territories types using virus neutralization data. 
Journal of General Virology, 92, 2297–2309. doi:10.1099/vir.0.032839-0 
Marti-Renom, M. A., Stuart, A. C., Fiser, A., Sanchez, R., Melo, F., & Sali, A. (2000). 
Comparative protein structure modeling of genes and genomes. Annual Review of 
Biophysics and Biomolecular Structure, 29, 291–325. 
Mateu, M. G. (1995). Antibody recognition of picornaviruses and escape from 
neutralization: a structural view. Virus Research, 38, 1–24. 
Mateu, M. G., Hernandez, J., Martinez, M. A., Feigelstock, D., Lea, S., Perez, J. J., … 
Domingo, E. (1994). Antigenic heterogeneity of a foot-and-mouth disease virus 
serotype in the field Is mediated by very limited sequence variation at several 
antigenic sites. Journal of Virology, 68(3), 1407–1417. 
Mateu, M. G., Martinez, M. A., Capucci, L., Andreu, D., Giralt, E., Sobrino, F., … 
Domingo, E. (1990). A single amino acid substitution affects multiple overlapping 
epitopes in the major antigenic site of foot-and-mouth disease virus of serotype C. 
Journal of General Virology, 71, 629–637. doi:10.1099/0022-1317-71-3-629 
McCahon, D., Crowther, J. R., Belsham, G. J., Kitson, J., Duchesne, M., Have, P., … 
De Simone, F. (1989). Evidence for at least four antigenic sites on Type O foot-
and-mouth disease virus involved in neutralization; identification by single and 
multiple site monoclonal antibody-resistant mutants. Journal of General Virology, 
70, 639–645. 
McCullough, K. C., De Simone, F., Brocchi, E., Capucci, L., Crowther, J. R., & Kihm, U. 
(1992). Protective immune repsonse against foot-and-mouth disease virus. Journal 
of Virology, 66, 1835–1840. 
 198 
Melo, F., Devos, D., Depiereux, E., & Feytmans, E. (1997). ANOLEA: A www server to 
assess protein structures. In T. Gaasterland (Ed.), Fifth International Conference 
on Intelligence Systems for Molecular Biologu (p. 187). Michigan: Association for 
the Advancement of Artificial Intelligence Press. 
Melo, F., & Feytmans, E. (1997). Novel knowledge-based mean force potential at 
atomic level. Journal of Molecular Biology, 267, 207–222. 
Meloen, R. H., Puyk, W. C., Meijer, D. J. A., Lankhof, H., Posthumus, W. P. A., & 
Schaaper, W. M. M. (1987). Antigenicity and immunogenicity of synthetic peptides 
of foot-and-mouth disease virus. Journal of General Virology, 68, 305–314. 
doi:10.1099/0022-1317-68-2-305 
Monod, J., Wyman, J., & Changeux, J. (1965). On the nature of allosteric transitions: A 
plausible model. Journal of Molecular Biology, 12, 88–118. 
Moult, J., & James, M. N. G. (1986). An algorithm for determining the conformation of 
polypeptide segments in proteins by systematic search. Proteins: Structure, 
Function and Bioinformatics, 1(2), 146–163. 
Needleman, S. B., & Wunsch, C. D. (1970). A general method applicable to the search 
for similarities in the amino acid sequence of two proteins. Journal of Molecular 
Biology, 48, 443–453. 
Newman, J. F., Cartwright, B., Doel, T. R., & Brown, F. (1979). Purification and 
identification of the RNA-dependant RNA polymerase of foot-and-mouth disease 
virus. Journal of General Virology, 45, 497–507. 
Newton, S. E., Carroll, A. R., Campbell, R. O., Clarke, B. E., & Rowlands, D. (1985). 
The sequence of foot-and-mouth disease virus RNA to the 5’ side of the poly(C) 
tract. Gene, 40, 331–336. 
Novotny, J., Handschumacher, M., Haber, E., Bruccoleri, R. E., Carlson, W. B., 
Fanning, D. W., … Rose, G. D. (1986). Antigenic determinants in proteins coincide 
with surface regions accessible to large probes (antibody domains). Proceedings of 
the National Academy of Sciences of the USA, 83, 226–230. 
doi:10.1073/pnas.83.2.226 
OIE. (2012). Foot and mouth disease. In Manual of Diagnostic Tests and Vaccines for 
Terrestrial Animals (7th ed.). Paris: OIE. 
Opperman, P. A., Maree, F. F., Van Wyngaardt, W., Vosloo, W., & Theron, J. (2012). 
Mapping of antigenic determinants on a SAT2 foot-and-mouth disease virus using 
chicken single-chain antibody fragments. Virus Research, 167, 370–379. 
doi:doi:10.1016/j.virusres.2012.05.026 
Opperman, P. A., Rotherham, L. S., Esterhuysen, J., Charleston, B., Juleff, N., 
Capozzo, A. V, … Maree, F. F. (2014). Determining the epitope dominance on the 
 199 
capsid of a SAT2 foot-and-mouth disease virus by mutational analyses. Journal of 
Virology, 88(15), 8307–8318. 
Ouldridge, E. J., Barnett, P. V., Parry, N. R., Syred, A., Head, M., & Rweyemamu, M. M. 
(1984). Demonstration of neutralizing and non-neutralizing epitopes on the trypsin-
sensitive site of foot-and-mouth disease virus. Journal of General Virology, 65, 
203–207. 
Palmenberg, A. C. (1990). Proteolytic processing of picornaviral polyprotein. Annual 
Reviews in Microbiology, 44, 603–623. 
Parker, J. M., Guo, D., & Hodges, R. S. (1986). New hydrophilicity scale derived from 
high-performance liquid chromatography peptide retention data: correlation of 
predicted surface residues with antigenicity and X-ray-derived accessible sites. 
Biochemistry, 19, 5425–5432. doi:10.1021/bi00367a013 
Parry, N., Fox, G., Rowlands, D., Brown, F., Fry, E., Acharya, R., … Stuart, D. (1990). 
Structural and serological evidence for a novel mechanism of antigenic variation in 
foot-and-mouth disease virus. Nature, 347, 567–572. 
Paton, D. J., & Taylor, G. (2011). Developing vaccines against foot-and-mouth disease 
and some other exotic viral diseases of livestock. Philosophical Transactions of the 
Royal Society B: Biological Sciences, 366(1579), 2774–2781. 
doi:10.1098/rstb.2011.0107 
Pearson, W. R., & Lipman, D. (1988). Improved tools for biological sequence 
comparison. Proceedings of the National Academy of Sciences of the USA, 85, 
2444–2448. 
Pellequer, J., Westhof, E., & VanRegenmortel, M. (1991). Predicting the location of 
continuous epitopes in proteins from their primary strucutre. Methods in 
Enzymology, 203, 176–201. doi:10.1016/0076-6879(91)03010-e 
Peters, B., Sidney, J., Bourne, P., Bui, H. H., Buus, S., Doh, G., … Kubo, R. (2005). 
The immune epitope database and analysis resource: From vision to blueprint. 
Immunogenetics, 57(326-336). doi:10.1371/journal.pbio.0030091 
Petterson, E. F., Goddard, T. D., Huang, C. C., Couch, G. S., Greenblatt, D. M., Meng, 
E. C., & Ferrin, T. E. (2004). UCSF Chimera-a visualization system for exploratory 
research and analysis. Journal of Computational Chemistry, 25(13), 1605–1612. 
Pfaff, E., Mussgay, M., Bohm, H. O., Shulz, G. E., & Schaller, H. (1982). Antibodies 
against a preselected peptide recognise and neutralise foot-and-mouth disease 
virus. European Molecular Biology Organization Journal, 1, 869–874. 
Ponder, J. W., & Richards, F. M. (1987). Tertiary templates for proteins. Use of packing 
criteria in the enumeration of allowed sequences for different structural classes. 
Journal of Molecular Biology, 193(4), 775–791. 
 200 
Ponomarenko, J. V, & Bourne, P. E. (2007). Antibody-protein interactions: benchmark 
datasets and prediction tools evaluation. BMC Structural Biology, 7, 64. 
doi:10.4016/5328.01 
Ponomarenko, J. V, Bui, H., Li, W., Fusseder, N., Bourne, P. E., Sette, A., & Peters, B. 
(2008). Ellipro: a new structure-based tool for the prediction of antibody epitopes. 
BMC Bioinformatics, 9, 514–522. doi:10.1186/1471-2105-9-514 
Protein Variability Server. (2008). Retrieved February 6, 2015, from 
http://imed.med.ucm.es/PVS/ 
Rossmann, M. G., Arnold, E., Erickson, J. W., Frankenberger, E. A., Griffith, J. P., 
Hecht, H. J., … Vriend, G. (1985). Structure of a human common cold virus and 
functional relationship to other picornaviruses. Nature, 317, 145–153. 
Rost, B. (1999). Twilight zone of protein sequence alignments. Protein Engineering, 
12(2), 85–94. 
Rubinstein, N., Mayrose, I., Martz, E., & Pupko, T. (2009). Epitopia : a web-server for 
predicting B-cell epitopes. BMC Bioinformatics, 10, 287–293. doi:10.1186/1471-
2105-10-287 
Rubinstein, N., Mayrose, I., & Pupko, T. (2009). A machine-learning approach for 
predicting B-cell epitopes. Molecular Immunology, 46, 840–847. 
doi:10.1016/j.molimm.2008.09.009 
Rweyemamu, M. M., Booth, J. C., Head, M., & Pay, T. W. F. (1978). Microneutralization 
tests for serological typing and subtyping of foot-and-mouth disease virus strains. 
Journal of Hygiene Cambridge, 81, 107–123. 
Ryan, M. D., Belsham, G. J., & King, A. M. Q. (1989). Specificity of enzyme-substrate 
interactions in foot-and-mouth disease virus polyprotein processing. Journal of 
Virology, 173, 33–45. 
Ryan, M. D., King, A. M. Q., & Thomas, G. P. (1991). Cleavage of foot-and-mouth 
disease virus polyprotein is mediated by residues located within a 19 amino acid 
sequence. Journal of General Virology, 2727–2732. 
Saiz, J. C., Gonzalez, M. J., Borca, M. V, Sobrino, F., & Moore, D. M. (1991). 
Identification of neutralizing antigenic sites on VP1 and VP2 of Type A5 foot-and-
mouth disease virus, defined by neutralization- resistant variants. Journal of 
Virology, 65(5), 2518–2524. 
Sali, A., & Blundell, T. L. (1993). Comparative protein modelling by satisfaction of 
spatial restraints. Journal of Molecular Biology, 234(3), 779–815. 
Samuel, A. R., & Knowles, N. J. (2001). Foot-and-mouth disease type O viruses exhibit 
genetically and geographically distinct evolutionary lineages (topotypes). Journal of 
General Virology, 82, 609–621. 
 201 
Sanchez, R., & Sali, A. (1997). Evaluation of Comparative Protein Structure Modelling 
by Modeller-3. Proteins: Structure, Function and Genetics, (Supplement 1), 50–58. 
Sangar, D. V., Newton, S. E., Rowlands, D. J., & Clarke, B. E. (1987). All foot-and-
mouth disease virus serotypes initiate protein synthesis at two separate AUGs. 
Nucleic Acids Research, 15, 3305–3315. 
Sangar, D. V., Rowland, D. J., Harris, T. J., & Brown, F. (1977). A protein covalently 
linked to foot-and-mouth-disease virus RNA. Nature, 268, 648–650. 
Sangula, A. K., Siegismund, H. R., Belsham, G. J., Balinda, S. N., Masembe, C., & 
Muwanika, V. N. (2011). Low diversity of foot-and-mouth disease serotype C virus 
in Kenya: evidence for probable vaccine strain re-introductions in the field. 
Epidemiology and Infection, 139(2), 189–96. doi:10.1017/S0950268810000580 
Schlessinger, A., Ofran, Y., Yachdav, G., & Rost, B. (2006). Epitome: database of 
structure-inferred antigenic epitopes. Nucleic Acids Research, 34, D777–D780. 
doi:10.1093/nar/gkj053 
Selwyne, R. A., Kholmurodov, K. T., & Koltovaya, N. A. (2011). Homology modelling 
and molecular dynamics of cyclin-dependent protein kinases. In S. H. Rao (Ed.), IT 
for Real World Problems (pp. 1–72). University Press (India). 
Shehu, A., & Kavraki, L. E. (2012). Modeling structures and motions of loops in protein 
molecules. Entropy, 14, 252–290. 
Sievers, F., Wilm, A., Dineen, D., Gibson, T. J., Karplus, K., Li, W., … So, J. (2011). 
Fast, scalable generation of high-quality protein multiple sequence alignments 
using Clustal Omega. Molecular Systems Biology, 7(539). 
Simons, K. T., Strauss, C., & Baker, D. (2001). Prospects for ab initio protein structural 
genomics. Journal of Molecular Biology, 306, 1191–1199. 
Smith, T. F., & Waterman, M. S. (1981). Identification of common molecular 
subsequences. Journal of Molecular Biology, 147, 195–197. 
Sobrino, F., Saiz, M., Jimenez-Clavero, M. A., Nunez, J. I., Rosas, M. F., Baranowski, 
E., & Ley, V. (2001). Foot-and-mouth disease virus: a long known virus , but a 
current threat. Veterinary Research, 32, 1–30. 
Soon, W. W., Hariharan, M., & Snyder, M. P. (2013). High-throughput sequencing for 
biology and medicine. Molecular Systems Biology, 9, 640–654. 
Spackman, K. A. (1989). Signal detection theory: Valuable tools for evaluating inductive 
learning. In Sixth International Workshop on Machine Learning (pp. 160–163). San 
Mateo, California: Morgan Kaufman. doi:10.1016/b978-1-55860-036-2.50047-3 
Srinivasan, S., March, C. J., & Sudarsanam, S. (1993). An automated method for 
modeling proteins on known templates using distance geometry. Protein Science, 
 202 
2(2), 277–289. 
Stanway, G. (1990). Structure, function and evolution of Picornaviruses. Journal of 
Virology, 71, 2483–2501. 
Strebel, K., & Beck, E. (1986). A second protease of foot-and-mouth disease virus. 
Journal of Virology, 58(3), 893–899. 
Sun, J., Wu, D., Xu, T., Wang, X., Xu, X., Tao, L., … Cao, Z. W. (2009). SEPPA : a 
computational server for spatial epitope prediction of protein antigens. Nucleic 
Acids Research, 37, 612–616. doi:10.1093/nar/gkp417 
Sun, P., Ju, H., Liu, Z., Ning, Q., Zhang, J., Zhao, X., … Li, Y. (2013). Bioinformatics 
resources and tools for conformational B-Cell epitope prediction. Computational 
and Mathematical Methods in Medicine, 2013. doi:10.1155/2013/943636 
Sweredoski, M. J., & Baldi, P. (2008). PEPITO: improved discontinuous B-cell epitope 
prediction using multiple distance thresholds and half sphere exposure. Structural 
Bioinformatics, 24(12), 1459–1460. doi:10.1093/bioinformatics/btn199 
Swets, J. A. (1988). Measuring the accuracy of diagnostic systems. Science, 240, 
1285–1293. doi:10.1126/science.3287615 
SWISS-MODEL. (2006). Retrieved May 26, 2014, from http://swissmodel.expasy.org/ 
Taylor, W. R., Thornton, J. M., & Turnell, W. G. (1983). An ellipsoidal approximation of 
protein shape. Journal of Molecular Graphics, 1, 30–38. doi:10.1016/0263-
7855(83)80001-0 
Thomas, A. A. M., Woortmeijer, R. J., Puijk, W., & Barteling, S. J. (1988). Foot-and-
Mouth Disease Virus Type A10. Journal of General Virology, 62(8), 2782–2789. 
Thomson, G. R. (1995). Overview of foot-and-mouth disease in Southern Africa. Review 
of Science and Technology (International Office of Epizootics), 14(3), 503–520. 
Thornton, J. M., Edwards, M. S., Taylor, W. R., & Barlow, D. J. (1986). Location of 
“continuous” antigenic determinants in the protruding regions of proteins. European 
Molecular Biology Organization Journal, 5(2), 409–413. 
Unger, R., Harel, D., Wherland, S., & Sussman, J. L. (1989). A 3D building blocks 
approach to analyzing and predicting structure of proteins. Proteins, 5(4), 355–373. 
Usherwood, E. J., & Nash, A. A. (1995). Lymphocyte recognition of picornaviruses. 
Journal of General Virology, 76, 499–508. doi:10.1099/0022-1317-76-3-499 
Valdazo-González, B., Knowles, N. J., Hammond, J., & King, D. P. (2012). Genome 
sequences of SAT2 foot-and-mouth disease viruses from Egypt and Palestinian 
Autonomous Territories (Gaza Strip). Journal of Virologyirology, 86(16), 8901–
8902. doi:10.1128/JVI.01231-12 
 203 
VanGunsteren, W. F., & Brendsen, H. J. C. (1977). Algorithms for macromolecular 
dynamics and constraint dynamics. Molecular Physics, 34, 1311–1327. 
Virella, G. (2001). Antigen-antibody reactions. In G. Virella (Ed.), Medical Immunology 
(5th ed., pp. 140–160). CRC Press. 
Vosloo, W., Knowles, N. J., & Thomson, G. R. (1992). Genetic relationships between 
southern African SAT-2 isolates of foot-and-mouth-disease virus. Epidemiology and 
Infection, 109, 547–558. 
Vyas, V. K., Ukawala, R. D., Ghate, M., & Chintha, C. (2012). Homology modeling a fast 
tool for drug discovery: current perspectives. Indian Journal of Pharmaceutical 
Sciences, 74(1), 1–17. 
Weber, S., Granzow, H., Weiland, F., & Maruardt, O. (1996). Intracellular membrane 
proliferation in E. coli induced by foot-and-mouth disease virus 3A gene products. 
Virus Genes, 12, 5–14. 
Wu, T. T., & Kabat, E. A. (1970). An analysis of the sequences of the variable regions of 
Bence Jones proteins and myeloma light chains and their implications for antibody 
complementarity. Journal of Experimental Medicine, 132, 211–250. 
Xiang, W., Andino, A. V., & Wimmer, E. (1997). RNA signals in entero- and rhinovirus 
genome replication. Sem. Virology, 8, 256–273. 
Xie, Q. C., McCahon, D., Crowther, J. R., Belsham, G. J., & McCullough, K. C. (1987). 
Neutralization of foot-and-mouth disease virus can be mediated through any of at 
least three separate antigenic sites. Journal of General Virology, 68, 1637–1647. 
Zhang, C. (1997). Relations of the numbers of protein sequences, families and folds. 
Protein Engineering, 10(7), 757–761. 
Zhang, H. (2002). Protein Tertiary Structures : Prediction from Amino Acid Sequences. 
In Encyclopaedia of Life Sciences. 
Zhang, Y., Kolinski, A., & Skolnick, J. (2003). Touchstone II: A New Approach to Ab 
Initio Protein Structure Prediction. Biophysical Journal, 85(2), 1145–1164. 
Zhao, L., Wong, L., Lu, L., Hoi, S., & Jinyan, L. (2012). B-cell epitope prediction through 
a graph model. Biomed Central Bioinformatics, 13(Suppl 17). doi:10.1186/1471-
2105-13-S17-S20 
 
